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ABSTRACT 
 
This thesis reports a series of laboratory and clinical studies designed to investigate the acute 
effect of surgical palliation on ventricular function in children with functionally single ventricle 
anatomy. Ventricular volume and pressure were measured using a combined pressure-
conductance catheter.  
Initial laboratory-based experiments were performed using a physical model of the left ventricle, 
which allowed examination of the measurement techniques used in the clinical studies but under 
controlled conditions. These experiments identified a non-linear conductance-absolute volume 
relationship and demonstrated for the first time that the calibration coefficient, αSV produced a 
significant, volume-dependent measurement error. These experiments also demonstrated that 
conductance volume measurements were adversely influenced by other electrical signals. The 
ventricular electrogram produced clinically important measurement error that has not previously 
been described..  
Two clinical studies were then undertaken to investigate the separate effects of the bidirectional 
cavo-pulmonary anastomosis (BCPA) and the completion total cavo-pulmonary connection 
(TCPC). These studies represent the core of the thesis. Both procedures were associated with 
significant changes in the pressure and volume conditions of the dominant ventricle. In addition, 
the BCPA was associated with a substantial and immediate improvement in ventricular systolic 
function but this was accompanied by an increase in diastolic chamber stiffness. By contrast, the 
TCPC was not associated with a significant change ventricular systolic or diastolic function in 
spite of the changes in ventricular load. Comparable changes were observed in patients with a 
dominant ventricle of either left or right ventricular morphology.  
These studies provide a more detailed understanding about the acute events that accompany 
surgical palliation in children with functionally single ventricle anatomy. These findings confirm 
the validity of staged surgical palliation in the management of these children. 
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CHAPTER 1. GENERAL OVERVIEW 
 
Congenital heart disease is the single most common form of birth defect, which affects 
approximately 1% of all children born in the United Kingdom. The term functionally single ventricle 
anatomy refers to a heterogeneous group of complex heart malformations, in which one of the 
two ventricular chambers is either absent or severely underdeveloped. These heart defects 
preclude the establishment of a normal, biventricular circulation because the hypoplastic 
ventricular cavity is unable to support either the systemic or the pulmonary circulation. 
Without surgical intervention, children with functionally single ventricle anatomy have a very 
poor prognosis. Long-term survival is dependent on a series of palliative operations, which 
culminate in the Fontan procedure. This procedure involves the direct connection of the central 
veins to the central pulmonary arteries, which creates a circulation in which the systemic and 
pulmonary circulations are connected in series, without an intervening ventricle. The single 
ventricle acts as a systemic ventricle only while blood flow through the pulmonary circulation is 
maintained by the venous pressure in the systemic veins. 
The successful management of functionally single ventricle anatomy is thus fundamentally 
dependent on the performance of the dominant ventricle. Unfortunately, the children with 
functionally single ventricle anatomy are characterised by abnormal circulatory haemodynamics, 
which change during the course of surgical palliation. These abnormal circulatory 
haemodynamics may profoundly influence the performance of the ventricle and hence could 
potentially influence the clinical outcome of children with functionally single ventricle anatomy. 
For that reason, accurate measurements of cardiac volume, pressure and blood flow are critically 
important to allow a comprehensive evaluation of changes in ventricular function that may 
accompany each stage of surgical palliation and the subsequent post-operative period. 
The main purpose of the experimental and clinical studies described in this thesis was to measure 
critical indices of ventricular performance to help determine the effect of surgical palliation in 
children with functionally single ventricle anatomy. As a necessary framework to these studies, 
Chapter 1 
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Chapter 2 traces the history of present knowledge and basic physiology of normal cardiac 
function and its assessment together with an outline of congenital heart disease. This is followed 
in Chapter 3 by a detailed consideration of the methods that have been used to measure cardiac 
function in man for the assessment of pressure, volume and flow within the heart. This leads to 
the aims and objectives of the subsequent investigations.  
The results of the research are described in four separate chapters. In order to gain a more 
accurate assessment of ventricular performance in children with functional single ventricle 
anatomy, a pressure-conductance catheter was used to invasively measure the intraventricular 
pressure and volume. This is the first clinical study that has used this catheter in these children. 
Therefore, the performance of this catheter was thoroughly investigated in a series of laboratory-
based experiments using different sized balloons to simulate the functional single ventricle. The 
results of these experiments are described in Chapters 4 and 5. The final two results chapters 
describe the use of the pressure-conductance catheter in two separate clinical studies. These 
studies were designed to investigate the changes in ventricular function that accompany two 
surgical procedures performed at Birmingham Children‟s Hospital. 
The overall aim of this thesis was to provide important new information about ventricular 
function and the effects of surgical palliation in children with functionally single ventricle 
anatomy. This information may help inform the post-operative care of these children as well as 
establishing a benchmark for any subsequent investigation. 
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CHAPTER 2. GENERAL INTRODUCTION 
 
2.1 NORMAL CARDIOVASCULAR SYSTEM 
The normal adult human cardiovascular system consists of two separate circulations, the systemic 
circulation and pulmonary circulation. The systemic circulation delivers oxygenated blood to the 
organs of the body. The pulmonary circulation transports blood to the lungs for gas exchange 
with oxygen uptake and release of carbon dioxide. The two circulations are connected in series; 
blood flows through the systemic circulation then the pulmonary circulation before returning to 
the systemic circulation, Figure 2.1 [1]. Blood flow is maintained by the function of the heart, 
which acts as an integral pump within the cardiovascular system. In particular, intermittent 
contraction of the left ventricle supports blood flow through the systemic circulation and 
synchronous contraction of the right ventricle supports blood flow through the pulmonary 
circulation.  
 
Figure 2.1 Schematic illustration of the normal cardiovascular system. This includes the heart together with the 
arteries, veins and capillaries that form both the systemic and pulmonary circulations.  Reproduced from 
http://academic.kellogg.cc.mi.us/herbrandsonc/bio201_McKinley/f22-1_cardiovascular_sy_c.jpg 
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The normal human heart consists of four separate chambers and two arterial trunks that are 
connected sequentially. The left atrium connects to the left ventricle through the mitral valve and 
the left ventricle is connected to the aorta through the aortic valve. Oxygenated pulmonary 
venous blood flows from the pulmonary veins through the left atrium, left ventricle and then into 
the aorta (the systemic circulation). Similarly, the right atrium connects to the right ventricle 
through the tricuspid valve and the right ventricle is connected to the pulmonary trunk through 
the pulmonary valve. Deoxygenated systemic venous blood flows from the superior and inferior 
vena cavae into the right atrium, right ventricle and then into the pulmonary trunk (the 
pulmonary circulation), Figure 2.2 [1]. 
 
Figure 2.2 Schematic illustration of the inside of the normal human heart, including the four chambers, four 
valves and two outflow tracts. The arrows indicate the direction of blood flow through the heart. Reproduced from 
http://www.nhlbi.nih.gov/health/dci/images/heart_interior.gif.  
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2.2 THE PUMP FUNCTION OF NORMAL MYOCARDIUM 
The ability of the heart to function as a pump is determined, firstly, by events at the level of the 
individual cardiac myocyte and, secondly, by how these myocytes function together within the 
cardiac chambers.  
2.2.1 Cardiac myocyte anatomy 
The myocardium of the mammalian heart consists of a three-dimensional branching network of 
myocytes embedded within a supporting connective tissue matrix [2,3]. The myocytes are 
organised into bundles, called myofibres that are arranged in a series of layers around the 
chambers of the heart [2,3]. The myocytes are connected end to end with one another by 
specialised domains within the plasma membrane, called intercalated discs. Intercalated discs 
mediate electrical and structural coupling between adjacent cells [4], allowing the myocardium to 
operate as a functional syncitium.  
2.2.2 The sliding filament model of contraction 
The sarcomere represents the fundamental contractile unit within the myocyte. Each sarcomere is 
composed of two sets of parallel and partly overlapping filaments. The thin filaments are 
composed mainly of actin and the thick filaments are made of myosin. During muscle 
contraction, the actin filaments at each end of the sarcomere slide between the myosin filaments 
towards the middle of the sarcomere. Consequently, the sarcomere shortens without any change 
in the lengths of the filaments themselves. This is known as the sliding filament model of 
contraction [5,6].  
The force produced by myocyte contraction is dependent on a number of factors, including the 
length of the sarcomere [7]. In isolated cardiac muscle preparations, there is a rapid rise in the 
active force developed as the sarcomere length is increased from 1.8µm to 2.2µm, Figure 2.3. The 
force developed then declines rapidly as the sarcomere length is increased beyond 2.2 µm.  
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Figure 2.3 The relation between tension development and sarcomere length in cat papillary muscle. The relation in 
skeletal muscle fibres has been superimposed for comparison. Reproduced from Sonnenblick & Skelton [7]. 
Most of the features observed in Figure 2.3 can be accounted for by the sliding filament model of 
contraction [8]. Maximum force is developed when sarcomere length produces optimum overlap 
of filaments, as this enables maximal cross-bridge formation. The decreased force generated at 
smaller lengths has been attributed to progressive penetration of the thin filaments across the 
midline and into the other half of the sarcomere. These additional thin filaments causes a steric 
interference of the normal thick-thin filament interaction, which inhibits cross-bridge formation 
[9]. The decreased force generated at higher sarcomere lengths occurs because there are a 
diminishing number of potential sites for cross-bridge formation.  
2.2.3 Myocardial function in isolated muscle preparations 
Much of our understanding about the mechanical behaviour of the heart has been obtained from 
in vitro experiments with isolated cardiac muscle specimens. The muscle specimen, placed in an 
oxygenated physiologic saline solution, is suspended within a myograph that allows simultaneous 
measurements of the tension and length of the muscle [8]. A simplified diagram of the myograph 
is illustrated in Figure 2.4. The lower end of the muscle is attached to a strain gauge and the 
upper end is connected to an isotonic lever. A series of weights can be attached to the other end 
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of the lever. This mechanical load is subdivided into preload and afterload. The term preload 
describes the small load that stretches the quiescent muscle to an initial pre-contracted length. A 
mechanical stop above the lever prevents further stretching of the muscle if additional load is 
added to the lever. This additional load is termed afterload and is only encountered by the muscle 
when it attempts to shorten. The muscle is then activated with a suprathreshold electrical 
stimulus. Contracting muscle may develop a force without shortening; shorten at various 
velocities; or may lengthen if the load is greater than the force that the muscle can generate.  
 
Figure 2.4 Diagrammatic illustration of the myograph. The papillary muscle is suspended in a physiological bath 
(not shown). The lower end of the papillary muscle is attached to a tension transducer and the upper end is attached 
to a lever system, which is free to move. The fulcrum of the lever system is shown on the right. Load (preload and 
afterload) is placed on the opposite end of the lever. The mechanical „stop‟ limits lever movement and thus 
determines the maximal length of the muscle specimen. Reproduced from Braunwald et al. [10], pp. 45. 
In isolated muscle preparations, the output of a muscle is described by three interrelated and 
interdependent variables, namely tension, length and time. The analysis of muscle performance is 
simplified by experimentally holding one variable constant and determining the relationship 
between the other two variables. This approach yields two types of muscle contraction: isometric 
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(same length) and isotonic (same tension) contraction. Analysis of these two types of contraction 
allows a complete evaluation of the mechanical properties of isolated muscle. 
Most of the original studies that investigated the behaviour of isolated cardiac muscle were 
performed with isolated papillary muscles obtained from the right ventricle of the cat. The 
muscle fibres in the feline papillary muscle are arranged in a longitudinal, parallel fashion. These 
muscles are also sufficiently thin to allow oxygen diffusion in vitro, thus avoiding potentially 
deleterious hypoxic damage to the muscle specimen under experimental conditions [9]. However, 
the muscle fibres do not have the geometric complexity observed in the intact ventricle. 
2.2.3a Isometric contraction and the length-tension relationship 
During isometric contraction, the muscle is stretched to a chosen resting length and both ends 
are then fixed. This prevents any external shortening of the muscle. When stimulated, the muscle 
develops tension, which rises to a peak before returning to the quiescent level [11]. The maximal 
tension and time to peak tension developed during isometric contraction are primarily influenced 
by changes in either the resting muscle length or the level of inotropy [11]. 
The length-tension curve provides a more complete description of the relationship between 
muscle length and tension in isolated muscle [11,12]. This curve is obtained by measuring the 
muscle tension, both at rest and during isometric contraction, as the resting muscle length is 
increased. The force generated by contraction (active tension) represents the difference between 
total tension and resting tension. Typical length-tension curves from feline papillary muscle are 
shown in Figure 2.5. In this example, the starting length, L0 was defined as the muscle length 
where resting tension was zero and active tension was approximately zero [12]. 
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Figure 2.5 Length-tension relation of cat papillary muscle. Total tension = resting (or passive) plus active (or 
developed) tension. Reproduced from Sonnenblick et al. [12]. 
 Active length-tension relationship 
In cardiac muscle, like all forms of striated muscle, the force generated during isometric 
contraction varies as a function of muscle length. There is a rise in active tension as muscle 
length is increased from L0. Active tension reaches a maximum when the resting muscle length is 
increased by approximately 45%. This muscle length, Lmax marks the apex of the active length-
tension curve. Further increases in muscle length are associated with a decline in active tension. 
Active tension developed is almost zero when the resting muscle length is increased by 
approximately 100% (Figure 2.5) [12]. By convention, the active length-tension relation is 
described as two separate parts; the active length-tension relation between L0 and Lmax is called 
the ascending limb of the curve while the relation beyond Lmax is termed the descending limb of 
the curve [13]. 
Under physiological conditions, the myocardium normally functions only on the ascending limb 
of the active length-tension relation [12]. The upper limit of end-diastolic pressure in the normal 
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heart is about 12 mmHg. This pressure corresponds with a sarcomere length of 2.2μm [14], the 
sarcomere length at which active tension is maximal. Therefore, in the intact heart, increasing 
muscle length produces a greater force of contraction. This relationship forms the basis of the 
Frank-Starling law [15,16] in which, “the larger the diastolic volume of the heart … the greater is 
the energy of its contraction” [16].  
 Resting length-tension relationship 
The resting length-tension curve in cardiac muscle is characterised by a non-linear length-tension 
relation, Figure 2.5. The resting tension is zero at L0 [13] but rises exponentially as the muscle 
length is increased [17]. As a result, resting tension contributes between 15 to 50% of the total 
muscle tension at Lmax [7,18].  
The relatively high resting tension in cardiac muscle is due to passive elastic elements within the 
heart muscle [19]. These include collagen and elastin fibres found primarily in the extracellular 
matrix of the myocardium [18,20] but also ultrastructural components within the myocyte [21]. 
These passive elastic elements prevent excessive lengthening of cardiac muscle and ensure that 
the cardiac muscle operates on the ascending limb of the length-tension relation under 
physiological conditions [22].  
2.2.3b Isotonic contraction and the force-velocity relationship 
The complete assessment of the mechanical properties of cardiac muscle involves the analysis of 
muscle shortening and shortening velocity, as well as the force-generating characteristics of the 
muscle. The shortening characteristics are measured during isotonic contraction.  
During simple isotonic contraction, one end of the muscle is fixed while the other end is attached 
to the mobile isotonic lever. Preload attached to the other end of the lever determines the initial 
muscle length. Stimulation causes the muscle shortens to a minimum length (ΔL) before 
elongating to the resting length. The shortening velocity (dl/dt, v) rises to a peak during early 
contraction and then declines as shortening ensues. The muscle tension remains constant 
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throughout simple isotonic contraction [23]. When afterload is also added to the lever 
(afterloaded isotonic contraction), the muscle must initially contract isometrically until the muscle 
tension equals the total load (P, i.e. preload plus afterload), after which isotonic muscle 
shortening can begin [11]. Increments in afterload are associated with a delay in the time to peak 
velocity and a progressive fall in both the peak velocity and extent of shortening. 
There is an inverse relationship between the velocity of shortening and the total load, as 
illustrated in the force-velocity curve (Figure 2.6). When the afterload is increased until no 
shortening occurs, the maximum isometric tension (P0) is developed. As the load is reduced, 
there is a progressive increase in the shortening velocity, which is greatest when the load is 
smallest. The velocity of shortening at zero load (unloaded shortening, vmax) cannot be measured 
directly but can be estimated by extrapolation of the force-velocity curve to zero load. The 
parameters, P0 and vmax define the limits for a given force-velocity curve and reflect the 
contractile properties of the muscle specimen [11].  
In cardiac muscle, the force-velocity relation is not fixed but varies with changes in the initial 
muscle length (i.e. preload) and the level of inotropy. Increments in the initial muscle length are 
accompanied by an increase in P0 and a rise in the shortening velocity at each individual load. 
This results in a rightward shift in the force-velocity curve. However, vmax remains essentially 
unchanged. By contrast, inotropic stimuli are associated with an increase in both P0 and vmax. 
This, in turn, results in a rightward and upward shift in the force-velocity curve [11].  
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Figure 2.6 Force-velocity relations obtained during afterloaded isotonic contractions. A, Velocity of shortening is 
plotted as a function of load. As the load increases, the velocity of shortening decreases. When velocity is zero, the 
force is equivalent to the isometric contraction (P0). When the curve is extrapolated to zero load, vmax is obtained.  
B and C, Power and work are shown as a function of increasing afterload. Power and work are zero at both zero 
load and isometric contraction; both peak at an intermediate load. Reproduced from Braunwald et al. [10], pp. 
45. 
Sonnenblick proposed that vmax may represent an index of cardiac contractility, since it was 
apparently unchanged by changes in preload but was altered by changes in the contractile state 
[11]. However, the number of assumptions and uncertainties involved in the calculation has 
limited the value of vmax in routine practice [24]. In addition, it has been demonstrated that vmax 
varies somewhat with preload and the model used to calculate it [24,25].  
In addition to the assessment of contractile properties, force-velocity relation obtained from 
afterloaded isotonic contractions allow quantification of work and rate of work, i.e. power 
produced by the heart muscle (Equations 2.1 and 2.2, respectively).  
Equation 2.1 PLWork  
Equation 2.2  PvPower   
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For a given muscle length in a constant physicochemical environment, work and power vary as a 
function of the total load (Figure 2.6). Work increases with increasing afterload and reaches a 
peak at a load approximately 40% of P0. Further increases in afterload result in a decline in work, 
which is zero when the load is too great to allow shortening. Increases in preload and inotropy 
are associated with an increase in maximal work and the load at which maximal work was 
performed. However, the shape of the workload curve remains essentially unchanged. Work per 
contraction is thus a complex function of the initial muscle length, the load and the force-velocity 
curve on which the muscle operates. A similar relationship also exists for muscle power  
(Figure 2.6). 
2.3 MYOCARDIAL FUNCTION IN THE INTACT HEART 
Early studies of cardiac function attempted to extrapolate the behaviour of isolated cardiac 
muscle to the function of the intact heart as a whole [26,27]. However, the complex three-
dimensional arrangement of muscle fibres [3] means that it is very difficult to accurately measure 
the tension or length of individual myofibres within the ventricular mass [28]. For example, the 
length of the sarcomere also varies according to the position within the ventricular wall; 
sarcomeres in the subendocardial layer are generally longer than those in the subepicardial layer 
[29]. In addition, the normal pattern of ventricular contraction is characterised by marked 
regional heterogeneity, with more pronounced deformation and wall motion in the left 
ventricular free wall than the interventricular septum [30]. These factors have limited the 
applicability of the length-tension relation to the assessment of ventricular function, particularly 
the assessment in vivo.  
2.3.1 Changes in ventricular pressure and volume in the intact heart 
At the turn of the twentieth century, Frank established the basis of modern cardiodynamics [28]. 
He postulated that the performance of the ventricle could be defined, like a mechanical pump, by 
changes in pressure, volume and flow within the ventricle [31]. This approach involves the 
assessment of the ventricle as a system rather than the analysis of the individual muscle properties. 
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However, the two approaches are interrelated. Ventricular volume (V) varies as a function of the 
dimensions of the heart (i.e. radius) and, by extension, the sarcomere length [32]. Similarly, the 
intraventricular pressure is related to wall tension by Laplace‟s law (Equation 2.3).  
Equation 2.3 
r
hT
P
2
 
where P is the intraventricular pressure; T is wall tension; h is the ventricular wall thickness; and r 
is the radius of the spheroid.  
2.3.1a Changes in ventricular pressure 
In a series of experiments using isolated, perfused ranine hearts, Frank recorded the active and 
passive pressure within the frog ventricle during isovolumic and isobaric contractions [15]  
(Figure 2.7). The passive intraventricular pressure increased with increments in the ventricular 
volume (Figure 2.7A). There was a progressive rise in the isovolumic pressure as the ventricular 
volume is increased (curves 1 – 6; Figure 2.7A). However, beyond a certain level of filling, the 
isovolumic pressure declined (curves 3 – 4; Figure 2.7B). 
 
Figure 2.7 Effect of increasing initial filling on the isovolumic pressure curve. A, The peak isovolumic pressure 
and passive pressure both increased with increments in initial filling. B, Beyond a certain level of filling, peak 
isovolumic pressure declined. Reproduced from Zimmer [33].   
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2.3.1b Changes in the pressure-volume relations of the intact heart 
Frank devised a schematic diagram to characterise contractions of the frog ventricle in a 
pressure-volume diagram [28] (Figure 2.8). The top curve, labelled “Isomet. maxima” represents 
the peak pressure developed during isovolumic contraction at various ventricular volumes. Frank 
called this curve the maximal isometric pressure curve, although we now know that the wall fibre 
length is not constant during isovolumic contraction [34]. The maximal pressure curve rises 
rapidly with the increase in volume. Beyond a certain volume, the curve levels off and then falls 
to a final point where it meets the passive pressure-volume curve (“Isomet. minima”). These two 
curves are equivalent to the active and passive length-tension curves obtained in isolated muscle 
specimens, as previously described (Figure 2.5).  
 
Figure 2.8 Schematic pressure-volume diagram based on data observed in the isolated frog ventricle. The 
“isometrische minima” reflects the pressure-volume curve of the resting ventricle. The “isometrische maxima” and 
“isotonische maxima” reflects the active pressure-volume curves during isovolumic and isotonic contractions, 
respectively.  Reproduced from Sagawa et al. [35], pp 8. 
Chapter 2 
- 16 - 
Frank also demonstrated that the pressure-volume curve obtained during isobaric contraction 
(“Isoton. maxima”) was quite different from the isovolumic pressure-volume curve (Figure 2.8). 
The maximal isobaric pressure-volume curve is positioned to the right of the isovolumic 
pressure-volume curve. While both curves are non-linear, the maximal isobaric pressure-volume 
curve is less curvilinear than the corresponding isovolumic pressure-volume curve.  
As will be discussed in more detail in the following section, left ventricular contraction in vivo 
begins with an isovolumic phase and becomes quasi-isobaric during the ejection phase. Frank 
inferred that the end-systolic points of physiological ventricular contraction would be found on a 
line somewhere in the area bounded by the isovolumic and isobaric pressure-volume curves. The 
“Unterstütz. Z.” curve represents one possible example of the end-systolic pressure-volume 
curve that may be obtained (Figure 2.8).  
The end-systolic pressure-volume curve, together with the passive pressure-volume curve, 
defines the limits of the pressure-volume diagram of the ventricle under constant 
physicochemical conditions [35]. Frank included the pressure-volume diagram of an engine 
(points a – d; Figure 2.8) to illustrate this concept. During filling of the ventricle (points d – a), 
Frank assumed that the pressure and volume within the ventricle would follow the passive 
pressure-volume curve (“Isomet. minima”). During contraction, the ventricle would undergo 
periods of pressure generation (points a – b) and change in volume (points b – c). Frank 
concluded that, at the end of these processes, the pressure and volume would lie at some point 
along the end-systolic pressure-volume relation (“Unterstütz. Z.”). The ventricle would then 
undergo a period of pressure decline (points c – d) before filling resumed. 
Volume measurements were originally obtained using a cardiometer, in which the heart was 
hermetically sealed in a cup. Changes in the air pressure within the cup reflected changes in the 
ventricular volume. In 1955, Katz described an improved cardiometer that allowed more accurate 
measurements, so that the ventricular volume could be measured throughout the cardiac cycle 
[36]. This demonstrated that the shape of the pressure-volume loop in the normal left ventricle 
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has a characteristic quadrilateral shape (Figure 2.9), which is qualitatively similar to the pressure-
volume diagram from an engine, which Frank had used to express the stroke work.  
 
 
Figure 2.9 Pressure-volume loop diagrams obtained in the canine left ventricle before and after norepinephrine 
infusion. Reproduced from [36]. 
During the early part of the twentieth century, the studies of Frank were re-examined by a 
number of separate groups [36-44]. The studies of Sulzer [39] and Reichel & Kapel [40] identified 
comparable results in the isolated ranine ventricle. Studies in the canine ventricle were also 
broadly similar. The end-systolic pressure-volume relation also remained essentially linear over 
the physiological range [43,45]. Furthermore, these studies did not find wide separation between 
the end-systolic pressure-volume curves of isovolumic and ejecting contractions. As an 
approximation, the two curves could be superimposed on top of one another [46]. This is in clear 
contrast with the studies in the isolated frog ventricle.  
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2.4 THE NORMAL CARDIAC CYCLE 
The cardiac cycle defines the period from the beginning of one heartbeat to the beginning of the 
next heartbeat. Each cycle consists of a complex sequence of electrical and mechanical events 
that determine the characteristic pattern of pressure and volume within each cardiac chamber, as 
well as well as the timing of heart sounds and murmurs [47]. A comprehensive illustration of the 
changes that occur during the cardiac cycle is shown in Figure 2.10, in which the surface 
electrocardiogram (ECG) serves as a useful time reference [48].  
2.4.1 Electrical activity and the electrocardiogram 
Each cycle begins with the rhythmic, automatic generation of action potentials within the sino-
atrial (SA) node. The sino-atrial node, lying in the terminal groove formed between superior vena 
cava (SVC) and the right atrium [49], acts as the natural pacemaker for the mammalian heart [50]. 
Action potentials generated in the sino-atrial node to spread rapidly across the atria and results in 
the almost simultaneous contraction of the right and left atria. Electrical activity then spreads to 
the ventricle through the atrio-ventricular (AV) node [49]. The atrio-ventricular node produces a 
short temporal delay in the wave of depolarisation (approximately 150 – 200 ms), which ensures 
that atrial contraction precedes ventricular activation. After the short delay, the wave of activation 
passes rapidly along the His-Purkinje system and results in the coordinated depolarisation of the 
left ventricle and, shortly thereafter, the right ventricle [51,52].  
The overall pattern of electrical depolarisation and subsequent repolarisation within the heart can 
be non-invasively recorded using pairs of electrodes positioned on the skin surface. The typical 
ECG consists of a P wave, QRS complex and T wave that correspond with atrial depolarisation, 
ventricular depolarisation and ventricular repolarisation, respectively. The PR interval equates to 
the time delay between atrial and ventricular excitation and the RT interval corresponds to the 
ventricular action potential duration (Figure 2.10). This normal pattern of electrical excitation 
may be altered in patients with congenital heart disease [53].  
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Figure 2.10 Events in the normal human cardiac cycle. From top to bottom, pressure in the aorta, left ventricle 
and left atrium; heart sounds; pressure in the pulmonary artery, right ventricle and right atrium; blood flow in the 
aorta and pulmonary artery; and ECG. Valve opening and closure for the aortic valve are indicated by AO and 
AC, respectively; MO and MC for the mitral valve; PO and PC for the pulmonary valve and TO and TC for the 
tricuspid valve. Reproduced from Milnor [48], pp. 112. 
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2.4.2 Mechanical events within the cardiac cycle 
The ventricular cycle consists of two separate phases; an active contraction phase called systole 
followed by a filling phase called diastole [54]. Three distinct definitions of systole and diastole 
have been proposed [45,47,55], which can be differentiated from one another primarily according 
to the definition of end-systole.  
Wiggers defined systole as the period that begins with the rise in ventricular pressure and ends 
with the, “cessation of tension development”, which occurred during the finite period 
immediately preceding closure of the semi-lunar valve. This point could conveniently be 
identified by the end of ejection [47].  
Brutsaert et al. proposed an alternative definition, in which systole was extended to include the 
period of active ventricular relaxation (i.e. isovolumic relaxation phase and period of rapid 
ventricular filling). Accordingly, diastole was limited to the period when the ventricle was 
completely relaxed (i.e. diastasis and atrial filling only) [55]. This definition was based on the 
observation that early muscle relaxation is load-dependent, just as muscle function during 
contraction is load-dependent. Nevertheless, this definition is not suitable for studying 
contractility using the end-systolic pressure-volume relation approach that will be discussed in the 
following sections. 
For the purposes of this thesis, I have used the definition of systole proposed by Suga et al. This 
definition, like Wiggers‟ definition, considered systole as a phase of active force development 
[45]. However, Suga et al. defined end-systole as the period where force of contraction (or 
elastance) is maximal rather than the end of ejection. Elastance (E) was defined by the 
incremental pressure-volume ratio of the ventricle (dP/dV), Equation 2.4:  
Equation 2.4 dVdPE  
Elastance represents the reciprocal of the ventricular compliance (dV/dP).  
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In the normal left ventricle, the end of ejection and end-systole occur effectively simultaneously 
[56]. However, changes in the pressure loading conditions loading can alter the relative timing of 
these two events; a rise in afterload causes ejection to end relatively early and vice versa. By 
contrast, end-systole remains relatively constant [57,58]. 
2.4.2a Normal left ventricular cycle 
In the left ventricle (LV), there is a rapid rise in pressure (LVP) following ventricular excitation 
(i.e. the QRS complex on the ECG). When LVP exceeds the pressure in the left atrium (LAP), 
the mitral valve closes and the isovolumic contraction phase begins. As the name suggests, this phase is 
not associated with any change in the intraventricular volume as both mitral and aortic valves are 
closed. Isovolumic contraction in vivo is considered broadly equivalent to isometric contraction 
in vitro [34].  
When LVP rises above aortic blood pressure (AoP), the aortic valve opens and blood is rapidly 
ejected from the ventricle into the aorta (ejection phase). Approximately 70% of ejection occurs 
during the initial third of the ejection phase. Ventricular pressure rises to a peak and then declines 
with a reduction in the rate of ejection. During the latter part of ejection, the momentum of 
blood maintains forward flow into the aorta, even though LVP may be slightly lower than AoP. 
Eventually, LVP falls more sharply and the aortic valve closes.  
Closure of the aortic valve is followed by the isovolumic relaxation phase, during which there is no 
change in the intraventricular volume. When LVP falls below LAP, the mitral valve opens and 
the ventricle begins to fill (filling phase). During the initial period of filling, LVP continues to fall as 
the ventricular volume increases. This reflects the effects of continued active relaxation, which 
produce a „suction‟ effect that actively fills the ventricle [59,60].  This period of rapid ventricular 
filling lasts for approximately the first third of diastole and accounts for most of ventricular filling 
[61]. The middle third is characterised by a very small flow of blood into the ventricles as blood 
continues to drain from the central veins into the atria (diastasis). Atrial systole occurs during the 
final third of ventricular diastole and this is accompanied by a secondary increase in the rate of 
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ventricular filling. During the filling phase, the ventricular volume is increased from the end-
systolic residual volume to the end-diastolic volume, in preparation for the next ventricular cycle.  
The length of ventricular diastole and systole vary with heart rate. At a resting heart rate of 75 
beats per minute, diastole occupies approximately two thirds of the cardiac cycle. Both periods 
shorten at faster heart rates, but the effect upon diastole is proportionately greater. 
2.4.2b Normal right ventricular cycle 
The changes that occur in the normal right ventricle (RV) are qualitatively similar to the changes 
that occur in the LV (Figure 2.10). However, there are important differences, which primarily 
reflect differences in the pressure loading characteristics of the two ventricles [62]. In the left and 
right ventricles, the rate of pressure rise (dP/dt) at the start of contraction is essentially the same. 
However, since pulmonary artery pressure (PAP) is approximately one-fifth the level of aortic 
pressure, ejection commences earlier in the RV. The isovolumic contraction time in the RV is 
correspondingly shortened. Similarly, the low hydraulic impedance of the normal pulmonary 
circulation means that the RV continues to eject for a considerable time after right ventricular 
pressure begins to decline [63,64]. In the LV, by comparison, the end of ejection and end-systole 
are effectively simultaneous [56].  
2.4.3  The normal ventricular pressure-volume loop 
The changes in ventricular cycle can be summarised in the pressure-volume curve. This is 
obtained by plotting the instantaneous ventricular pressure against the corresponding ventricular 
volume; this effectively integrates the separate ventricular pressure-time and volume-time traces 
(Figure 2.11).  
2.4.3a  The normal left ventricular pressure-volume loop 
As previously illustrated, the normal LV pressure-volume curve has a characteristic quadrilateral 
shape or loop (Figure 2.11A). The bottom right-hand corner corresponds with end-diastole. 
Starting from this point, the curve passes in an anti-clockwise direction. Each side of the curve 
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corresponds with one of the four phases of the cardiac cycle. The right-hand side (points A-B) 
represents the isovolumic contraction phase; the upper surface (points B-C) represents the 
isotonic, ejection phase; the left-hand side (points C-D) represents isovolumic relaxation; and the 
lower surface (points D-A) represents ventricular filling. The upper left-hand corner (point C, 
Figure 2.11A) corresponds with end-systole, as defined by Suga et al. [45]. 
 
 
Figure 2.11 Typical examples of left and right ventricular pressure-volume loops. A, the left ventricular pressure-
volume loop has a characteristic quadrilateral shape. Points A – D represent end-diastole, start of ejection, end-
ejection and start of ventricular filling, respectively. B, The normal right ventricular pressure-volume loop has a 
broadly triangular shape.   
Reproduced from Redington et al. [64]. 
A number of basic haemodynamic indices are evident from the pressure-volume curve. The 
horizontal width corresponds with the stroke volume, SV. This is the difference between the 
ventricular volume at end-diastole (EDV; lower right-hand corner, A) and end-systole (ESV; 
Equation 2.5): 
Equation 2.5 ESVEDVSV  
From this, the ejection fraction (EF) can be calculated (Equation 2.6):   
Equation 2.6 EDVSVEF  
Chapter 2 
- 24 - 
In addition, the area subtended by the pressure-volume curve, the pressure-volume area (PVA) 
gives a measure of energy used by the heart to pump blood into the systemic circulation; this is 
known as the stroke work, SW (Equation 2.7): 
Equation 2.7 
EEV
EDV
dVtPSW   
where EDV and EEV represent the end-diastolic and end-ejection volume, respectively; P(t) 
represents the time-varying pressure; and dV is the instantaneous change in volume [65]. 
Changes in either the SV or the maximal pressure developed (i.e. the vertical height of the 
pressure-volume curve) will alter pressure-volume area, thus indicating a change in the work 
performed by the heart. 
2.4.3b  The normal right ventricular pressure-volume loop 
The normal RV pressure-volume curve is substantially different from that of the LV, Figure 
2.11B. It has a triangular or trapezoidal in shape, with poorly defined periods of isovolumic 
contraction and relaxation.  
Although the shape of the RV pressure-volume loop may reflect differences in the performance 
of the two ventricles, the shape is also a reflection of acute or chronic changes in the loading 
conditions. For example, in patients with transposition of the great arteries following an atrial 
switch procedure (i.e. Mustard or Senning operation), the RV supports the systemic circulation 
while the LV supports blood flow through the pulmonary circulation. Pressure-volume loops 
obtained in these patients are distinctly different from normal. The LV pressure-volume loop has 
a trapezoidal shape (like the normal RV) whereas the RV pressure-volume loop has a 
quadrilateral shape (like the normal LV; Figure 2.12). 
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Figure 2.12 Representative examples of right (A) and left (B) ventricular pressure-volume loop in separate 
patients with transposition of the great arteries following atrial switch procedure (Mustard operation). Reproduced 
from Derrick et al. [66] and Redington et al. [67], respectively. 
2.5  PHYSIOLOGICAL DETERMINANTS OF VENTRICULAR FUNCTION 
The cardiovascular system ordinarily operates as a closed-loop system, in which the heart and the 
vasculature are connected with one another to form a hydraulic loop. The performance of one 
part of the system depends on its interaction with the rest of the system. In vitro and in vivo studies 
have identified four major factors that influence cardiac performance, namely preload, afterload, 
heart rate and contractility [68].  
In order to illustrate the effect of these factors on ventricular function, it is first necessary to 
define a measure of that function. The most basic index of ventricular function is the volume of 
blood that the heart can pump in one minute. This is known as the cardiac output (CO). The CO 
is the product of the stroke volume (SV) and heart rate (HR; Equation 2.8). 
Equation 2.8  HRSVCO  or HRESVEDVCO , 
where EDV is end-diastolic volume and ESV is end-systolic volume. 
2.5.1  Preload and afterload 
The terms preload and afterload, used in the context of isolated papillary muscle experiments, 
have very precise definitions [11]. Preload refers to the resting tension within the muscle. This is 
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calculated as the force applied to the resting muscle (i.e. the weight attached to the isotonic lever) 
divided by the cross-sectional area of the muscle. This term allows for direct comparison between 
specimens with different thicknesses. Similarly, afterload refers to the muscle tension the 
shortening phase of isotonic contraction. Like preload, this is calculated as the weight lifted 
during contraction normalised for the cross-sectional area of the muscle. 
The terms preload and afterload have also been applied to the study of ventricular function in 
vivo. However, their definition in the intact ventricle is less clear. As already described, the 
tension within the myofibres cannot be directly measured and, furthermore, varies according to 
the location within the ventricular mass and point in the cardiac cycle. What then is the best 
estimate for preload and afterload in vivo? 
 
2.5.1a  Preload 
The relationship between preload and cardiac output have been described using isolated canine 
heart-lung preparations and chronically instrumented dogs in vivo [37,69,70]. These studies have 
demonstrated that cardiac output rises to a plateau during acute changes in preload, as indicated 
by the change in right atrial pressure (Figure 2.13). 
In clinical practice, central venous pressure (CVP) and pulmonary capillary wedge pressure 
(PCWP) are often used as proxy measurements of right ventricular and left ventricular end-
diastolic pressures, respectively. However, these pressures are associated with significant 
limitations as measures of preload, as they are altered by changes in compliance within the 
ventricle as well as changes in the intrathoracic pressure [71,72]. 
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Figure 2.13 Relationship between cardiac output and mean left atrial pressure. The relationship is illustrated 
during control states (●), vagal blockade (○) and vagal blockade plus isoprenaline (▲). 
Reproduced from Bishop & Horwitz [73]. 
Preload in the intact circulation is probably best represented by the end-diastolic volume (EDV) 
[74]. The end-diastolic volume represents the degree of filling of the ventricle. Changes in EDV 
therefore reflect changes in the shape of the ventricle and, by extension, changes in the length of 
the myofibres within the ventricular mass [29]. For the purposes of this thesis, preload has been 
defined as the ventricular end-diastolic volume.  
2.5.1b  Afterload 
In its simplest form, afterload reflects the amount of work the ventricle must perform in order to 
produce a given pulsatile blood flow at a fixed preload. However, as the ventricle is not called on 
to lift a weight but to move a viscous fluid into a viscoelastic system, it cannot be adequately 
described using a single, simple quantity.  
Afterload has been defined based on the analysis of the properties of the arterial system, the 
arterial input impedance. The arterial input impedance influences but is independent of cardiac 
ejection into the vascular tree [75]. Systolic blood flow and pressure can be considered as 
coupling variables that reflect the interaction between the ventricular pump and afterload. The 
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arterial system load can be approximated using a three-element Windkessel model [76,77], based 
on analysis of aortic pressure and flow in the frequency domain [78]. Using this method, arterial 
impedance can be separately described according to the characteristic impedance (Zc), arterial 
compliance (C), and arterial resistance (R).  
The influence of acute changes in arterial impedance on left ventricular function were examined 
by Maughan et al. in an isolated canine heart preparation [79]. A four-fold increase in arterial 
resistance, R was associated with a substantial reduction in stroke volume, as illustrated by the 
pressure-volume loop becoming taller and thinner (Figure 2.14, top panel). By contrast, 
comparable changes in the arterial compliance, C and characteristic impedance, Zc changed the 
shape of the systolic portion of the curve but did not alter stroke volume substantially (Figure 
2.14, middle and bottom panels).  
 
Figure 2.14 Pressure-volume loops in a canine left ventricle with three levels of arterial resistance (top panel), three 
compliance (middle panel) and characteristic impedance (Rc, lower panel). Reproduced from Sagawa et al. [35], pp. 
116. 
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Arterial input impedance is not generally used to assess afterload in clinical practice. In this 
context, afterload is most often approximated using the mean arterial pressure or vascular 
resistance. Systemic and pulmonary vascular resistance are calculated using the standard formulae 
[1]. However, neither of these measures reflects the dynamic nature of the resistance to blood 
flow during ejection [80].  
 An alternative approach to characterise the arterial system has been proposed by Sunagawa et al., 
based on analysis of the pressure-volume loop [81]. Since the arterial pressure-flow relationship is 
linear over the physiological range [82], the total arterial resistance can be estimated as the slope 
of the ventricular end-systolic pressure-stroke volume relation (Equation 1.9). This slope is 
known as the effective arterial elastance, Ea [82]. 
Equation 1.9 
c
TES
a
T
R
SV
P
E , 
where RT is total mean vascular resistance and Tc is cardiac cycle length. 
Under experimental conditions, Segers et al. demonstrated that Ea varied as a linear function of 
total resistance (i.e. the sum of total peripheral resistance, R and characteristic impedance, Zc) and 
inversely with arterial compliance, C [83]. Effective arterial elastance has been validated as a 
measure of afterload under a variety of experimental and clinical conditions [84-86]. This index is 
particularly useful because it can be linked with indices of ventricular function to assess the 
mechanical efficiency of the cardiovascular system as a whole [81,87,88]. For these reasons, 
effective arterial elastance, Ea has been used as the principal measure of afterload in this thesis.   
2.5.2  Heart rate 
Changes in heart rate represent a third major determinant of cardiac function. Studies in isolated 
muscle preparations have demonstrated a positive relationship between the stimulation frequency 
and the force of contraction [11,89]. A sudden increase in the heart rate causes the amplitude of 
each successive contraction to increase until a new, steady-state level is reached. This is known as 
the positive staircase or Treppe phenomenon [90].  
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In the normal heart in the conscious patient, physiological tachycardia results in the reduction in 
length of the cardiac cycle. The duration of systole and diastole are both shortened, but the effect 
upon the diastolic filling time is greater. This potentially reduces the end-diastolic volume and 
cardiac output. Freeman et al. demonstrated that increments in heart rate were also associated 
with increased ventricular contractility [91]. As a result, the heart can deliver the same or 
increased stroke volume at a lower end-diastolic volume. Tachycardia represents an important 
mechanism for increasing cardiac output, particularly during exercise [92]. However, if the heart 
rate is increased excessively, diastolic filling time will decrease to such a degree that cardiac 
output will eventually fall, in spite of the improved ventricular contractility [93].  
2.5.3  Contractility 
The term contractility describes the “performance potential” of the heart independent of changes 
in the loading conditions [10,15]. This term represents the intrinsic property of the myocardium 
and predicts how cardiac function will change in response to external stimuli. It follows that if 
one is to make a valid comparison of ventricular function, cardiac output and its derivatives are 
only useful if preload, afterload and heart rate are not allowed to change. This is often not 
practicable, especially in vivo [94]. 
The ideal index of ventricular function would be exquisitely sensitive to changes in the inotropic 
state of the ventricle, insensitive to changes in the loading conditions and heart rate, reproducible 
and would not require excessive assumptions for its derivation. A wide variety of indices of 
ventricular function have been developed [95-98]. The sheer number of indices suggests that this 
important attribute cannot be adequately defined by a single measurement [35,99].  
2.5.3a  Assessment of systolic function 
The assessment of ventricular function is pragmatically divided into the separate evaluation of 
ventricular systolic and diastolic function. Conventional measures of ventricular systolic function, 
like ejection fraction or the peak rate of rise of ventricular pressure during the isovolumic 
contraction phase (dP/dtmax) [100], are generally based on the assessment of changes in 
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ventricular volume or pressure in the time domain. However, these measurements are implicitly 
dependent on loading conditions as well as contractility [101-103]. For example, the stroke 
volume from a given end-diastolic volume (and thus ejection fraction as well) decreases linearly 
with increments in left ventricular end-systolic pressure [102]. Similarly, increments in end-
diastolic volume are associated with a progressive rise in the measured left ventricular dP/dtmax 
[104]. This load-dependence limits the value of these measurements as indices of ventricular 
systolic function. 
It has long been recognised that further insight into ventricular function can be obtained from an 
analysis of the instantaneous pressure-volume relationship [28]. Studies in the canine left ventricle 
in vivo have demonstrated that there is a linear relationship between pressure and volume over the 
physiological range [43,45]. In a series of reports, Suga demonstrated that the instantaneous end-
systolic pressure-volume relationship was virtually independent of changes in preload and 
afterload [103,105]. However, this ratio did vary markedly with inotropic interventions [106] and 
he concluded that the slope of the end-systolic pressure-volume relationship could be used to 
characterise ventricular contractility [45].  
Suga et al. used the same approach to examine the time course of the pressure-volume ratio over 
the entire cardiac cycle [45]. They defined the elastance at any point in the cardiac cycle, E(t) as: 
Equation 2.10 0)()( VtVtPtE , 
where P(t) and V(t) are the instantaneous ventricular pressure and volume, respectively; and V0 is 
the equilibrium volume, i.e. the minimum ventricular volume at which contraction generates a 
pressure greater than atmospheric pressure [45].  
The time-varying elastance curve (Figure 2.15) is characterised by a trapezoidal curve that rises to 
a peak, Emax and then declines. The time from the start of systole to Emax is termed tmax. Suga et al. 
demonstrated that time-varying elastance was independent of end-diastolic volume and arterial 
pressure within their physiological ranges but was affected specifically and sensitively by inotropic 
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interventions. Inotropic interventions increased Emax, decreased tmax or caused a combination of 
the two [45,107].  
Regardless of the changes in Emax and tmax that followed changes in the level of inotropy, the 
unique basic shape of the systolic part of the time-varying elastance curve remains unchanged 
[107]. Therefore, any given time-varying elastance curve can be fully represented by the 
parameters, Emax and tmax and the normalised E(t) curve. The process of normalisation for 
elastance and time are described in Figure 2.15. This curve, in turn, provides a simplified, 
phenomenological description of contraction within the ventricular chamber [56].  
 
Figure 2.15 Plot of many normalised pressure-volume ratio curves, EN against normalised time, TN to 
demonstrate their relatively constant shape. The two equations in the Figure describe the process of normalisation. 
Reproduced from Suga et al.[45]. 
Three discrete indices of ventricular function have been derived from the time-varying elastance 
model of contraction. These are the end-systolic pressure-volume relation (ESPVR) or end-
systolic elastance (EES) [45]; the dP/dtMAX-EDV index [108]; and preload recruitable stroke work 
(PRSW) [109]. These indices represent the slope parameters of the end-systolic pressure-volume 
relationship; the dP/dtMAX-EDV relationship; and the stroke work-EDV relationship, respectively.  
The end-systolic elastance,dP/dtMAX-EDV relation and preload recruitable stroke work are all 
relatively load-dependent and are therefore better indices of intrinsic systolic function. However, 
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each of these indices has inherent limitations. In general, the more sensitive the index is to 
changes in contractility, the more affected it is by changes in vascular load [110,111]. I have used 
all three of these indices in this thesis in order to appreciate changes in systolic function. 
End-systolic elastance, EES; the dP/dtMAX-EDV relation; and preload recruitable stroke work, 
PRSW are all calculated from pressure-volume loops that are obtained at different loading 
conditions (Figure 2.16). One way to alter the preload is to temporarily occlude the inferior vena 
cava (IVC), using either a balloon within or a tape around the IVC [112,113].   
 
Figure 2.16 Diagram of pressure-volume loops during IVC occlusion. The end-systolic pressure-volume relation 
(ESPVR) and end-diastolic pressure-volume relation (EDPVR) are derived from this “family” of pressure-volume 
loops. Reproduced from Steendijk et al.[114]. 
2.5.3b  Assessment of diastolic function 
The assessment of diastolic function of the ventricle reflects the inter-relationship between a 
number of complex phenomena within the heart [55]. These include ventricular relaxation; elastic 
recoil and ventricular suction; the viscoelastic properties of the heart, as well as restraint provided 
by the contralateral ventricle, pericardium and lungs [95]. It is not surprising that diastolic 
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function cannot be quantified using any one measure [115]. However, it is possible to simplify 
the analysis of diastolic function by considering active ventricular relaxation and the passive 
properties separately. Although this separation is artificial and simplistic, it provides a practical 
framework for the identification of quantification of diastolic dysfunction.  
 Assessment of ventricular relaxation 
Ventricular relaxation is an essential process by which the ventricle returns to its resting pressure 
and volume state after contraction. This involves an active biochemical process that result in the 
progressive decline of ventricular pressure during early diastole. Relaxation is a complex energy-
dependent process that may use up to 15% of the total energy output of the beating heart [111]. 
The rate of pressure decline is influenced by a variety of physiological factors [116,117] including 
the magnitude of elastic recoil within the heart caused by systolic contraction [118], the arterial 
load [55,119] and spatial and temporal non-uniformity of the process within the ventricle as a 
whole [55,120]. Impaired ventricular relaxation may reflect changes in any one of these factors 
[55]. 
Ventricular relaxation may be impaired in a number of conditions including myocardial ischaemia 
caused by coronary artery disease [121], ventricular hypertrophy [55] and both dilated and 
hypertrophic cardiomyopathy [122,123]. Delay of ventricular pressure decline plays an important 
role in the clinical manifestations of these conditions [124]. In addition, these changes in 
ventricular relaxation are present before changes in systolic function become evident [55].  
Assessment of ventricular relaxation is based on the analysis of pressure decline during 
isovolumic relaxation. A number of separate indices of ventricular relaxation have been used, 
including the maximal rate of pressure decline (dP/dtMIN) [125] and the time required for pressure 
to decline by 50% of its starting value (T1/2) [122]. Studies also identified that the fall in 
ventricular pressure usually followed an exponential decline. As a result, it was considered 
possible to describe the rate of pressure decay in terms of a time constant of relaxation or tau (τ; 
the time for pressure to decay to 1/e of any pressure) [126]. A number of mathematical models 
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can be used to calculate tau, which reduce the sensitivity of this index to loading conditions and 
pericardial constraint [123,127].  
In this thesis, tau has been calculated using a monoexponential decay in which pressure decays to 
a non-zero asymptote (P∞), (Equation 2.11) [128]. 
Equation 2.11 PePPP
t /
0 , 
where P0 is the pressure at time, t=0 and τ is the time constant of pressure decay.  
This equation can be rewritten in the form of a linear relation between pressure and its first 
derivative with respect to time (dP/dt; Equation 2.12). 
Equation 1.12 PPdtdP 1 . 
 Assessment of ventricular compliance 
The second major component of diastolic function is the passive chamber stiffness or its inverse, 
compliance. Ventricular compliance can only be derived from the analysis of the pressure-volume 
relationship during the diastolic filling period [129,130]. However, as the normal pressure-volume 
relation during this period is curvilinear, chamber compliance is not constant but varies as a 
function of ventricular volume; compliance is high at low ventricular volumes but decreases as 
the ventricle is filled. This can be compared to inflating a football with a hand-pump. As the ball 
fills, more effort is required in order to fill the ball further.  
The ventricular compliance is equivalent to the passive length-tension relation in vitro. It reflects 
the passive elastic properties of the ventricular chamber as a whole. Compliance is reduced in 
patients with ventricular hypertrophy, ventricular fibrosis and in patients where the ventricle is 
dilated [96,129,131,132]. However, it should be noted that diastolic pressure-volume relations do 
not only relate to the properties of the ventricular chamber per se. Other factors, including 
volume loading in the contra-lateral ventricle through so-called “ventriculo-ventricular 
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interactions” [133]; pericardial constraint [134]; and extrinsic compression of the heart can all 
affect the measured diastolic pressure-volume relation and parameters derived from these data.  
The period of diastasis is arguably the best portion of the cardiac cycle from which to derive 
indices about the passive properties of the heart. This is because there will be little influence from 
either ventricular relaxation or atrial systole. However, only limited data are obtained from a 
single cardiac cycle if this is the only part of the filling curve analysed. An alternative approach is 
to measure pressure-volume relations from several cardiac cycles at varying levels of volume 
loading and then combining the data in a single relation, as illustrated in Figure 2.16 [122].  
Once obtained, the data are analysed using a mathematical curve fitting to derive parameters 
related to ventricular compliance. In this thesis, the passive pressure-volume relationship was 
described by a monoexponential formula (Equation 2.13): 
Equation 2.13 10
VV
eP  
where V0 is the volume of the heart at zero end-diastolic pressure, β is the chamber stiffness 
coefficient and α is a stiffness and a scaling coefficient.  
This equation can be rewritten in the form of a linear relation between chamber stiffness (dP/dV) 
and pressure (Equation 2.14). 
Equation 2.14 PdVdP  
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2.5.4  Extrinsic control of cardiac function 
In addition to the four major factors that influence cardiac function described, ventricular 
function is also influenced by the autonomic nerves supplying the heart and a number of cardio-
active substances in the blood supply.  
2.5.4a Cardiac autonomic nerves 
The heart is supplied by two sets of nerves, one emanating from the nuclei in the lower 
brainstem (parasympathetic vagal nerves) and the other from the upper thoracic segments of the 
spinal cord (T1 – T8; cardiac sympathetic nerves). Cardiac vagal nerves terminate in a ganglia 
lying in the fat pads in various regions of the heart whereas cardiac sympathetic nerves terminate 
in the stellate inferior cervical and associated ganglia. Post-ganglionic sympathetic and 
parasympathetic fibres project to the atria, conducting tissues and the ventricular myocardium 
[135]. The parasympathetic vagal supply decreases heart rate by direct actions on the pacemaker 
tissue and decreases atrial and ventricular contractility, probably mainly through an interaction 
with the sympathetic supply.  The sympathetic supply has the opposite actions.  
2.5.4b  Hypoxia and Hypercapnia 
The partial pressure of oxygen (PaO2) and carbon dioxide (PaCO2) in the in the arterial blood may 
also affect ventricular function [48]. Chronic hypoxia, in particular, is associated with a depletion 
of the main energy source for the heart (adenosine triphosphate, ATP) and a decrease in baseline 
ventricular function [136,137]. This, in turn renders the heart more susceptible to ischaemic 
injury during cardiac surgery, which may result in less favourable early post-operative recovery 
[137,138].  
Chapter 2 
- 38 - 
2.6  NORMAL DEVELOPMENT OF THE HEART 
The earliest functioning embryonic heart is a single, straight tubular pump. During the early 
phases of development, this primary heart tube undergoes a process called cardiac looping 
(Figure 2.17), which transforms the primary heart tube into the normal four chambered heart 
[139]. Cardiac looping is the key process in cardiac morphogenesis and any disturbances in this 
process can lead to the development of several congenital cardiac malformations [140]. 
 
Figure 2.17 Electron micrograph of ventral views of the chick embryo during the various stages of cardiac 
looping. This involves the formation of the straight and almost symmetric heart tube (A); followed by dextral-
looping (B) and then the formation of the S-shaped loop (C). Subsequent ballooning of secondary myocardium 
results in the formation of separate left and right atria (D) and left and right ventricles (E). Reproduced from 
Manner [139,140]. 
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In the human, the primary heart tube develops during the third week of gestation by the fusion 
of bilateral cardiogenic cells in the anterior lateral plate mesoderm at the cranial border of the 
embryonic disc [141]. This creates a single undivided lumen lined by endothelial cells and 
enveloped in contractile myocardial cells[142]. 
The primary heart tube is aligned along the ventral midline of the embryo. It is bilaterally 
symmetrical with a shape like an inverted Y, Figure 2.17A. The two caudal arms are continuous 
with the developing venous tributaries and the short cranial stem is connected to the aortic sac 
and pharyngeal arch arteries [139]. Although there is minimal variation in the structure at this 
stage, the heart tube can be subdivided along the antero-posterior axis into a number of separate 
modules [143]. Each module has a distinct pattern of gene expression that regulates subsequent 
segmentation, differentiation and expansion into the various cardiac components of the normal 
four-chambered heart [143,144]. Cells at the caudal pole sequentially give rise to the myocardium 
of the inflow tract, atria and atrio-ventricular canal [142] whereas the short cranial stem forms the 
left ventricle [145]. The cranial pole of the primary heart tube is elongated by the addition of cells 
from a second cardiogenic centre. The cells from this secondary or anterior heart field are 
primarily associated with the development of the right ventricle and the primitive outflow tract 
[146].  
The primary heart tube undergoes cardiac looping during the fourth to seventh weeks of human 
gestation. During this process, the heart tube undergoes a sequential change in shape with the 
initial formation of a C-shaped loop convex to the right (Figure 2.17B) and the subsequent 
transformation into an S-shaped loop (Figure 2.17C). Dextral looping (D-loop) establishes the 
left-right asymmetry of the embryonic heart whereas the formation of the S-shaped loop brings 
the segments of the heart tube and the great vessels into effectively their final topographical 
relationships [140].  
At the start of cardiac looping, the primary heart tube can be divided into atrial and ventricular 
segments together with a single outflow tract. The atrial and ventricular segments are separated 
by the atrio-ventricular canal and the outflow tract is supported by the distal part of the 
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ventricular segment. The three segments are connected in series, so that blood flowing through 
the primary atrium must pass through the entire ventricular segment in order to reach the 
outflow tract.  
The major step in the formation of the separate atrial and ventricular chambers involves 
ballooning of secondary myocardium from the outer curvature of the primary heart tube (Figure 
2.17D). In the primary atrium, this gives rise to the separate left and right atrial appendages. The 
formation of the atrial appendages, together with a change in the orientation of the atrial 
segment, is a prerequisite for normal atrial septation [142,147]. At the same time, the atrio-
ventricular canal undergoes complex growth, rightward expansion and remodelling. As a result, 
the atrio-ventricular canal is incorporated into both atria and eventually leads to the establishment 
of separate left and right atrio-ventricular connections [148]. 
Sequential balloon dilatation of the proximal and distal parts of the ventricular segment is also 
responsible for the formation of the left and right ventricles, respectively (Figure 2.17E) [142]. As 
these outpouchings develop, they develop characteristic trabeculations that differentiate the two 
ventricles from each other [149]. Remodelling of the primary interventricular foramen and the 
inner curve of the ventricular segment is ultimately responsible for the formation of the inlet 
portions of both ventricles, the outlet portion of the left ventricle and ventricular septation 
[142,147,150]. 
The outlet portion of the primary heart tube develops as a myocardial structure that extends from 
the outlet portion of the ventricular loop to the aortic sac. During subsequent development, the 
walls of the outflow tract change from a myocardial to an arterial phenotype. The distal portion 
divides to form the intrapericardial portions of the aorta and pulmonary trunk while the proximal 
portion forms the semilunar valves, arterial sinuses and sub-pulmonary infundibulum. Septation 
of the outflow tract establishes direct and separate connections between the left ventricle and 
aorta; and the right ventricle and pulmonary trunk [151].  
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2.7  THE FOETAL CIRCULATION 
Almost all of our current understanding of the foetal circulation has been acquired largely from 
angiographic investigations in the foetal lamb [152-154] together with a limited number of studies 
in exteriorised human foetuses [152].  
Foetal blood rich in oxygen (oxygen saturation, 80%) and nutrients returns to the foetus from the 
placenta in the umbilical veins. On approaching the liver, the majority of blood in the umbilical 
vein flows directly into the IVC through the ductus venosus. A smaller proportion passes 
through the liver parenchyma and mixes with deoxygenated blood from the portal circulation. In 
the IVC, blood from the ductus venosus mixes with deoxygenated blood from the hepatic veins 
as well as blood return from the lower trunk and extremities.  
Inferior vena cava blood represents approximately 70% of the systemic venous return to the 
heart. Within the right atrium, inferior vena caval return is divided into two streams by a fold in 
the endocardium (crista dividens). The larger stream is deflected through the foramen ovale into 
the left atrium, where it mixes with the deoxygenated pulmonary venous return. The blood in the 
left atrium (oxygen saturation, 62%) then flows into the left ventricle, where it is pumped into 
ascending aorta to supply the coronary arteries, head and upper extremities, and the remainder 
passes into the descending thoracic aorta [152,153].  
The SVC brings deoxygenated venous blood (oxygen saturation, 40%) from the upper portion of 
the body. The blood in the SVC flows into the right atrium where it mixes with the smaller 
stream of blood from the IVC. The blood in the right atrium then passes into the right ventricle 
and is pumped into the pulmonary trunk [152,153]. The pulmonary vascular resistance (PVR) in 
the foetus is high, primarily due to pulmonary arterial hypoxia-mediated increased vasomotor 
tone [154,155]. As a result, only a small proportion of blood passes through the pulmonary 
vasculature; the major part of the right ventricular output flows through the ductus arteriosus 
into the descending thoracic aorta[156]. The blood in the descending thoracic aorta supplies the 
lower part of the body and the placenta, via two umbilical arteries [153]. The organs distal to the 
ductus arteriosus are supplied with blood that has a lower oxygen saturation (oxygen saturation, 
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58%) than blood supplying the brain and upper extremities. This arrangement ensures the 
placenta receives blood with a lower oxygen saturation, maximising the efficiency of placental gas 
exchange.  
The left and the right sides of the foetal circulation function effectively in parallel. Both sides of 
the heart contribute to blood flow in the systemic circulation of the foetus [152,157]. This parallel 
configuration is associated with pressure and volume loading conditions of the foetal heart that 
are markedly different from the adult circulation. In the foetal circulation, the right ventricle 
ejects approximately 65% of the combined ventricular output, whereas the left ventricle ejects 
only 35% [157]. The large ductus arteriosus allows equalisation of the pressure between the aorta 
and the pulmonary trunk. Left and right ventricular afterload are therefore equivalent. Direct 
measurements of the ventricular pressure in the foetus have shown that pressure generated in the 
left and right ventricles are equal (systolic blood pressure, 60 mmHg) [158,159]. As a result of 
these loading conditions in utero, the left and right ventricles have a similar size and wall 
thickness at birth [152]. The parallel arrangement of blood flow in the foetus and the normal 
physiological adaptation may explain why most complex congenital heart defects are well 
tolerated in utero. 
2.8  THE TRANSITION FROM FOETAL TO NEONATAL CIRCULATION 
The transition from foetal to neonatal extrauterine circulation is associated with sudden and 
dramatic changes in the circulation as gas exchange is transferred from the placenta to the 
neonatal lungs [159]. This is accompanied by substantial changes in the pressure and volume 
loading conditions of the two ventricles, as the circulation changes from a parallel arrangement to 
an in-series arrangement, in which the left ventricle is connected exclusively to the aorta and the 
right ventricle is connected exclusively to the main pulmonary artery (MPA) [160-162]. 
At birth, smooth muscle contraction within the umbilical arteries, vein and ductus venosus result 
in the functional closure of these vessels within a few minutes [152]. The interruption of the 
umbilical vessels causes a substantial increase in systemic vascular resistance (SVR). Concurrently, 
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the onset of respiration is associated with a rapid decrease in the PVR and a five-fold increase in 
pulmonary blood flow [163].  
The increase in pulmonary blood flow and pulmonary venous return results in a rise in left atrial 
pressure. There is a corresponding reduction in right atrial pressure following the cessation of 
placental flow. The changes in atrial pressure result in the reversal of the foetal right-to-left atrial 
pressure gradient, which in turn cause the septum primum to become apposed to the septum 
secundum, functionally closing the foramen ovale [164]. The two septa subsequently fuse, 
although there is considerable variation in the age at which fusion occurs [165]. 
The decrease in PVR coupled with the rise in SVR results in a reversal of the flow through the 
patent ductus arteriosus from the foetal right-to-left direction to provide a left-to-right shunt 
[166]. However, within a few minutes following birth, the large ductus arteriosus begins to 
constrict primarily in response to the rise in arterial oxygen saturation. Constriction of the ductus 
arteriosus is progressive and usually results in the functional closure within 12 to 24 hours 
following birth in the mature infant [152]. There is subsequent anatomical obliteration of the 
ductus arteriosus that is usually complete by about 2 months of age [165].  
The fall in PVR is accompanied by an exponential decline in pulmonary arterial and right 
ventricular pressure [167] such that the pulmonary artery pressure achieves an adult level within 
two weeks following birth (systolic pulmonary artery pressure, < 25 mmHg; PVR, 1 – 3 Woods 
units∙m-2) [168]. In the systemic circulation, cessation of placental blood flow is associated with an 
abrupt rise in the systemic blood pressure [159] and there is a further, more gradual rise in the 
blood pressure during the first 6 weeks of life [167,169]. The blood pressure then remains 
relatively constant until about 6 years (systolic blood pressure, 100 mmHg; SVR, 15 – 20 Woods 
units∙m-2)[169]. 
At the time of birth, the left and right ventricles have a similar size and wall thickness. The 
changes in pressure and volume loading after birth result in a marked physiological adaptation in 
both ventricles. The left ventricle undergoes a rapid increase in left ventricular mass, such that 
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the left ventricular mass indexed to body surface area increases by almost 20% within the first 2 
weeks after birth [170]. The increase in ventricular mass is much slower in the absence of 
systemic pressure loading [171,172]. Consequently, there is a gradual involution of the right 
ventricular mass index. This progressive right ventricular “deconditioning” means that the right 
ventricle is no longer able to maintain adequate cardiac output against a systemic afterload 
beyond about 1 month of age [173]. 
2.10 OVERVIEW OF CONGENITAL HEART DISEASE 
In approximately 1% of births, the development to the heart does not follow this normal pattern. 
This results in the development of a number of congenital cardiac malformations [140].  
Congenital heart disease (CHD) is defined, “as a gross structural abnormality of the heart or 
intrathoracic great vessels that is actually or potentially of functional significance” and is present 
at birth [174].The definition proposed by Mitchell et al. excludes functionless abnormalities of the 
great veins and the branches of the aortic arch [174].  
Congenital heart disease is the single most common form of birth defect, which affects 4 – 14 per 
1000 live births [174,175]. Congenital heart disease occurs with a similar frequency in all ethnics 
groups and in all regions of the world [176]. Hoffman et al. identified that there had been a 
progressive increase in the published incidence of CHD, which was mainly attributed to an 
improved ability to identify patients with clinically less important lesions [176]. If children with a 
small patent ducts arteriosus, small ventricular septal defect or the potentially important bicuspid 
aortic valve were also included, CHD may affect as many as 75 per 1000 live births [176].  
Congenital heart disease encompasses a wide spectrum of heart defects with varying levels of 
severity, which can be classified according to the type and severity of the lesion [176-178] or the 
functional impact on the patient [179].  
Hoffman et al. defined three grades of CHD (mild, moderate and severe) according to the 
severity of the lesion [176]. The incidence of CHD varies according to the severity of the lesion. 
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Hoffman et al. estimated that the incidence of moderate and severe CHD is 3 per 1,000 live births 
and 2.5 – 3 per 1,000 live births, respectively [176]. Based on these estimates, approximately 2000 
children are born in the United Kingdom each year with severe CHD [180].  
Severe CHD included all patients with cyanotic heart disease, in which relatively deoxygenated 
blood circulates around the systemic circulation. This occurs in patients with transposition of the 
great arteries, tetralogy of Fallot and functionally single ventricle anatomy, for example. Severe 
CHD also included patients with severe forms of acyanotic heart disease, such as patients with 
critical aortic or pulmonary valve stenosis, critical coarctation of the aorta or a large ventricular 
septal defect. The majority of children that require medical intervention, surgery or die with CHD 
in the neonatal period or during infancy have severe CHD [181].  
Moderate CHD was defined as less severe forms of acyanotic heart disease. This included 
patients with moderate aortic or pulmonary valve disease, non-critical coarctation of the aorta or 
a large atrial septal defect. These patients will also usually require specialist treatment during their 
lifetime [181], although this treatment is generally less intensive than that required for patients 
with severe CHD [176].  
Mild CHD included patients with a small atrial or ventricular septal defect or a small patent 
ductus arteriosus. Most of these patients are asymptomatic and many of these lesions may close 
spontaneously or never cause medical problems. 
Over the last 30 years, advances in the diagnosis and treatment of patients with CHD together 
with a greater understanding of the anatomy and physiology have led to a substantial 
improvement in the long-term outcome for children with congenital heart disease. Currently, 
approximately 94% of children will survive for at least one year following paediatric cardiac 
surgery in the United Kingdom [182]. It is estimated that at least 85% of patients with even the 
most serious heart defects can now expect to reach adult life [183,184]. However, few patients 
with CHD are actually cured. The life expectancy for adults with severe CHD is 35 – 40 years 
and 55 years for adults with moderate CHD [183]. The majority of patients with CHD will 
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require life-long follow-up in order to manage the medical, social and psychological issues faced 
by children and adults with CHD [185].  
2.10.1  Classification and nomenclature of congenital heart disease 
The classification of CHD requires a nomenclature system that allows the abnormal anatomical 
features to be described accurately, succinctly and unambiguously [186]. Historically, congenital 
heart disease was usually defined as a series of discrete categories according to their characteristic 
morphology, as illustrated by the terminology agreed upon by the New York Heart Association, 
NYHA [187]. Complex and unusual malformations did not fit within these rigid classification 
systems and were usually assigned to a “miscellaneous” group. Several centres developed more 
inclusive systems for the classification of CHD. In 2002, these systems were unified in, „The 
International Paediatric and Congenital Cardiac Code‟ (IPCCC) [188]. The IPCCC provides a 
comprehensive nomenclature system to describe congenital heart malformations, associated 
symptoms and genetic syndromes as well as surgical and interventional procedures used to 
palliate or correct them [189,190].  
2.10.1a  Segmental approach to classification of congenital heart disease 
The IPCCC classification of CHD is based on the segmental approach to the description of 
congenital heart defects [186,191-196]. In the segmental approach, the heart is considered to have 
atrial, ventricular, and arterial segments. Normal and congenitally abnormal hearts are described 
according to how these segments are sequentially connected; what associated anomalies are 
present in each of the cardiac segments; and what spatial relationship the segments have with one 
another and the heart has within the thorax [192]. Van Praagh et al. advocate that this description 
may be summarised using a special, three-letter notation [197].  
The first step in the segmental analysis requires the identification of the segments of the heart. 
Each segment is made up of a strictly limited number of components (Figure 2.18). In the 
normal heart, the atrial segment consists of the left and right atria, the ventricular segment 
comprises the left and right ventricles and the arterial segment consists of the aortic and 
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pulmonary trunks. These cardiac chambers and the arterial trunks components can be identified 
based on their normal, characteristic appearances [193,198].  
 
Figure 2.18 Sequential analysis of the heart. The three segments of the heart are made up of a strictly limited 
components. The atria may be of left or right atrial morphology. The ventricles may be of right, left, or 
indeterminate morphology. Four types of arterial trunk can be recognised according to the pattern of branching. 
Reproduced from Anderson et al.[192]. 
In congenitally malformed hearts, the most constant parts of each component are also used to 
identify the morphology of each component, regardless of their relative position. The shape of 
the atrial appendage and the nature of the junction of the atrial appendage with the remainder of 
the atrium determine whether the atrium is morphologically left or right (Figure 2.18). Each atrial 
component may be morphologically left or right allowing the possibility of one left and one right 
atrium, two left atria (left atrial isomerism) or two right atria (right atrial isomerism). The 
ventricular segment usually consists of two components, one has left ventricular morphology and 
the other has right ventricular morphology. Rarely, there may be only a single ventricle of 
indeterminate morphology. The morphology of the ventricular component is defined by the 
pattern of the trabeculations within the apical part of the ventricle (Figure 2.18). The arterial 
segment usually consists of two trunks. Occasionally, the segment may have a common or a 
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solitary arterial trunk. The morphology of the arterial segment is defined by the branching 
patterns of the arterial trunk, in particular the origin of the brachiocephalic arteries (Figure 2.18) 
[192,199].  
The greater majority of hearts have biventricular atrioventricular connections, where each atrial 
component is connected to a separate ventricle. There is atrioventricular concordance if the 
morphological left atrium (mLA) connects with the morphological left ventricle (mLV) and the 
morphological right atrium (mRA) connects with the morphological right ventricle (mRV). 
Atrioventricular discordance occurs when the mLA connects with the mRV and the mRA 
connects with the mLV [200]. In hearts with atrial isomerism the atrioventricular connections are 
ambiguous (Figure 2.19).  
 
Figure 2.19 The atria can be connected to the ventricles in either a concordant (left panel) or discordant fashion. 
Reproduced from Anderson et al.[192]. 
The ventriculo-arterial junction is described in a similar manner to the atrioventricular 
connection. The ventriculo-arterial junction is concordant when the aorta arises from the mLV 
and the MPA arises from the mRV. The ventriculo-arterial junction is discordant when the aorta 
arises from the mRV and the MPA arises from the mLV. This is more commonly known as 
transposition of the great arteries. A double outlet ventricle occurs when both arterial 
components arise from a single ventricular component. When an arterial valve overrides a 
ventricular septal defect, the arterial trunk is considered to belong to the ventricle that supports 
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the greater part of its circumference. This may, therefore, result in the ventriculoarterial junction 
being normal, transposed or double-outlet.  
In some patients, only one arterial trunk arises from the ventricular segment. This may be a 
common truncus; a solitary aorta when the MPA is not connected to the ventricular chambers; a 
solitary MPA when the aorta is not connected to the ventricular chambers [201]; or a solitary 
trunk, which occurs in patients with certain types of pulmonary atresia, ventricular septal defect 
and major aorto-pulmonary collateral arteries [202]. 
In addition to abnormal connections, congenital heart malformations are characterised by 
abnormalities of each heart segment. These may include abnormalities of the systemic and 
pulmonary venous return; the atria and atrial septum; the atrioventricular junction; the ventricle, 
ventricular septum and ventricular outflow tract; and the great arteries. In the majority of cases, 
these associated anomalies are the only abnormalities present [198,201].  
Finally, complex congenital heart malformations are often associated with cardiac malposition. 
This may affect the topology or spatial arrangement of the cardiac chambers within the heart 
[197,198] or the position and alignment of the heart within the thorax [198,201].  
2.10.1b Form and function 
The accurate and appropriate classification of heart malformations is of fundamental importance 
to the successful management of CHD. Alterations in anatomy are associated with predictable 
physiological changes that determine the patient‟s symptoms, signs and functional well-being. 
These changes in cardiac form and function evolve over time. This may occur as part of the 
natural history of the disease or the development of pathophysiological processes such as 
ventricular hypertrophy, acquired obstruction of the outflow pathways or the development of 
atrioventricular valve regurgitation. Knowledge of predictable and possible abnormalities of 
cardiac form and function allow clinicians to determine what interventions will be required, when 
they should be performed and what effect that intervention should have on the natural history of 
the disease [203]. 
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2.11 FUNCTIONALLY SINGLE VENTRICLE ANATOMY 
The term functionally single ventricle anatomy refers to a heterogeneous group of heart malformations 
that are characterised by only one ventricle within the ventricular mass that can independently 
support blood flow in either the systemic or pulmonary circulation [204]. In fact, most of these 
hearts actually have two ventricles, one large and one small [204-209] although rarely the heart 
may contain a truly solitary ventricle [205,207,209,210]. However, none of these hearts are 
suitable for a biventricular repair and long-term survival is dependent on the function of the 
dominant or single ventricle [208].  
2.11.1 Nomenclature of functionally single ventricle anatomy 
Although physiologically equivalent, the term functionally single ventricle anatomy encompasses 
a wide spectrum of distinct anatomic abnormalities [207,209,211]. This morphological variability 
is reflected in the nomenclature; for example, Van Praagh et al. identified twenty-one different 
terms that had been used to describe hearts with apparently only one ventricle [205]. According 
to the segmental approach previously outlined, the atrial segment may consist of any one of the 
four atrial arrangements. The ventricular segment may consist of a dominant ventricle with left 
ventricular morphology and a small or rudimentary ventricle of right ventricle morphology, or 
vice versa; or, very rarely, a single ventricle of indeterminate morphology. The atrial and 
ventricular segments are joined by a univentricular or biventricular atrio-ventricular connection 
[208,211]. Any one of the arterial trunks and ventriculo-arterial connections may be observed 
along with a wide variety of associated cardiac anomalies [204,209,211].  
Hearts with functionally single ventricle anatomy can be grouped into two broad categories 
according to the atrio-ventricular connection. In the majority of cases, there is a univentricular 
atrio-ventricular connection, Figure 2.20 [204,206,208]. This can occur when the left or right-
sided atrioventricular connection is absent, like in tricuspid atresia or mitral atresia, for example. 
Alternatively, there may be double-inlet ventricle, in which both atria connect to the dominant 
ventricle.  
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Figure 2.20 This diagram illustrates how the atrial, atrio-ventricular junctions and ventricular segments are 
arranged within the ventricular mass.  
(Ind. = indeterminate; LV = left ventricle; RV = right ventricle) 
Reproduced from Anderson & Ho [208]. 
In the series reported by Barlow et al., hearts with a univentricular atrio-ventricular connection 
made up approximately two-thirds of hearts with functionally single ventricle anatomy [207]. In 
the remaining third, there was a biventricular atrio-ventricular connection [207]. In these cases, 
ventricular hypoplasia occurs because the atrio-ventricular valve are present but imperforate; the 
atrio-ventricular valves are “straddling”; or there is a double-outlet or discordant ventriculo-
arterial connection. Obstruction of either outflow tract in combination with an intact ventricular 
septum and a biventricular atrio-ventricular connection also results in ventricular imbalance, 
producing the hypoplastic left or right heart syndromes [204,208,211,212].  
Chapter 2 
- 52 - 
2.11.2 Ventricular morphology and functionally single ventricle anatomy 
The normal left and right ventricles can both be divided into three parts, namely the inlet, apical 
component and outlet [213,214] , as illustrated in Figure 2.21 and Figure 2.22.  
 
Figure 2.21 Internal view of the human LV showing the inlet, apical and outlet components. Reproduced from 
Crick et al. [214]. 
 
Figure 2.22 Internal view of the human RV showing the inlet, apical and outlet components. Reproduced from 
Crick et al. [214]. 
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The inlet part extends from the atrioventricular junction to the distal attachments of the tension 
apparatus that support the corresponding atrioventricular valve. The apical component is heavily 
trabeculated. The trabeculations are coarse in the right ventricle and comparatively fine in the left 
ventricle. The outlet part is a comparatively small region of the ventricle, which lies beneath the 
semilunar valve. In the left ventricle, the mitral and aortic valves are in fibrous continuity with 
one another. By contrast, the outlet of the right ventricle is a freestanding muscular structure, the 
infundibulum that supports the pulmonary valve. The tricuspid and pulmonary valves are thus 
widely separated. In functionally single ventricle anatomy, the ventricular mass usually contains 
one dominant ventricle and one small or rudimentary ventricle [213,214]. The dominant ventricle 
is morphologically normal, possessing an inlet, an apical component together with an inlet and an 
outlet. The small ventricle may be either rudimentary (if it lacks one or more of its component 
parts) or normal in form but hypoplastic. The dominant ventricle will be of left ventricular or 
right ventricular morphology, as defined by the trabecular pattern within the apical component. 
Left and right ventricles always coexist within the same ventricular mass. Therefore, if the 
dominant ventricle has a left ventricular morphology then the small ventricle will have right 
ventricular morphology and vice versa [213,214]. 
Very rarely, the ventricular mass may contain a truly solitary ventricle. These hearts usually 
consist of a double-inlet and double-outlet from a ventricle of indeterminate ventricular 
morphology. The apical portion of the ventricle is coarsely trabeculated with trabeculae that are 
even coarser than those found in the morphologic right ventricle [204,208,211].   
The morphology of the dominant ventricle is particularly important in functionally single 
ventricle anatomy because the dominant ventricle must support blood flow through both 
systemic and pulmonary circulations. The ability of the morphological right ventricle to support 
the entire circulation has been questioned because of anatomical, geometrical and functional 
differences between the morphological left and right ventricles [215].  
The differences in the shape and structure of the two ventricles relate in part to their different 
embryological origins [146]. The normal right ventricle has a complex, truncated asymmetric 
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pyramidal shape, in which the septal contour is indented by the left ventricle [62,216]. The inlet is 
a complex ellipse; the apical portion, which triangulates at the apex, is variably flattened by the 
left ventricle; and the outlet is approximately cylindrical. By contrast, the normal left ventricle has 
a prolate spheroidal [217,218] or catenoidal shape [219,220]. This relatively simple geometry may 
be intrinsically better suited to sustained, high pressure contractile function.  
In conjunction with the differences in ventricular shape, there are also intrinsic differences in the 
arrangement of myocytes within the normal left and right ventricle. Three distinct, concentric 
layers can be identified within the wall of the left ventricle, according to the orientation of the 
myofibres relative to the surface of the heart [220,221]. The myofibres in the superficial layer are 
orientated obliquely, circumferentially in the middle layer and the myofibres in the deep layer are 
aligned longitudinally. Contraction of the thick middle layer results in short-axis shortening and 
the clockwise “wringing” motion, which are primarily responsible for left ventricular force 
generation and ejection [222,223]. However, the normal right ventricle does not contain a middle 
layer [221]. Right ventricular contraction is therefore dependent on longitudinal shortening 
[62,224], which results in a sequential, peristalsis-like contraction that begins in the right 
ventricular inlet and extends into the outlet [225,227,228].  
In addition to the anatomic and geometric considerations, there is considerable debate about 
whether myocytes in the left and right ventricle are intrinsically different. The current evidence 
suggests that the left and right ventricles are broadly similar under experimental conditions. 
Rouleau et al. examined the mechanical characteristics of isolated muscle preparations from the 
canine left and right ventricular free walls [225]. Peak total tension and the rate of tension 
development were similar. These similarities persisted during changes in loading conditions, 
calcium concentration and inotropic agents. However, the right ventricle had a faster rate of 
shortening and attained peak tension more quickly. The authors suggested that this difference 
may reflect physiological adaptation to the normal, low-pressure pulmonary circulation [225].  
Comparable findings have also been identified in isolated, perfused hearts during isovolumic 
contraction. Burkhoff et al. reported that the force-interval relationships in the canine left and 
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right ventricles are virtually identical [226] and the time course for pressure generation is very 
similar [227]. Joyce et al. also identified that systolic function and active diastolic relaxation are 
equivalent, although the right ventricular compliance was also significantly greater [228]. The 
clinical implications of these similarities and subtle differences have not been fully elucidated. 
In spite of this experimental research, there is a long-standing and on-going concern that the 
morphologic right ventricle may be intrinsically less well suited to support either the systemic 
circulation [229] or the entire circulation [230-233]. Patients with a systemic right ventricle have a 
significant risk of heart failure that is accompanied by high mortality [229]. It has a relatively low 
ejection fraction and reduced myocardial functional reserve [234], and it is associated with a 
relatively poor functional adaptation to pressure and volume overload [235,236]. In addition, the 
right ventricle has only a single coronary artery supply, and relative coronary insufficiency has 
been cited as a potential cause of progressive RV failure, particularly were RV hypertrophy co-
exists [237]. At present, however, the clinical importance of these differences remains essentially 
speculative [238]. 
2.11.3  Natural history of functionally single ventricle anatomy 
The natural history of various forms of functionally single ventricle anatomy has been determined 
based on population-based registries of children with congenital heart disease [239-242]; autopsy 
studies [243,244]; together with cohort and series analyses from individual institutions [245-249]. 
The relative merits of each these various study designs have been previously discussed [250]. 
Nevertheless, all of these studies confirmed that functionally single ventricle anatomy is 
associated with a very poor prognosis without palliative or definitive surgical treatment. There is 
a high early mortality rate and a subsequent, progressive attrition with time. Indeed, the survival 
prospects for children with functionally single ventricle are sufficiently poor that diagnosis alone 
strongly indicates the need to proceed along the pathway of surgical palliation. Surgical palliation 
culminates in the Fontan procedure, which connects the systemic and pulmonary circulations in 
series, powered by the single function ventricle. 
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2.12  PROCEDURES TO BYPASS THE RIGHT-SIDE OF THE HEART  
The right or sub-pulmonary ventricle represents an integral part of the normal cardiovascular 
system [255-257]. Contraction of the right ventricle provides the driving force for pulmonary 
blood flow [251]. Right ventricular function also maintains a low pressure in the systemic venous 
system, which prevents systemic venous distension and the development of massive peripheral 
oedema [252].  
Although the right ventricle is intrinsically important, it is not essential to maintain blood flow 
through the pulmonary circulation. For example, long-term survival has been reported in patients 
with tricuspid atresia and congenital aplasia of the right ventricular myocardium [253,254]. 
Experimental studies that deliberately damaged the right ventricle also confirmed that adequate 
pulmonary blood flow and normal venous pressure could be maintained in the absence of the 
pumping function of the right ventricle [252,255,256]. 
Studies in comparative anatomy demonstrated that the pulmonary arterial pressure in fish, 
amphibians, reptiles, mammals and birds were all of the order of 25/10 mmHg. Rodbard & 
Wagner suggested that the force for pumping systemic venous blood through the lungs could be 
adequately supplied by the central venous pressure [257,258].  
A wide variety of surgical procedures were developed to determine the feasibility of partial or 
complete bypass of the right ventricle as well as provide surgical palliation for patients with 
various forms of cyanotic congenital heart disease (Figure 2.23). The historical developments that 
led to these procedures have been thoroughly reviewed in a number of separate articles 
[255,256,259-262]. 
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Figure 2.23 The development of procedures to bypass the right ventricle. The figure includes the experimental 
procedures performed by Rodbard & Wagner (Figure 2.23a) and Haller et al. (Figure 2.23c); Carlon et al. 
(Figure 2.23d) and Robiscsek et al. (Figure 2.23e). The Figure also includes the clinical procedures used by 
Fontan & Baudet (Figure 2.23f) and Kreutzer et al. (Figure 2.23g).These procedures are discussed in more detail 
in the accompanying text. Reproduced from RM Sade [255] 
2.12.1 Partial bypass of the right ventricle 
2.12.1a Superior cavo-pulmonary anastomosis 
Several groups independently demonstrated that partial bypass of the right ventricle could be 
successfully achieved using a superior cavo-pulmonary anastomosis [256]. For example, Carlon et 
al. described a procedure in 1951 where the distal end of the right pulmonary artery was 
anastomosed to the caval origin of the azygos vein and the cavo-atrial junction was ligated (D, 
Figure 2.23) [263]. As a result, blood in the SVC drained directly into the right pulmonary artery 
with no intervening pumping chamber. These experiments formed the basis for the superior 
cavo-pulmonary anastomosis that Glenn used in the first successful clinical case in 1958 [264].  
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The original superior cavo-pulmonary anastomosis (or Glenn shunt) was used to successfully 
palliate a wide variety of congenital heart defects. The procedure was relatively simple to perform 
and had a low operative mortality in properly selected patients. It also provided effective relief of 
cyanosis and satisfactory, sustained long-term palliation [265-270].  
The superior cavo-pulmonary anastomosis has distinct physiologic advantages compared with 
aorta-pulmonary shunts (e.g. Blalock-Taussig, Waterston and Potts-Smith shunts) that were 
traditionally used to provide long-term palliation for patients with cyanotic heart disease [271]. 
The superior cavo-pulmonary anastomosis is associated with more efficient gas exchange because 
only desaturated systemic venous blood in the SVC is directed into the pulmonary arteries rather 
than an arteriovenous mixture. Consequently, equivalent or improved systemic arterial oxygen 
saturations are achieved even though total pulmonary blood flow is reduced [271]. The superior 
cavo-pulmonary anastomosis is also associated with a reduced volume load of the heart 
compared with aorto-pulmonary shunts. This represents the principal haemodynamic advantage 
of the superior cavo-pulmonary anastomosis, as “volume offloading” is associated with better 
long-term preservation of ventricular function and improved overall outcome [269,272,273].  
Despite initial enthusiasm, a number of difficulties were subsequently identified with the Glenn 
shunt. The procedure was associated with an increased risk in infants as a result of small 
pulmonary arteries and higher PVR [266,267,274]. The increased PVR was associated with 
decreased pulmonary blood flow and decreased arterial oxygen saturations [275]. The Glenn 
shunt was also associated with a late clinical deterioration with a fall in the arterial saturations. 
This is primarily due to the growth of the child and the change in the relative proportion of 
systemic venous blood that flows through the SVC, Figure 2.24 [276]. However, the development 
of collateral venous channels from superior to the inferior vena cava; pulmonary arteriovenous 
fistulas; and abnormalities in regional pulmonary perfusion also contributed [277-280]. In 
addition, rapid progress in surgical techniques, extracorporeal perfusion, anaesthesia and post-
operative care made complete repair of congenital anomalies safer at a much earlier age [281]. 
This removed the need for the relatively irreversible Glenn shunt as a “first stage” palliative 
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procedure [282]. Finally, the successful development of the Fontan procedure for the treatment 
of tricuspid atresia and other forms of functionally single ventricle anatomy further decreased the 
need for permanent shunt palliation [283-286].  
 
Figure 2.24 Plot showing the relation between the ratio of superior vena caval (SVC) and pulmonary arterial 
(PA) flows and age in years. Solid line indicates the mean; dotted line, ±1 SD; and broken line, ±2 SD. 
Reproduced from Salim et al.[276]. 
More recently, there has been renewed interest in using a bidirectional cavo-pulmonary 
anastomosis (BCPA) to provide interim palliation prior to the ultimate Fontan procedure 
[271,287-290]. This staging procedure was initially advocated for patients with less favourable 
anatomy and physiology as it may decrease the risks associated with the subsequent Fontan 
procedure [267,288,290,291]. Other units have applied this staged palliation more widely [292-
294]. For example, at Birmingham Children‟s Hospital, the BCPA has been performed as an 
interim stage in all patients prior to completion of the Fontan procedure since 1994 [294].  
Currently, the BCPA is generally performed using one of two separate operative techniques: the 
bidirectional Glenn procedure [268,271,295] or the hemi-Fontan procedure [296-298]. Some 
surgeons advocate the bidirectional Glenn procedure because it is simpler, while others advocate 
the hemi-Fontan procedure because it potentially simplifies the subsequent Fontan procedure 
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[299]. Nevertheless, both procedures leave the central pulmonary arteries in continuity. Blood 
flow in the SVC can therefore pass into the left or right pulmonary arteries (i.e. there is 
bidirectional flow). Studies based on computational fluid dynamics have also demonstrated that 
both procedures perform nearly identically [300,301]. 
2.12.1b  Inferior cavo-pulmonary anastomosis 
While the superior cavo-pulmonary anastomosis has proved highly successful, initial attempts to 
connect the IVC directly to the pulmonary artery were generally unsuccessful. The procedure was 
associated with a high operative mortality and almost all the animals that survived developed 
venous congestion in the splanchnic system and massive ascites [256,302].  
More recently, Mace et al. established that it is possible to safely connect the inferior vena to the 
pulmonary arteries using a tube conduit in an in vivo canine model [303]. Nevertheless, the 
authors demonstrated that the inferior cavo-pulmonary shunt was associated with a significantly 
higher systemic venous pressure and lower cardiac output than the equivalent superior cavo-
pulmonary shunt. These differences were felt to primarily reflect the degree of right-heart bypass 
rather than problems with the inferior cavo-pulmonary shunt per se [303]. 
In a separate article, Mace et al. described the use of the inferior cavo-pulmonary shunt to 
successfully palliate two infants with functionally single ventricle anatomy [304]. However, this 
procedure represented only a small fraction of their normal practice (< 1%) and the inferior 
cavo-pulmonary anastomosis is not widely used to provide interim palliation prior to the Fontan 
procedure. 
2.12.2  Complete bypass of the right ventricle 
The first attempt to completely bypass the right ventricle was made by Rodbard & Wagner in 
1948 [257]. In these canine experiments, the right atrial appendage was anastomosed to the main 
pulmonary artery and the main pulmonary artery was ligated proximal to the anastomosis (A, 
Figure 2.23). Most of the animals survived for periods of up to 2 months after the procedure. 
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However, although the procedure was successful, the right ventricle still contributed to the 
pulmonary circulation as a result of functional tricuspid regurgitation.  
Similar experiments were performed by other groups [305,306]. However, in these experiments 
complete right heart bypass was achieved by also occluding the tricuspid valve orifice. None of 
the animals survived more than a few minutes after the procedure. Rose et al. concluded that,  
“… when the right ventricle is acutely excluded from the circulation, the resulting elevated 
venous pressure is not capable of maintaining adequate lung perfusion” [306]. 
Complete right heart bypass was eventually described in 1966 [307]. In these canine experiments, 
Haller et al. performed a side-to-side superior vena cava-right pulmonary artery anastomosis. 
Then, at a second stage, the tricuspid valve orifice was ligated. All the vena caval blood drained 
via the cavo-pulmonary anastomosis (C, Figure 2.23). In three of the long-term survivors, 
complete obliteration of the tricuspid valve was confirmed with cineangiography. The authors 
postulated that the right atrium may represent an efficient power source.  
This experimental research culminated in 1971, when Fontan et al. described the treatment of 
three patients with tricuspid atresia. The operation was successful in two patients, who were 
followed up for 10 months and 30 months respectively [283]. The surgical procedure involved a 
series of steps (Figure 2.25) that connected the systemic vena cava to the right pulmonary artery 
and the right atrium to the left pulmonary artery, thus completely bypassing the right ventricle. 
This procedure creates a physiologically normal circulation, in which the systemic and pulmonary 
circulations are separate and in-series, powered by the single, functional ventricle.  
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Figure 2.25 Copy of the diagrams illustrating the procedure described by Fontan & Baudet [283]. 
A number of other reports confirmed the efficacy of the Fontan procedure in alleviating cyanosis 
and improving the clinical and functional well-being of selected patients with tricuspid atresia 
[284,285,308-310]. Based on this success, the principles of the Fontan procedure were 
subsequently applied to other more complex forms of congenital heart disease, including patients 
with double-inlet left ventricle, common atrio-ventricular connection, absent left atrio-ventricular 
connection and hypoplastic left heart syndrome [297,311-319]. At present, the Fontan procedure 
represents the procedure of choice for the management of all patients with functionally single 
ventricle anatomy as well as patients with atrio-ventricular or ventriculo-arterial valve anatomy 
that precludes a biventricular repair [320,321]. 
2.12.3 Surgical modifications of the Fontan procedure 
The original operation developed by Fontan & Baudet involved a series of steps, which resulted 
in the separation of the systemic and pulmonary circulation (Figure 2.25). Firstly, the SVC was 
anastomosed to the right pulmonary artery (i.e. a Glenn shunt). The atrial appendage was then 
connected to the proximal stump of the right pulmonary artery using a homograft valve, thus 
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ensuring all the blood in the right atrium flowed into the left lung. The atrial septal defect was 
closed during a period of cardio-pulmonary bypass and a further homograft valve was inserted 
into the orifice of the IVC. Finally, the pulmonary artery was ligated.  
Since the original description, the Fontan procedure has undergone a number of modifications. 
For example, the Glenn shunt, which Fontan included in his original procedure, was used in only 
4 of the 100 patients reported in 1983 [322]. Several other reports confirmed that it was not 
necessary to perform the cavo-pulmonary anastomosis as a simultaneous part of the 
procedure[255,284,285].  
Originally, Fontan & Baudet felt it was necessary to provide the right atrium with two valves to, 
“… prevent free flow between the inferior vena cava, right atrium and pulmonary artery ... and 
stasis in the lower half of the body and inadequate cardiac filling” [283]. It soon became evident 
that the inlet and outlet valves were dispensable [262,320]. Late follow-up studies demonstrated 
that the valves tended to remain open throughout the cardiac cycle [323]. The valves also 
represented a potential source of obstruction to the blood flow through the Fontan circulation 
[316,324,325]. Therefore, inlet and outlet valves are not included in the Fontan procedure used 
currently.  
Fontan & Baudet believed that the hypertrophied right atrium present in tricuspid atresia was 
necessary to provide the additional work to propel the blood from the IVC into the pulmonary 
circulation. The application of the Fontan procedure to other forms of congenital heart disease 
demonstrated that a non-hypertrophied right atrium [297,311,312,316] and even atrial chambers 
grossly distorted by atrial septation procedures could be successfully incorporated in the Fontan 
circulation [314,318-320]. Although right atrium contraction contributed to forward flow through 
the Fontan circulation [326], this contribution was small and not clinically important [325,327]. 
Moreover, atrial contraction created turbulence, which actually increased the resistance to blood 
flow through the Fontan circulation [320].  
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The in vitro experiments conducted by de Leval et al. led to the development of the total cavo-
pulmonary connection (TCPC) [320]. This consists of a BCPA together with the construction of 
a tubular connection between the IVC and the pulmonary arteries. The inferior vena caval blood 
travels through a cylindrical channel of uniform diameter. As a result, the blood flow pattern is 
laminar, which is in contrast to the turbulent blood flow pattern observed in the atrio-pulmonary 
connection [320,328]. The procedure is also technically simple and can be reproduced in virtually 
all forms of functionally single ventricle anatomy [320]. 
Currently, the Fontan procedure is generally constructed using the TCPC. The tubular 
connection between the IVC and the pulmonary arteries consists of either an intra-atrial baffle 
that runs along the lateral aspect of the right atrium [261,320,329] or an extracardiac tube conduit 
that lies adjacent to the heart [330,331]. Studies based on computational fluid dynamics have also 
demonstrated that both procedures perform nearly identically [300,301]. 
A final modification of the Fontan procedure has involved the deliberately leaving a small hole or 
“fenestration” between the systemic venous pathway and the pulmonary venous atrium [332]. 
This allows blood in the high-pressure systemic venous pathway to flow directly into the 
pulmonary venous atrium, particularly during transient and reversible increases in PVR. This 
right-to-left shunt decompresses the systemic venous system, increases venous return and thus 
improves cardiac output, albeit at the expense of a small fall in systemic arterial oxygenation. The 
introduction of this modification into clinical practice has been associated with an improved 
outcome following the Fontan procedure, especially in high-risk patients [231,333]. 
Hosein et al. recently reviewed the surgical practice at Birmingham Children‟s Hospital [294]. The 
Fontan procedure was introduced at this hospital in 1988 and involved one of three distinct 
techniques, which evolved over time. Between 1988 and 1995, the Fontan procedure was 
generally performed using a direct, valveless atrio-pulmonary connection, in which the roof of 
the right atrium was anastomosed to the underside of the pulmonary artery. In 1995, the unit 
adopted the TCPC. This initially involved a lateral atrial tunnel, in which the atrial septum was 
resected and a surgical baffle was constructed to direct flow from the IVC to the superior end of 
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the atrio-pulmonary anastomosis. However, since 1998, the Fontan procedure has been 
performed using an extracardiac conduit TCPC. This involved the interposition of a 
polytetrafluoroethylene (PTFE) tube conduit between the IVC and the right pulmonary artery. 
This technique remains the current practice [294] and represents the technique that has been used 
in the clinical studies reported in this thesis. 
2.13 Current management of functionally single ventricle anatomy 
The current management of children with functionally single ventricle anatomy begins at birth 
and generally involves three separate, staged operations during the first few years of life. This 
management strategy has developed to ensure adequate interim palliation as well as optimal 
preparation for the eventual formation of the Fontan procedure [292,334]. 
Early survival and with functionally single ventricle anatomy requires a balanced circulation, in 
which systemic and pulmonary blood flows are approximately equal. Some children with 
functionally single ventricle anatomy are born with a well-balanced circulation and require no 
surgery at this stage. However, the majority of children have associated heart defects, which limit 
blood flow through either the systemic or pulmonary circulation [335]. These children require 
urgent surgical intervention as a neonate or young infant [334]. This initial palliation represents 
the first and most critical stage of the management of children with functionally single ventricle 
anatomy [292].  
The aims of initial palliation are to create a circulation in which there is unobstructed systemic 
blood flow from the ventricle; unobstructed systemic and pulmonary venous return; and reliable 
and controlled pulmonary blood flow such that the systemic and pulmonary circulations are well-
balanced [292,336]. The initial surgical palliation can be divided into three broad categories 
according to whether the child has inadequate pulmonary blood flow or pulmonary blood flow 
dependent on a patent ductus arteriosus; unobstructed systemic and pulmonary blood flow; or 
systemic outflow obstruction with unobstructed pulmonary blood flow. The details of the 
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surgical palliation for each group have been thoroughly reviewed in a number of textbooks and 
review articles. 
The second stage in the surgical management of children with functional single ventricle anatomy 
involves the formation of the bidirectional cavo-pulmonary anastomosis, as previously described. 
This is usually performed when the child is approximately 6 months of age [294]. The third and 
final stage involves a modified Fontan procedure to connect the IVC to the central pulmonary 
arteries. This results in the completion of the Fontan circulation and the complete bypass of the 
right side of the heart. At Birmingham Children‟s Hospital, this involves a TCPC using a 
fenestrated extracardiac conduit, which is electively performed when the child is approximately 4 
years of age [294]. 
2.14 Haemodynamic changes associated with staged palliation 
The successful management of patients with functionally single ventricle anatomy is 
fundamentally dependent on the performance of the dominant ventricle, which must support 
blood flow through the systemic and pulmonary circulations [320]. However, functionally single 
ventricle anatomy is also characterised by abnormal circulatory haemodynamics, which change 
during the course of surgical palliation. These abnormal circulatory haemodynamics may 
profoundly influence the performance of the dominant ventricle and thus could potentially 
influence the clinical outcome of children with functionally single ventricle anatomy.  
Initial surgical palliation establishes a circulation in which the systemic and pulmonary 
circulations are connected in parallel with one another (Figure 2.26A). Subsequent surgical 
management results in the progressive and ultimately complete separation of the systemic and 
pulmonary circulations. The BCPA results in partial separation by creating a circulation in which 
the pulmonary circulation is connected in series with the systemic circulation of the upper half of 
the body only (Figure 2.26B). Finally, the Fontan procedure creates a “physiologically normal” 
circulation in which the systemic and pulmonary circulations are separate and in series with one 
another (Figure 2.26C).  
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Figure 2.26 Schematic diagram of the circulation (A) with a balanced in-parallel circulation, (B) following 
formation of the BCPA and (C) following the Fontan procedure. 
QP, pulmonary blood flow; QS, systemic blood flow; CO, cardiac output.  
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Barnea et al. demonstrated that oxygen availability in a parallel circulation varies according to 
cardiac output, oxygen capacity, pulmonary oxygenation and oxygen consumption of the whole 
body. Maximal oxygen availability occurs when the systemic-pulmonary flow ratio is equal to or 
slightly less than 1[337]. Therefore, the ventricle must eject between approximately 5.0 L∙min-1∙m-
2 in order to maintain a systemic cardiac index of 2.5 L∙min-1∙m-2. As a result, the parallel 
circulation is characterised by obligate volume loading of the single functional ventricle [338].  
Chronic volume loading severely affects the morphologic and functional characteristics of the 
ventricle. It induces a progressive dilatation and spheroid remodelling of the dominant ventricle 
[345-348], such that the indexed end-diastolic volume (EDVI) is approximately 50% higher than 
normal [339]. There is a corresponding increase in the ventricular mass, which helps preserve the 
normal ventricular mass-volume ratio [338,339]. Nevertheless, in spite of these adaptive changes, 
ventricular dysfunction and failure eventually develop in most children with functionally single 
ventricle anatomy that are palliated for a long time [340].  
The subsequent surgical management of functionally single ventricle anatomy abolishes the 
volume overload, reduces the EDVI by approximately 50% [339] and increases the total vascular 
resistance (TVR) by more than two-fold [341]. In particular, the formation of the BCPA is 
associated with a 25% reduction in the EDVI within 30 days of the operation [342]. The TVR is 
also 40% higher in patients with a BCPA compared with patients who had undergone initial 
palliation only [343]. Completion of the Fontan circulation is associated with a further 20% 
reduction in the EDVI and 20% increase in TVR within 6 weeks of the operation [343].  
The early reduction in ventricular dimensions, which accompanies the successful management of 
functionally single ventricle anatomy, is associated with the development of an increasingly 
ellipsoid shaped ventricle. This is subsequently followed by the regression of the ventricular mass, 
such that the ventricle ultimately develops a normal ventricular volume and wall thickness [338]. 
However, the rate of decrease in ventricular mass is much slower than the reduction in 
ventricular volume. There is, therefore, a temporary increase in the ventricular mass-volume ratio 
during the early post-operative period [344]. 
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There is a complex interdependence between ventricular function, the volume and pressure 
loading characteristics and the ventricular shape. The changes in circulatory haemodynamics and 
ventricular geometry, which accompany the management of functionally single ventricle anatomy, 
may both influence the function of the dominant ventricle. The reduction in volume load and the 
development of a more ellipsoid ventricular shape provide more favourable working conditions 
for the ventricle, and this should be accompanied by an improvement in ventricular systolic 
function [338]. By contrast, the temporary increase in mass-volume ratio is generally associated 
with the development of diastolic dysfunction, with both impaired active ventricular relaxation 
and reduced ventricular compliance [345-347]. This diastolic dysfunction has been identified as a 
primary determinant of early outcome following the Fontan procedure [346,348,349]. The 
increase in TVR might also be expected to affect the performance of the dominant ventricle, with 
the development of systolic or diastolic dysfunction. Equally importantly, acute changes in TVR 
may alter the balance between ventricular systolic function and vascular load. Acute changes in 
this ventricular-vascular coupling ratio are generally characterised by a reduction in the 
mechanical efficiency of the ventricle and impaired global cardiovascular function [341,350]. 
A limited number of studies have been undertaken to determine the effect of surgical 
management on ventricular function in children with functionally single ventricle anatomy. There 
are no contemporary studies that have evaluated the effect of the BCPA on ventricular function. 
In addition, there have been only two studies to quantitatively evaluate the effect of the Fontan 
procedure on ventricular function in children with a pre-existing BCPA [343,351]. Tanoue et al. 
reported that the Fontan procedure was associated with an improvement in ventricular systolic 
function and an increase in the mechanical efficiency, despite an increase in the TVR [343]. 
However, this study was associated with two important limitations. Firstly, it did not evaluate 
changes in diastolic function, which may represent the primary determinant of outcome following 
the Fontan procedure. Secondly, the study involved repeat studies, which were undertaken 6 
weeks post-operation. These results may, therefore, not be representative of the changes that 
occur during the high-risk, early post-operative period.  
Chapter 2 
- 70 - 
2.15 CONCLUSION 
This chapter describes the basic anatomy and physiology of the normal human heart. The normal 
human heart is a complex organ that is composed of two muscular pumps, which are connected 
in-series with the vasculature to deliver oxygenated blood to the body. The performance of the 
heart as a muscular pump is controlled by intrinsic and extrinsic factors that influence the 
function of both individual myocytes as well as the heart as a whole. 
The performance of the heart as a muscular pump is defined by changes in pressure and volume 
within the ventricle. A series of relatively load-independent indices of ventricular systolic and 
diastolic function can be calculated based on the instantaneous pressure-volume relation. This 
method of analysis was considered essential for this thesis, which sought to examine ventricular 
function and the effects of surgical palliation in children with functionally single ventricle 
anatomy. The advantages and disadvantages of methods available for measuring ventricular 
pressure and volume are discussed in Chapter 3.  
   
CHAPTER 3 
GENERAL METHODS 
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CHAPTER 3. GENERAL METHODS 
 
The management of children with congenital heart disease is highly dependent on imaging. Both 
non-invasive and invasive diagnostic techniques are routinely used to define the intracardiac 
anatomy; evaluate cardiac and valvular function; and determine the most appropriate 
management strategy for each patient. Many patients also require serial investigations to monitor 
changes in haemodynamics, which generally predate changes in clinical and functional 
performance [352].  
This Chapter will outline the various techniques that can be used to assess the ventricular 
volume; ventricular and intravascular pressure; and blood flow within the cardiovascular system.  
3.1  VENTRICULAR VOLUME MEASUREMENTS 
A variety of different imaging modalities are used to measure ventricular volume in routine 
clinical practice. These include echocardiography, magnetic resonance imaging (MRI), 
radionuclide angiography and conventional X-ray angiocardiography [353,354]. All of these 
techniques work well and are sufficiently accurate in most routine cases. The decision about 
which one to use will depend on the clinical question and information required, the need for 
reproducibility, the costs involved as well as the risks to the patient and clinical team. A detailed 
understanding of the capabilities of each method is less important than choosing an appropriate 
technique and using it well [355]. 
3.1.1 Echocardiography 
Echocardiography is a specialised type of ultrasound examination, which uses high-frequency 
sound wave (2 – 10 MHz) to generate images using a pulse-echo technique [356]. The ultrasound 
transducer produces a brief pulse of high-frequency sound waves that is transmitted into the 
patient. The transducer then becomes a receiver to detect sound waves reflected from the tissues 
(i.e. echoes). The depth of the reflecting surface is determined by the time it takes for the sound 
wave to return to the transducer. The strength of the reflected signal is illustrated by shades of 
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grey. This information is used to construct one-dimensional (M-mode) or two-dimensional (B-
mode) tomographic images of the heart. More advanced ultrasound transducers have now been 
developed, which produce three-dimensional ultrasound images in real-time [357].  
Trans-thoracic echocardiography is the first-line investigation for children with congenital heart 
disease. It produces high quality images of the heart and great vessels, which can be used to 
accurately assess ventricular function. Two-dimensional and Doppler echocardiography can also 
be used to assess valvular, myocardial, pericardial and extra-cardiac abnormalities. Of all the non-
invasive techniques currently available, echocardiography is the most versatile, provides the most 
additional information and has the lowest cost [358]. Nevertheless, echocardiography is 
associated with a number of limitations. Firstly, ultrasound does not readily cross tissue-gas or 
tissue-bone boundaries. As a result, the acoustic windows may be limited by the sternum, ribs or 
the lungs. These problems are particularly important in patients with congenital heart disease, 
since assessment of the right ventricle is frequently required. The right ventricle normally lies 
directly beneath the sternum and is, therefore, frequently inaccessible to ultrasound. In addition, 
patients may have undergone multiple operations that can further reduce the acoustic windows. 
Secondly, the endocardial surface for the greater part of the ventricular cavity lies parallel to the 
ultrasound beam and is, therefore, not well demonstrated. There may also be areas of signal 
“drop-out” where the endocardium is not demonstrated at all. As a result, a considerable 
subjective element is often present when the cavity is outlined on echocardiographic images [96].  
At Birmingham Children‟s Hospital, quantitative left ventricular volume measurements are 
calculated using the area-length method. This method was not used in the studies reported in this 
thesis for the following reasons. The area-length method is based on the assumption that the 
shape of the left ventricle can be modelled as an ellipsoid of revolution. These assumptions may 
not reflect the actual changes in geometry that occur during the normal cardiac cycle [359,360]. 
While Mercier et al. demonstrated that left ventricular end-diastolic volume and ejection fraction 
calculated using this method were highly correlated with measurements made using X-ray 
angiocardiography [361], other studies have demonstrated that these volume measurements may 
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underestimate ventricular volume by up to 40% [218,362]. There are also reports of poor 
repeatability between duplicate measurements on the same patient [96]. These problems 
potentially limit the usefulness of echocardiography to continuously measure intraventricular 
volume. Consequently, two-dimensional echocardiography was not used in this thesis.  
3.1.2 X-ray angiocardiography 
Traditionally, more detailed anatomical and functional assessment has been acquired with X-ray 
angiocardiography, also known as cardiac catheterisation. At Birmingham Children‟s Hospital, 
patients considered for complete surgical repair of complex congenital heart defects will usually 
undergo cardiac catheterisation as part of the pre-operative investigation. This procedure is 
primarily used to help define the cardiac anatomy, quantify shunts between cardiac chambers, 
measure gradients across stenotic vessels or valves and quantify PVR. Cardiac catheterisation is 
not used in all patients because it is associated with an increased risk compared with non-invasive 
trans-thoracic echocardiography. This is as a consequence of the invasive nature of the 
procedure; the exposure to ionising radiation; and the use of iodinated contrast medium.   
Angiocardiography images are acquired as two-dimensional planar images and are characterised 
by high spatial and temporal resolution. Accurate and reproducible left and right ventricular 
volumes can be calculated from single or biplane images [64,363]. However, like two-dimensional 
echocardiography, these measurements make assumptions about ventricular shape that may not 
reflect the actual geometry, especially in patients with congenital heart disease. In addition, there 
may be some uncertainty about the position of the endocardium on angiocardiographic images, 
which results in an underestimate of ventricular volume at end-systole [364]. Both of these 
factors potentially affect the absolute accuracy of volume measurements made using this 
technique [365-367].  
At Birmingham Children‟s Hospital, X-ray angiocardiography is used to provide a qualitative 
assessment of ventricular function [368], but it is not used to quantify either left or right 
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ventricular function for the reasons previously outlined. Similarly, this technique was not used in 
this thesis. 
3.1.3 Radionuclide angiography 
Radionuclide imaging has been used to quantify ventricular function and intracardiac shunting as 
well as to assess relative pulmonary perfusion [369-371]. The production of radionuclide images 
involves the intravenous injection of a radioactive tracer molecule (such as 99mTc-labelled red 
blood cells) and mapping the distribution of the radio-labelled pharmaceutical within the body 
using a gamma camera. The amount of radiopharmaceutical within a particular organ is 
quantified by measuring the radiation emitted within a particular time. 
Radionuclide angiography with ECG-gating allows the construction of time-activity curves that 
measure “time-averaged” left and right ventricular volumes throughout the cardiac cycle 
[371,372]. Quantitative measurements of ejection fraction in both the left and right ventricles are 
highly accurate provided that the images separate the chambers from one another [371]. 
However, radionuclide imaging is not suitable for beat-to-beat measurements of ventricular 
volume. The technique is also associated with a significant radiation exposure [373] and 
equivalent information can generally be obtained using other lower-risk techniques. 
Consequently, this technique was not used in this thesis. 
3.1.4 Magnetic resonance imaging 
More recently, cross-sectional cardiovascular imaging, using MRI and multi-detector computed 
tomography, have developed as important techniques for the diagnosis and follow-up in patients 
with congenital heart disease [374,375]. MRI is currently the three-dimensional imaging modality 
of choice, as it allows accurate assessment of intracardiac anatomy, function and flow without 
ionising radiation or the potential complications of iodinated contrast media [353]. Ventricular 
volume measurements are generally obtained using 8 to 12 contiguous time-resolved short-axis 
slices that extend from just above the atrio-ventricular valve to the apex of the heart. The 
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endocardial borders are traced on all images at the phases of interest (i.e. end-diastole and end-
systole). The ventricular volume is then calculated using Simpson‟s rule (Equation 3.1).  
Equation 3.1  
n
dAV
0
,  
where V is the volume, A is the measured area, d is the slice thickness and n is the number of 
slices.  
MRI is the most accurate method for measuring volume in the left and right ventricle, since it 
makes no assumptions about the shape of the ventricle [376]. Consequently, MRI is currently 
regarded as the clinical “gold standard” for the assessment of ventricular volume and mass 
[377,378]. Kuehne et al. have also demonstrated that MRI volume measurements can be 
combined with synchronous pressure measurements to analyse ventricular function using 
instantaneous pressure-volume relations [379].  
It should be acknowledged that MRI is associated with a number of practical difficulties. For 
example, the complete evaluation of the heart and central vessels requires a number of separate 
MRI sequences. The majority of these sequences are acquired using ECG-gating while the patient 
holds their breath to reduce the artefacts associated with respiratory motion. As a result, cardiac 
MRI examinations are time consuming. The complete evaluation of complex case, for example, 
may take up to 1 hour. In addition, cardiovascular MR imaging in children less than 8 years of age 
is only performed under general anaesthesia. Because of these practical problems, this technique 
was not used in the studies reported in this thesis. 
3.1.5 Conductance catheter technique 
In addition to the conventional imaging techniques already described, ventricular volume can also 
be measured using the conductance catheter technique. This technique uses a multi-electrode 
catheter to produce continuous, real-time ventricular volume measurements based on the 
electrical conductance of blood within the ventricular cavity [380-382]. Although this technique is 
not used in routine practice, it has been used extensively in both animal experiments and clinical 
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studies to evaluate normal physiology and determine the effects of various pharmacological, 
interventional and surgical procedures on systolic and diastolic ventricular function [97,98]. 
3.1.5a History of conductance volume measurements 
Electrical conductance or its reciprocal electrical impedance has been used to used to measure 
intravascular volume since the beginning of the twentieth century [97,383,384]. In 1953, Rushmer 
et al. fixed electrodes to the left and right ventricular myocardium in dogs to record electrical 
impedance during the cardiac cycle. The authors demonstrated that the impedance increased 
during ejection and decreased during filling of the ventricle [385]. In 1966, Geddes et al. applied 
this technique to measure the continuous stroke volume using two bipolar electrodes inserted 
into the base and apex of the canine left ventricle. These measurements were combined with 
simultaneous intraventricular pressure measurements to produce probably the first 
intraventricular pressure-impedance diagram [386].  
All of the initial experimental studies used electrodes that were attached to the myocardium. In 
1967, Palmer showed it was possible to measure impedance using a catheter placed inside the 
ventricle (Reported in White & Redington, [384]). This catheter consisted of five electrodes, two 
of which could be used to measure volume. However, while the catheter produced high-quality 
volume recordings, the measurements were characterised by a high variability [387].  
In 1981, Baan et al. reported a new conductance catheter that could be used to accurately measure 
the continuous stroke volume in the dog [380]. The authors subsequently demonstrated that the 
same catheter could be used to measure the absolute volume in both canine and human left 
ventricles [381]. The current design of the conductance catheter is essentially the same as that 
developed by Baan et al. [380,381], as will be discussed in more detail in the following sections. 
3.1.5b Theoretical basis of conductance catheter technique 
Electrical conductance is a measure of how easily electricity flows through an electrical element. 
It is the reciprocal of electrical impedance, which represents the total resistance to an alternating 
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current. In biological materials like blood and muscle, impedance arises from both the resistive 
and dielectric properties (capacitance or inductance) of the material [388].  
The conductance catheter technique is based on the principle that the bioelectrical properties of 
the ventricle vary as a function of the ventricular volume [383,389]. This principle can be 
illustrated using a physical model like a cylinder. The impedance of the cylinder, Z will vary 
according to length, L and cross-sectional area of the cylinder, A; and the resistivity, ρ of the 
material (Equation 3.2).  
Equation 3.2  ALZ  
The volume can be affected by changes either in the length or the cross-sectional area of the 
cylinder. However, these two effects cause opposite changes in the measured impedance. The 
measured impedance will increase with increments in cylinder length while conversely the 
measured conductance will increase with increments in the cross-sectional area [383].  
In the conductance catheter technique, the relative positions of the electrodes on the catheter are 
fixed, so that change in the measured conductance signal reflects a change in the cross-sectional 
area of the ventricle. Consequently, the conductance signal is high when the ventricle is full (i.e. 
end-diastole) and low when the ventricle is only partially filled (i.e. end-systole) or empty. 
3.1.5c Volume measurements using the conductance catheter technique 
The conductance catheter consists of a series of up to twelve electrodes that are mounted along 
the distal end of a standard angiographic catheter. This catheter is inserted along the long-axis of 
the ventricular cavity, as illustrated in Figure 3.1.  
Chapter 3 
- 78 - 
 
Figure 3.1 The combined pressure-conductance catheter in the left ventricle. The electrodes are used to establish an 
intracavitary electric field and measure segmental conductance volumes. The pressure transducer is positioned in 
segment 3. Reproduced from Steendijk et al.[114]. 
The most proximal and most distal electrodes are used to generate an intracavitary electric field. 
The intensity and frequency of the current are chosen to ensure that the electric field does not 
cause heating or stimulate the heart [390]. Higher frequencies allow higher currents to be used, 
thus improving the signal to noise ratio [387]. In practice, frequencies in the range of 1 kHz – 100 
kHz can be used with a current of between 50 μA – ~5 mA, respectively.  
The remaining eight electrodes are “sensing” electrodes. They measure the potential difference 
between consecutive electrodes to derive up to seven segmental conductance signals, Gi(t). 
Conductance is defined as the applied current divided by the measured potential difference 
between adjacent electrodes. As a first approximation, the conductance signal measured between 
any two adjacent “sensing” electrodes can be considered as a cylinder in which the boundaries are 
defined by the endothelial surface of the myocardium and the equipotential surfaces of the 
electrodes. The total conductance signal within the ventricular cavity can then be likened to a 
column of cylinders stacked one on top of the other.  
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Absolute time-varying volume measurements, V(t) are obtained from the conductance signal 
using a simple algorithm (Equation 3.3), which takes into account the inter-electrode distance on 
the catheter, L and the specific resistivity of blood, ρ [381].  
Equation 3.3 
7
1
21
i
Pi GtGLtV , 
where α is a dimensionless calibration coefficient and GP is a volume offset called parallel 
conductance.  
The specific resistivity of blood, ρ is approximately 150 Ω∙cm at normal body temperature [391]. 
However, this value may vary between individuals and in the same patient under different 
conditions. Changes in the concentration and morphology of the red blood cells, electrolyte 
composition and blood temperature can all affect the measured blood resistivity [387]. 
Consequently, the specific blood resistivity should be measured in all patients and re-measured 
whenever it is likely to have changed [392].  
In this thesis, the resistivity was measured before each test using a dedicated measuring cuvette 
(CD Leycom, Zoetermeer, The Netherlands). 
3.1.5d Calibration of conductance volume measurements 
The conductance catheter technique is based on the assumptions that, firstly, the electric field 
produced by the catheter is homogeneous and parallel to the long-axis of the ventricle; and, 
secondly, that the electric field is contained within the ventricular cavity. In practice, however, 
neither is the case. The calculation of absolute ventricular volume from conductance 
measurements requires the estimation of a volume offset (parallel conductance, GP) and the 
dimensionless calibration coefficient, α (Equation 3.3).  
 Parallel conductance 
When the frequency of the current is between 20 kHz and 1 MHz, the resistivity of the 
myocardium (400 Ω∙cm) is only 2.5-times greater than the resistivity of blood [391]. As a 
Chapter 3 
- 80 - 
consequence, the electric field extends beyond the ventricular cavity into the surrounding 
structures (e.g. the myocardium, the contralateral ventricle, the atria and the pericardium). 
Therefore, the measured conductance signal tends to overestimate the actual blood volume due 
to this parallel conductance. 
In the experimental studies included in this thesis (Chapters 4 and 5), the problems posed by 
parallel conductance have been avoided by using a physical model of the left ventricle, which was 
develop by Dr A.H. Al-Khalidi as part of his PhD thesis [98]. However, parallel conductance is a 
potential problem in the clinical studies (Chapters 6 and 7). Consequently, the effect of parallel 
conductance on the accuracy of conductance volume measurements needs to be considered in 
detail.  
Several different methods have been described to deal with the problem of parallel conductance 
[381,393-395]. McKay et al. proposed a method that exploits the difference in resistivity between 
muscle and blood at different frequencies [395]. They developed a conductance catheter that used 
a frequency of 1.3 kHz. At this frequency, the myocardial resistivity is 1000 Ω∙cm or 7-times 
higher than that of blood and a much smaller proportion of the current will dissipate from the 
ventricle [395]. However, signal loss still occurs. In addition, the catheter was associated with a 
poor signal-to-noise ratio, which meant they were unable to obtain accurate measurements of 
absolute volume.  
The conductance catheter used in this thesis generates a current of 30 µA at 20 kHz, in order to 
ensure patient safety and good signal-to-noise ratio. These parameters mean that the method 
advocated by McKay et al. cannot be used. Instead, the contribution of parallel conductance is 
usually measured using the hypertonic saline injection method [381]. This involves injecting a 
small bolus of hypertonic saline (10%) into a central vein or the pulmonary artery [396]. The 
saline causes a dramatic fall in blood resistivity and an apparent increase in the measured 
intraventricular volume (Figure 3.2), while the parallel conductance is assumed to remain 
constant.  
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Figure 3.2 Plot of conductance volume, Q(t) versus time during the passage of a bolus of 0.25 ml∙kg-1 10% 
NaCl solution into the dominant ventricle. The conductance volumes at end-diastole (green squares) and end-systole 
(red circles) are identified for each beat. The “wash-in” and “wash-out” phases are also illustrated.  
The parallel conductance can be calculated using one of two linear regression analysis techniques 
[381,397]. In the method proposed by Baan et al., the maximum conductance (QED) is plotted 
against the subsequent minimum conductance (QES) of each beat, using at least eight data points 
during the “wash-in” phase (Figure 3.3A) [381,398]. The theoretical relationship between QED 
and QES represents a straight line. This line is extrapolated to the line of identity (i.e. QED = QES); 
the conductance at this point of intersection represents parallel conductance [381]. The 
alternative method proposed by Steendijk et al. involves plotting the maximum conductance 
(QED) against the stroke conductance (QSV = QED - QES) and the relation is extrapolated to the 
point where stroke conductance is zero (Figure 3.3B) [397]. Parallel conductance, GP is then 
subtracted from the measured conductance signal, as set out in Equation 3.3. 
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Figure 3.3 Linear regression analyses were used to calculate parallel conductance. The data corresponds with the 
data presented in Figure 3.2. The data-points from the “wash-in” phase (white inverted triangles) and other data 
(black circles) are both plotted. A, The relationship between end-systolic conductance versus end-diastolic 
conductance. The parallel conductance is equal to the point of intersection with the line of identity (x = y). B, The 
relationship between end-diastolic conductance and stroke conductance. Parallel conductance is equal to the 
intersection with the x-axis (i.e. stroke conductance = 0).  
Both of these methods make a number of assumptions about parallel conductance and the effect 
of hypertonic saline on parallel conductance. For example, parallel conductance is assumed to 
remain constant throughout the cardiac cycle; it is also assumed that the injection of hypertonic 
saline does not alter the ventricular volume or parallel conductance or the conductivity of the 
surrounding structures. Subsequent studies have demonstrated that some of these assumptions 
may not strictly be true [399-402].  
Despite these concerns, I have chosen to measure parallel conductance in the clinical studies 
using the method described by Baan et al. [381]. This choice was based on some preliminary 
studies in which I used both approaches. In addition, I was concerned that the method advocated 
by Steendijk et al. [397] may be more susceptible to measurement error. Specifically, the variance 
associated with stroke conductance (QSV) is equal to the variance associated with QED 
measurements plus the variance associated with QES measurements. In other words, the variance 
associated with QSV measurements will inevitably be greater than the variance associated with 
either individual conductance volume measurement.  
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 The dimensionless slope factor, α 
Conductance volume measurements are based on the assumption that the electrical field created 
by the catheter is homogeneously distributed within the ventricular cavity. This can only be 
achieved if the electrodes are large end-plate electrodes. However, if small electrodes are used (as 
in the conductance catheter), these electrodes act as a point source [388]. The electric field is 
concentrated around the outermost electrodes and attenuated in the middle of the catheter 
[403,404]. The density of the current also varies in the transverse plane, decreasing exponentially 
as the distance from the catheter increases [404-406]. 
A number of modifications to the conductance catheter technique have been proposed in order 
to address the problem of electric field non-homogeneity and improve the accuracy of 
conductance volume measurements. These have included the development of the dual-field 
excitation catheter [407]; together with mathematical techniques of field extrapolation to estimate 
the expected field distribution under ideal conditions [403,408-410]. 
The dual-field excitation catheter generates an electric field by applying an alternating current 
between the outermost electrodes and a second alternating current of opposite polarity between 
the two adjacent electrodes [411]. Dual-field excitation improves the field dispersion within the 
ventricular cavity by correcting the curvature of the equipotential lines close to the excitation 
electrodes [411,412]. This improves the accuracy of conductance volume measurements but the 
system is still not perfect [404,405].  
Despite the problems with dual-field excitation, we have used this system throughout this thesis. 
One alternating current (20 kHz, 30 µA RMS) was applied between the two outermost electrodes 
(electrodes 1 and 12) and a second alternating current of opposite polarity (20 kHz, -10 µA RMS) 
was applied between the two adjacent electrodes (electrodes 2 and 11).   
One consequence of electric field non-homogeneity is that the conductance catheter tends to 
slightly overestimate the absolute volume at low volumes and progressively underestimate the 
absolute volume with further increments in the ventricular volume [404,405]. In addition, the 
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conductance-derived stroke volume generally underestimates the actual stroke volume [381]. To 
address these problems, conductance volume measurements are calibrated with the dimensionless 
calibration coefficient in order to improve the accuracy of ventricular volume measurements 
[381]. This calibration coefficient represents the slope of either the conductance-absolute volume 
relationship [382] or the stroke conductance-stroke volume relationship [114]. 
In the isolated post-mortem canine heart, Mur & Baan reported that the conductance-volume 
relation was virtually linear over a finite volume range [382]. The authors predicted that a similar, 
virtually linear conductance-volume relation would be observed for the human left ventricle up to 
a volume of 200ml [382]. Unfortunately, in vivo experiments in the intact circulation have 
subsequently demonstrated that α is not constant but varies according to the ventricular volume 
[401,413,414].  
The non-linearity of the conductance-absolute volume relationship potentially affects the 
accuracy of conductance volume measurements calibrated using this technique. This is 
particularly important in patients with congenital heart disease, since the changes in volume-
loading conditions are generally more marked than those observed in patients undergoing 
diagnostic catheterisation or adult cardiac surgery. For this reason, this relationship was analysed 
in detail. This study is presented in Chapter 4.  
Despite these concerns, conductance volume measurements in the clinical studies (Chapters 6 
and 7) were calibrated using a calibration coefficient, α that represented the stroke conductance-
stroke volume relationship, in which stroke volume was independently measured using an transit-
time ultrasound flow meter with a probe placed around the ascending aorta (Transonic Systems 
Europe B.V., Maastricht, The Netherlands).  
3.1.5e Calibrated conductance volume measurements 
In spite of the potential limitations already described, the conductance catheter technique 
represents on of the most powerful tools for the assessment of cardiac function in vivo. The 
technique provides continuous measurements of ventricular volume in real-time. Animal 
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experiments and clinical studies have consistently demonstrated that, after calibration, the 
technique provides accurate and reproducible volume measurements that are highly correlated 
with volume measurements made using other techniques [413-417]. In addition, the technique 
does not make any specific assumptions about ventricular geometry and can therefore be used to 
measure left and right ventricular volume. 
The particular advantage of the conductance catheter technique, however, is that it can provide 
continuous and accurate volume measurements during rapid changes in ventricular volume, such 
as inferior vena caval occlusion (IVCO). When combined with simultaneous pressure 
measurements, this enables the accurate assessment of ventricular systolic and diastolic function 
using pressure-volume analysis. In this regard, the conductance catheter technique represents 
probably the most powerful method for the assessment of cardiac function in vivo.  
3.2 PRESSURE MEASUREMENTS 
Various methods are commonly used to measure blood pressure in clinical practice. Blood 
pressure is routinely measured non-invasively by external compression of an artery in the arm or 
leg with a sphygmomanometer [418]. Blood pressure can also be measured invasively by 
positioning a catheter within the desired cardiac chamber or vessel. The catheter is attached to a 
calibrated pressure transducer or manometer, which converts the pressure into a signal output 
(e.g. electrical voltage or current) to provide continuous blood pressure measurements in real-
time [419].  
Invasive measurements of arterial or central venous pressure are routinely performed in 
paediatric patients undergoing cardiac surgery using a fluid-filled catheter-manometer system. 
This consists of a disposable manometer mounted near the patient, which is connected to the 
intravascular cannula by a length of stiff, non-compliant fluid-filled tubing. A pressurised, 
continuous flush system is also connected to the catheter-manometer system in order to maintain 
the patency of the invasive pressure monitoring line [420]. The fluid-filled catheter-manometer 
system provides reliable pressure measurements that are adequate for most clinical situations. 
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However, when it is important to obtain precise pressure recordings (like the transvalvular 
pressure gradient, for example) micromanometer catheters may be used. These catheters have the 
manometer mounted at the tip of the catheter, which improves the accuracy of the measurements 
and also reduces some of the artefacts associated with fluid-filled catheter-manometer system.  
3.2.1 Accuracy of the catheter-manometer system 
The quantitative analysis of pressure waves requires a system that can faithfully reproduce the 
intravascular or intraventricular pressure waveform. The absolute accuracy of the measurements 
will vary according to the dynamic response characteristics of each catheter-manometer system 
[421]. It is important to understand the specific characteristics of the system being used and, in 
particular, the amplitude linearity or sensitivity; frequency and phase response; and stability of the 
system [48,387]. 
The pressure wave can be thought of as the sum of a series of sine waves, called harmonics. The 
fundamental sine wave, or first harmonic, has the same frequency as the heart rate and higher 
harmonics are multiples of this basic frequency [422,423]. At least 5 or 6 harmonics are required 
to replicate the original pressure waveform [424,425]; and at least 15 harmonics are necessary for 
accurate reproduction of the first-derivative of ventricular pressure with respect to time (dP/dt) 
[426]. The average heart rate in young children is approximately 100 beat∙min-1. Therefore, in 
these patients, the catheter-manometer system needs to have a constant frequency response up to 
at least 25 Hz in order to faithfully reproduce the time-varying pressure and dP/dt waves. 
The catheter-manometer system can be characterised as a second-order dynamic system [427]. 
This system is analogous to a bouncing tennis ball. When the tennis ball is dropped onto a hard, 
flat floor, it bounces several times before eventually coming to rest. With each bounce, the ball 
does not rise as high as on the previous bounce. Each bounce has a characteristic frequency and 
the time it takes for the ball to come to rest is related to the damping coefficient [428]. The 
frequency response of the catheter-manometer system can similarly be described by the natural 
frequency and damping coefficient of the system [429], Figure 3.4.  
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Figure 3.4 Plots illustrating the dynamic response characteristics of the catheter-manometer system. A, the 
amplitude – frequency curve; B, phase lag – frequency curve. Reproduced from WW Nichols & MF O‟Rourke 
[430]. 
The catheter-manometer system is usually “under-damped” with a damping coefficient of less 
than 0.3 [421,428]. If the pressure wave contains harmonics with a frequency similar to the 
natural frequency of the catheter-manometer system, the amplitude of these harmonics will be 
amplified. This is important clinically, as it may lead to an artefactual increase in the systolic 
blood pressure and a corresponding decrease in the diastolic blood pressure measurements [431]. 
Amplification of the pressure pulse can be avoided by increasing the damping coefficient, such 
that the system becomes “optimally damped”. However, increasing the damping coefficient alters 
the relative timing (or phase) of the separate harmonics. This phase distortion can result in a 
significant change to the shape of the overall pressure wave.  
Ideally, one would like to have accurate pressure measurements without any phase distortion. 
This requires a catheter-manometer system with a very high natural frequency and a very low 
damping coefficient. These specifications are best achieved by micromanometer catheters, which 
commonly have a natural frequency in the kilohertz range and a phase lag that can hardly be 
discriminated from zero [430]. Sufficiently accurate blood pressure measurements can also be 
made using a fluid-filled catheter-manometer system provided it has a sufficiently high natural 
frequency and is adequately damped [428,432].  
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3.2.2 Other problems with the catheter-manometer system 
In addition to the problems associated with the frequency and phase response of the catheter-
manometer system, pressure recordings are also affected by events that occur within the vascular 
system. Three specific problems, namely the “end-pressure artefact”, “catheter whip artefact” and 
the “catheter impact artefact” will be discussed.  
The end-pressure artefact arises if the tip of the catheter points upstream into the blood flow. In 
this position, the manometer will record the kinetic energy of blood flow as well as the lateral 
pressure within the vessel. This may add between 2 – 10 mmHg to the actual pressure reading. 
Although the absolute pressure generated is small, the end-pressure artefact can also substantially 
alter the shape of the pressure waveform as the peak velocity of blood flow tends to occur before 
the peak pressure [430]. This artefact can be avoided by measuring pressure through the side of 
the catheter rather than at the end.  
The catheter whip and catheter impact artefacts are similar. The catheter whip artefact occurs as a 
result of motion of the tip of the catheter in the heart or great vessels. By contrast, the catheter 
impact artefact occurs when the catheter is hit by the opening or closing of the valves or by the 
wall of the ventricular chamber. In each case, the movement results in the acceleration of the 
fluid within the catheter. This creates a transient pressure wave, which may add up to 10 mmHg 
to the actual pressure reading. Catheter whip and catheter impact artefacts are a particular 
problem in the fluid-filled catheter-manometer system. There effect is minimised in the 
micromanometer catheter primarily because of the absence of the fluid column within the 
catheter.  
3.2.3 Dynamic response characteristics of clinical catheter-manometer system 
Invasive pressure measurements at Birmingham Children‟s Hospital are generally performed with 
a fluid-filled catheter-manometer system. This consists of a disposable strain-gauge catheter-
manometer system (DPT-6000; Codan Ltd, Wokingham, UK) connected to a pressure transducer 
(M1006B; Philips Medical Systems, Reigate, UK) that is attached to the patient monitoring 
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system. The manometer is normally connected to the arterial or venous cannula with a 200cm 
fluid-filled extension tube (Vygon UK Ltd, Cirencester, UK). Direct measurements within the 
heart can also be made using a green needle attached to the end of the extension tube.  
I had originally planned to simultaneously measure other intracardiac and intravascular pressures 
using this system. However, the dynamic response characteristics of this system had not 
previously been determined (personal communication, Codan UK Ltd), even though this system 
has been used at Birmingham Children‟s Hospital since 1998.  
The dynamic response characteristics of the fluid-filled catheter-manometer system were 
determined using the free vibration method based on a sudden, transient “step” change in 
pressure. This pressure step causes the catheter-manometer system to oscillate at its damped 
natural frequency. The oscillations will be sinusoidal and will decay exponentially in accordance 
with the damping coefficient. 
3.2.3a Materials and Methods 
 Model ventricle 
A square-wave pressure step was generated using a physical model of the left ventricle, which is 
described in detail in Chapter 4. For the purposes of this experiment, the solenoid valve at the 
top of the model ventricle (Figure 4.1) remained closed throughout the model ventricular cycle 
thus producing isovolumic contractions.  
 Pressure measurements 
Instantaneous pressure within the model ventricle was measured using two separate catheter-
manometer systems. The first consisted of a high-fidelity solid-state micromanometer laterally 
positioned between electrodes 5 and 6 within the combined pressure-conductance catheter 
(Millar Instruments) that was amplified using a combined amplifier-interface unit (PCU-2000; 
Millar Instruments). This pressure signal represented the reference pressure, based on the known 
dynamic response characteristics of this system [433]. The second system consisted of the 
pressurised flush, fluid-filled catheter-manometer system, as previously described. Both catheter-
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manometer systems were zeroed according to the atmospheric pressure at the mid-ventricular 
level. 
 Experimental data 
Analogue signals representing the two pressure measurements within the model ventricle and the 
ECG signal were digitised at 12-bit accuracy and a sample frequency of 250 Hz. End-diastole and 
end-systole were retrospectively identified. End-diastole was defined as the R-wave on the ECG 
[434] and end-systole was defined as the point immediately prior to IABP circuit deflation. The 
simulated cardiac cycle was defined as the period between end-diastole of one beat to end-
diastole of the following beat. 
A typical step response recorded with a catheter-manometer system of low frequency response 
and damping is illustrated in Figure 3.5. 
 
Figure 3.5 Example of catheter-manometer response to square-wave change in pressure. Reproduced from WW 
Nichols & MF O‟Rourke [430], pp. 150 
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The damped natural frequency, fd is derived directly from the time period, Td of each completed 
cycle: 
Equation 3.4 
d
d T
f 1  
The damping coefficient, β is calculated from the logarithmic decrement of pressure, Λ, from 
cycle to cycle: 
Equation 3.5 
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where d1 and d2 are the first and second pressure overshoot, respectively. 
The damping coefficient, β is then found by solving Equation A.3: 
Equation 3.6 
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where β0 is the damping constant and ω0 is the angular frequency of undamped motion [430]. 
Finally, the undamped natural frequency, f0 was calculated according to the damped natural 
frequency, fd and the damping coefficient, β: 
Equation 3.7 
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0
1
dff  [424]. 
 Statistical analysis 
The experiment was repeated three times during a 1-hour period. Each experiment was 
conducted under steady-state conditions and data from 10 consecutive cardiac cycles was 
analysed. The estimated within-experiment standard deviation in the reference end-diastolic and 
end-systolic pressure measurements during the 30 cardiac cycles was 0.95 mmHg and 0.62 
mmHg, respectively. The standard deviation was not significantly correlated with the mean 
pressure (Kendall‟s τ coefficient = 0.18). Therefore, all subsequent analyses were based on the 
average data for the experiment as a whole [435].  
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Data were analysed using SPSS for Windows (v16, SPSS Inc., Chicago, Il, USA). All values are 
expressed as mean ± SD and comparative analyses have been made using the paired two-tail 
Student t-test. A probability, P<0.05, was taken to represent statistical significance. 
3.2.3b Results 
Representative data illustrating the time-varying pressure signal obtained during this experiment 
are illustrated in Figure 3.6.  
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Figure 3.6 Ventricular pressure measurements versus time. Pressure measurements were made using either the 
high-fidelity solid-state micromanometer (dark blue line) or the fluid-filled catheter-manometer system (purple line).  
The intraventricular pressure was characterised by a rapid increase and decrease in pressure that 
corresponded with inflation and deflation of the intra-aortic balloon pump (IABP). The pressure 
rise was associated with a pressure overshoot (point A; +7.3 mmHg), which then fell in a non-
linear fashion to the end-systolic pressure (79 mmHg). Similarly, deflation was associated with a 
pressure undershoot (point B; -11.9 mmHg) that then returned non-linearly to the end-diastolic 
pressure (0 mmHg).  
Pressure measurements made using the fluid-filled catheter-manometer system were characterised 
by a temporal delay of 28 ± 3 ms. In addition, this system slightly underestimated both the 
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maximal and end-systolic pressure (-3.3 mmHg and -0.5 mmHg, respectively; both P<0.05), 
although these differences are not clinically important.  
The response of the catheter-manometer system following IABP deflation was used to determine 
the natural frequency and damping coefficient of the system (Figure 3.7). The first and second 
pressure overshoots were calculated as the difference from the reference pressure trace, after 
correction for the temporal delay.  
The time between consecutive cycles, Td, was 72 ms, which equated to a damped natural 
frequency of 13.9 Hz (Equation 3.4). The first (d1) and second pressure overshoot (d2) were 5.7 
mmHg and 3.8 mmHg, respectively. This corresponds to a damping coefficient of 0.12 
(Equations 3.5 and 3.6). Finally, the undamped natural frequency was estimated at 14.0 Hz.  
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Figure 3.7 Detail of the time-varying ventricular pressure. The pressure signal from the fluid-filled catheter-
manometer system (purple line) has been adjusted to account for the temporal delay. The first and second pressure 
overshoot (▲) and pressure undershoot (●) are indicated.   
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3.2.3c Discussion and Conclusion 
The dynamic characteristics of the fluid-filled catheter-manometer system routinely used at 
Birmingham Children‟s Hospital were determined for the first time. These characteristics will 
allow accurate, finite pressure measurements (i.e. end-diastolic pressure or end-systolic pressure) 
in patients with a heart rate of up to approximately 140 bpm. By contrast, measurements of the 
first derivative of ventricular pressure with respect to time will only be accurate in patients with a 
heart rate up to 55 bpm.  
The dynamic characteristics of this catheter-manometer system enabled reasonably accurate 
measurements of aortic pressure to be obtained. However, the measurements were not 
sufficiently accurate to allow more complex analyses such as wave intensity analysis [436] or 
analysis of vascular load based on impedance spectra [437,438], for example. is not sufficiently 
accurate to allow more complex analyses such as wave intensity analysis [436] or analysis of 
vascular load based on impedance spectra [437,438]. This system was, therefore, only used to 
statically calibrate pressure measurements made using the high-fidelity solid-state 
micromanometer only. for use in the clinical studies reported in this thesis. However, the 
measurements were not sufficiently accurate 
3.2.4 Pressure measurements in this thesis 
For this thesis, pressure measurements were primarily made using a high-fidelity miniaturised 
semiconductor strain gauge manometer [433], which is laterally positioned between electrodes 5 
and 6 on the combine pressure-conductance catheter (Millar Instruments, Houston, TX, USA). 
This pressure signal was amplified using a combined amplifier-interface unit (PCU-2000; Millar 
Instruments). The frequency response of this micromanometer catheter is flat from 0 – 10 kHz, 
allowing accurate pressure measurements to be made over a wide range of pressure and 
temperature with high electrical safety [433,439].  
Aortic pressure measurements were made using the pressurised flush, fluid-filled catheter-
manometer system, as previously described. This system was also used to calibrate 
intraventricular pressure measurements made using the combined pressure-conductance catheter.  
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3.3 FLOW MEASUREMENTS 
Several different techniques have been developed to directly measure cardiac output, and thus 
blood flow through the cardiovascular system. The principle techniques used to monitor patients 
in the intensive care unit involve the Fick principle; an indicator-dilution technique or Doppler 
ultrasound of blood flow in the thoracic aorta [440,441]. Each of these techniques is relatively 
invasive, requiring the insertion of a catheter into the pulmonary artery or an ultrasound probe 
into the oesophagus. These techniques are therefore mainly reserved for adult and paediatric 
patients on the intensive care unit or in the operating theatre. It is also possible to make direct, 
invasive measurements of cardiac output during open heart surgery, using a flow meter with a 
probe positioned around the ascending aorta.  
3.3.1 The Fick principle 
The Fick principle is based on the law of conservation of mass for an indicator and states that the 
amount of substance taken up by the body per unit of time is equal to the arteriovenous 
concentration difference of the substance (i.e. the arterial concentration minus the venous 
concentration) multiplied by the blood flow (Equation 3.8).  
Equation 3.8 
t
dtCvCaQtM
0
)(   
where M(t) is the amount of indicator taken up in the period of time, t; Q  is the blood flow; and 
Ca and Cv are the arterial and venous concentrations of the substance, respectively.  
This principle can be used to determine cardiac output based on the oxygen concentration and 
the arteriovenous oxygen concentration difference. The oxygen consumption can be measured 
directly, based on the oxygen concentration in inspired and expired gases [442]. More commonly, 
oxygen consumption is only predicted according to the patient‟s gender and body surface area 
[443]. The arteriovenous oxygen difference is calculated using arterial and mixed venous blood 
samples taken from a peripheral arterial and pulmonary arterial catheter, respectively.  
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Measurements of cardiac output based on the Fick principle represent the “gold standard” in 
routine clinical practice. When performed carefully, the measurements are accurate to within 
approximately 5% of the actual cardiac output. However, the technique generally requires steady-
state conditions. Furthermore, the technique measures the average blood flow over a given 
period of time; it does not provide any information about the pulsatile nature of the blood flow.  
3.3.2 Indicator-dilution techniques 
The indicator-dilution technique, in its simplest form, involves the rapid injection of a known 
amount of indicator substance in the venous system and then its concentration is measured as it 
passes into the arterial system. The greater the cardiac output, the more rapidly the dilution curve 
of the substances appears and disappears in the arterial system. The cardiac output can be 
calculated based on the amount of indicator injected and the area under the dilution curve 
(Equation 3.9). 
Equation 3.9 1
0
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where m is the amount of indictor injected; C(t) is the time-varying concentration of the 
indicator; and t1 is the time after which the indicator has completely passed.  
A number of different indicators have been used, including indocyanine green and temperature. 
Transpulmonary thermodilution is the most commonly used indicator-dilution technique in 
current use. This uses a special four-lumen catheter that is positioned inserted via a central vein 
into the main pulmonary artery. Cold saline is rapidly injected through one lumen into the right 
atrium and the temperature change is detected using a thermistor on the tip of the catheter to 
record the dilution curve [444].  
Transpulmonary thermodilution is relatively simple technique, which has been validated against 
cardiac output measurements based on the Fick principle [445]. However, a number of studies 
have identified poor repeatability, which limits the value of the technique [446,447]. In addition, 
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the indicator-dilution technique only measures average blood flow over a given period of time 
and does not provide any information about the pulsatile blood flow.  
3.3.3 Oesophageal Doppler  
The oesophageal Doppler technique is based on the measurement of blood flow velocity in the 
descending aorta using an ultrasound transducer on the end of a flexible probe. The probe may 
be introduced orally in anaesthetised, mechanically ventilated patients and advanced until the 
transducer is located approximately in the mid-thoracic level. The probe is then positioned so 
that the transducer faces the descending aorta and the characteristic continuous Doppler wave 
signal is obtained [448].  
The volumetric flow in the descending aorta is calculated by measuring the area under the 
maximum aortic velocity profile (the velocity-time integral or stroke distance) multiplied by the 
cross-sectional area of the aorta. The total stroke volume can then be calculated by assuming the 
relative distribution of blood flow between the cephalic (i.e. the head and upper limbs) and caudal 
territories (i.e. the remainder of the systemic circulation). The cardiac output can then be 
calculated by multiplying the average stroke volume by the heart rate [448].  
The oesophageal Doppler technique involves a number of assumptions about the nature of 
blood flow in the descending thoracic aorta, the cross-sectional area of the aorta, and the division 
of blood flow within the systemic circulation. These assumptions potentially limit the accuracy of 
absolute measurements of cardiac output [449]. Despite these assumptions and potential sources 
of error, the oesophageal Doppler technique provides measurements of cardiac output that are at 
least as accurate as those made using transpulmonary thermodilution, as previously described 
[447-449]. In addition, this technique measures the instantaneous pulsatile blood flow in the 
thoracic aorta and thus provides important information about the beat-to-beat variation in stroke 
volume.  
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3.3.4 Aortic flow probes  
A number of commercially available flow meters are available, which can be used to measure 
blood flow in native vessels and vascular grafts during cardiovascular surgery. These flow meters 
measure blood flow using either electromagnetic fields or ultrasound.  
3.3.4a Electromagnetic flow meters 
Electromagnetic flow meters are based on Faraday‟s law that the motion of a conductor in a 
magnetic field generates an electromagnetic force (i.e. voltage) orientated at right-angles to the 
motion. As blood is a conductor of electricity, the velocity of blood flow can be measured by 
aligning the blood vessel across a magnetic field and recording the measured electromagnetic 
force (Equation 3.10). 
Equation 3.10 
LB
e
u  
where u is blood velocity, e is the electromagnetic force; B is the magnetic field strength; and L is 
the distance between recording electrodes. In the case of parabolic flow profiles, the flow 
measured u is replaced by the cross-sectional average flow velocity, ū. The volumetric flow can 
then be calculated by multiplying the average flow velocity by the cross-sectional area.  
Electromagnetic flow meters have been used to provide direct and reliable measurements of 
pulsatile blood flow in the ascending aorta [450]. However, the method is associated with several 
limitations that may affect the accuracy of the measurements [451-453]. The electromagnetic flow 
signal is influenced by the “fit” between the probe and the vessel, the angle of the probe relative 
to the vessel and the haemoglobin concentration in the blood. In addition, flow measurements 
need to be calibrated against an alternative measurement of cardiac output. These issues 
potentially limit the use of electromagnetic flow meters in clinical practice. 
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3.3.4b Ultrasound flow meters 
The transit-time ultrasound flow meter is based on the principle that ultrasound waves travelling 
in the direction of blood flow travel faster than ultrasound waves travelling in the opposite 
direction. The perivascular flow probe contains two piezoelectric crystals that are diagonally 
placed on either side of the vessel (Figure 3.8).  
 
Figure 3.8 Principles of transit-time ultrasound flow measurements. The arrows indicate the direction of travel of 
the ultrasound signal. Reproduced from G Beldi et al. [454]. 
Both crystals can act as transmitter and receiver. Each crystal emits a brief burst of ultrasound 
and then waits to receive the signal from the opposite crystal. The difference in transit time 
between the two crystals varies as a function of blood velocity in the axial direction, U(x); the 
distance between the two crystals, L; the angle of the ultrasound beam, ; and the velocity of 
ultrasound in blood, C (Equation 3.11). This process is repeated at a rapid rate in order to 
provide effectively instantaneous measurement of the mean blood flow through the vessel. 
Equation 3.11 
L
dxxU
C
t
0
2
)(
cos2
 
The accuracy of the transit-time ultrasound method is approximately the same as the 
electromagnetic technique. However, transit-time ultrasound does not require a particularly close 
fit between the probe and the vessel and does not require calibration in vivo. As a result, the 
transit-time ultrasound apparatus is simple to use and provides fast and comparatively more 
accurate measurements of blood flow [454-456].  
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3.3.5 Flow measurements in this thesis  
In the clinical studies described in this thesis, aortic flow measurements were made using a 
transit-time ultrasound flow meter (HT 323; Transonic Systems Europe B.V.) together with flow 
probes for vessels of 6 – 14mm in diameter (A-series flow probes; Transonic Systems Europe 
B.V.). These flow measurements were used primarily to calibrate conductance volume 
measurements made using the conductance catheter technique, as previously described. 
In addition to the measurement of blood flow, we used the flow signal to independently identify 
the start and end of ejection. However, it became apparent during the initial studies that the time-
varying aortic flow signal was delayed relative to the first-derivative of ventricular volume with 
respect to time (dV/dt). As a result, the onset of ejection and the end of ejection (defined using 
the aortic flow signal) occurred later than the equivalent points defined using the intraventricular 
pressure-volume measurements.  
Following discussions with the manufacturer, it transpired that this was because the aortic flow 
signal was filtered using a 10Hz second-order Butterworth filter (personal communication, 
Transonics Systems Europe B.V.). The dynamic frequency and phase response of this filter are 
illustrated in Figure 3.9.  
A transfer function was developed in Matlab® (The MathWorks) based on the dynamic frequency 
and phase response of the filter (Appendix A). This work was undertaken in conjunction with Dr 
D Ewert, North Dakota State University, ND, USA. This transfer function was applied to all 
aortic flow signals off-line in order to obtain a “defiltered”, delay-free aortic flow signal. This 
“defiltered” aortic flow signal was then filtered using a 170 Hz Butterworth filter.  
The effect of this process on the aortic flow signal is illustrated in Figure 3.6. Figure 3.6B 
illustrates the value of this technique, since the end of ejection identified using the aortic flow 
trace or the instantaneous change in intraventricular volume (-dV/dt) are comparable. All of the 
aortic flow data presented in the clinical studies used the 170Hz Butterworth filtered aortic flow 
signal.  
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Figure 3.9 Dynamic response characteristics of the second-order 10Hz Butterworth filter (HT-323). The phase response, frequency response and temporal 
delay are all illustrated as a function of frequency. 
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The effect of this process on the aortic flow signal is illustrated in Figure 3.10. Figure 3.10B 
illustrates the value of this technique, since the end of ejection identified using the aortic flow 
trace or the instantaneous change in intraventricular volume (-dV/dt) are comparable. All aortic 
flow data presented in the clinical studies used the 170Hz Butterworth filtered aortic flow signal.  
 
Figure 3.10 A, Plot of aortic flow versus time. 10Hz and 170Hz Butterworth filtered data have been presented 
for comparison. B, Plot of aortic flow and instantaneous change in ventricular volume (-dV/dt) versus time.  
3.4 DATA COLLECTION 
The conductance catheter lead of the pressure-conductance catheter was connected directly to 
the patient module of the signal-processor unit (CFL-512; CD Leycom). In addition, analogue 
signal outputs from the combined amplifier-interface unit (intraventricular pressure); the transit-
time ultrasound flow meter (aortic flow) and the lead II surface electrocardiogram (ECG) were 
each connected to the CFL-512. All data were displayed and acquired simultaneously at 12-bit 
accuracy and a sample frequency of 250 Hz.  
Data were analysed using custom-designed software developed with Professor D.E. Ewert, 
North Dakota State University, USA. This software program was developed using Matlab® (The 
MathWorks Ltd., Cambridge, UK) and was based on the previously described HEART program 
[457]. Subsequent analyses were performed using additional software developed in Delphi 
(Borland Software Corporation, Austin, TX, USA) with Mr J. Stickley, Birmingham Children‟s 
Hospital NHS Trust, UK.  
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3.5 CONCLUSION 
In this Chapter I have extensively reviewed the techniques that are available to measure 
ventricular volume, intravascular pressure and cardiac output and have highlighted the advantages 
and disadvantages of the various techniques. In the light of this earlier discussion, I have used the 
following techniques for the remainder of this thesis.  
Ventricular volume and pressure measurements were obtained using two commercially available 
pressure-conductance catheters (Millar Instruments). A 3-French catheter consisted of 10 evenly 
spaced platinum electrodes at the distal end of the catheter (inter-electrode spacing = 4.3 mm). A 
5-French catheter consisted of 12 evenly spaced platinum electrodes with an inter-electrode 
spacing of 10 mm. Simultaneous pressure measurements were obtained using a high-fidelity 
miniaturised semiconductor strain-gauge manometer, which was laterally positioned between 
electrodes 5 and 6. 
The 3-French pressure-conductance catheter was used in children up to 6 months of age and the 
5-French catheter was used in older children. These sizes were chosen in order to minimise the 
haemodynamic effect of the catheter in the ventricle. These catheters have received the CE mark 
of approval for use in humans and can be re-used up to five times following appropriate 
sterilisation [458].  
In the clinical studies described in this thesis, conductance volume measurements were calibrated 
using independent measurements of stroke volume obtained using a transit-time ultrasound flow 
meter (HT 323; Transonic Systems Europe B.V.) together with flow probes for vessels of 6 – 
14mm in diameter (A-series flow probes; Transonic Systems Europe B.V.). Each flow probe 
could also be re-used following appropriate sterilisation, as provided by the manufacturer. 
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CHAPTER 4. CALIBRATING VOLUME MEASUREMENTS MADE 
USING THE DUAL-FIELD CONDUCTANCE CATHETER 
 
4.1 INTRODUCTION 
The accurate measurement of cardiac volumes is essential to accurate diagnosis and management 
of patients with congenital heart disease. The conductance catheter technique represents one of 
the most powerful tools for the assessment of cardiac function in vivo. However, the technique is 
associated with certain limitations, notably parallel conductance and the non-homogeneous 
electric field distribution. This Chapter has been undertaken to further explore the effect of the 
non-homogeneous field distribution on conductance volume measurements. 
As described previously, the conductance catheter technique is an established method to measure 
the ventricular volume in real-time, based on the electrical conductivity of blood within the 
ventricular cavity [380-382]. Conductance volume measurements are based on the assumption 
that the electric field produced by the conductance catheter is homogeneously distributed within 
the ventricular cavity [380]. However, theoretical and experimental studies have demonstrated 
that this assumption is not valid [404,405,409]. As a result, the conductance catheter tends to 
overestimate the volume in small ventricles and underestimate the volume in larger ventricles 
[381,382].  
The dimensionless calibration coefficient, α, was introduced by Baan et al. [381] in order to 
account for the non-uniform conductance-absolute volume relationship [381]. This calibration 
coefficient represents the slope of the relationship between the conductance-derived volume and 
the true volume. The calibration coefficient, α may also vary with ventricular volume. It is 
relatively high in small animals [399], lower in humans [381] and intermediate values are found in 
dogs [381,400,401]. Experimental studies demonstrate that α also varies during IVCO [401] and 
may even fluctuate during the normal cardiac cycle [413,414]. 
The tissues and fluid surrounding the ventricular cavity also contribute to the measured 
conductance signal [381]. This creates a volume offset called parallel conductance. Parallel 
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conductance also varies according to the ventricular volume [399-402,405,406]. This volume-
dependent parallel conductance may confound the calibration coefficient estimation.  
This study was undertaken to examine the variation in the calibration coefficient, α, over a range 
of volumes pertaining to clinical studies, in a physical model of the left ventricle without parallel 
conductance.  
4.2 MATERIALS AND METHODS 
4.2.1 Model ventricle 
This study used a physical model of the left ventricle previously described by this laboratory 
[392]. This model consisted of an ellipsoid latex balloon enclosed in a pressurised Perspex 
chamber (Figure 4.1). The chamber was filled with distilled water and hydraulically pressurised 
with an intra-aortic balloon pump (IABP; Datascope Medical Co. Ltd, Huntingdon, UK) with a 
paediatric volume-limiting chamber. The IABP console was connected to two 25ml intra-aortic 
balloon catheters in parallel. The IABP circuit was filled with helium gas to ensure a rapid 
pneumatic response. 
The electrocardiogram (ECG) from a patient simulator (Bioma Research Inc, Quebec, Canada) 
was used to trigger the IABP console at a predetermined rate (60 beats·min-1). Inflation of the 
IABP balloon catheters caused a rise in the ventricular pressure. This displaced saline from the 
latex balloon through a 2/2-way solenoid valve (Bürkert GmbH, Ingelfingen, Germany) into a 
calibrated measuring cylinder at the top of the model ventricle. Deflation of the IABP balloon 
catheters caused ventricular pressure to fall, which allowed the latex balloon to refill. Electronic 
circuitry was used to control the opening and closure times of the solenoid valve in order to 
simulate different contraction patterns. 
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Figure 4.1 Schematic diagram of the model heart. This consists of a model ventricle and outflow tract. The position of the conductance catheter is also illustrated. 
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For the purposes of this study, the solenoid valve remained open throughout the model 
ventricular cycle to produce isobaric contractions. Each inflation of the IABP balloon catheters 
displaced a fixed stroke volume (SV) of 50ml. The stroke volume was independently quantified 
before each experiment. The IABP balloon catheters were manually inflated and the displaced 
volume was measured in the measuring cylinder. 
Three separate latex balloons were used to simulate the change in volume that may be observed 
during IVCO. Each balloon was 13 cm in length and had a maximal volume at atmospheric 
pressure of 125ml, 215ml and 500ml, respectively. The shape of the balloons was ellipsoid at low 
volumes and became increasingly spheroid as the volume increased. The length-diameter ratio at 
maximal filling decreased from 3.03 for the smallest balloon to 1.52 for largest balloon. 
During each experiment, the model ventricle was filled with a known volume of 0.9% normal 
saline at room temperature. The end-diastolic volume (EDV) was varied between 100 – 125ml for 
the 125ml balloon; 160 – 215ml for the 215ml balloon; and 410 – 500ml for the 500ml balloon. 
The resistivity (conductivity-1) of this solution was measured before each test using the dedicated 
measuring cuvette (CD Leycom). The mean ± SD resistivity was 68.3 ± 0.5 Ω·cm.  
4.2.2 Conductance catheter 
The principle of the conductance catheter technique for measuring LV volume has been 
described elsewhere [381]. In this study, a 7-French 12-electrode high-fidelity dual pressure-
volume conductance catheter (Millar Instruments) was used. The electrodes were mounted at 10 
mm intervals near the tip of the catheter. One alternating current (20 kHz, 30 µA RMS) was 
applied between the two outermost electrodes (electrodes 1 and 12) and a second alternating 
current (20 kHz, -10 µA RMS) was applied between the two adjacent electrodes (electrodes 2 and 
11). This dual-field configuration was used in all studies [407]. A signal processor unit (CFL-512; 
CD Leycom) was used to measure the potential difference between seven consecutive pairs of 
the remaining eight electrodes (electrodes 3 – 10). These measured voltages were converted into 
seven time-varying segmental conductance signals, Gi(t).  
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The conductance volume, Q(t), was measured using the following formula: 
Equation 4.1 P
i
i GtGLtQ
7
1
2 )()( , 
where ρ is the blood resistivity, L is the inter-electrode distance, and GP is parallel conductance.  
By assuming that parallel conductance is negligible (i.e. GP = 0), this formula can be simplified to: 
Equation 4.2 
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The volume estimated using the conductance catheter technique, Vg(t) was then calculated: 
Equation 4.3 )(
1
)( tQtVg , 
where α is the dimensionless calibration coefficient [381].  
4.2.3 Experimental data 
Analogue signals representing 7 segmental conductance volumes within the model ventricle and 
the ECG were digitised at 12-bit accuracy and a sample frequency of 250 Hz. End-diastole and 
end-systole were retrospectively identified. End-diastole was defined as the R-wave on the ECG 
and end-systole was defined as the point immediately prior to IABP circuit deflation. The 
simulated cardiac cycle was defined as the period between end-diastole of one beat to end-
diastole of the following beat. 
Two separate calibration coefficients were calculated. Firstly, the calibration coefficients, αV(t) was 
calculated by dividing the conductance-derived volume measurement by the absolute ventricular 
volume at either end-diastole or end-systole: 
Equation 4.4 
EDV
QED
tV )(  or 
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QES
, 
where SVEDVESV . 
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Including a “phase of measurement” (i.e. ED or ES) in this equation did not improve the 
goodness of fit of the model. The effect of “phase of measurement” was not statistically 
significant and was therefore not included in the model used to predict αV(t). 
The conductance-stroke volume quotient, αSV, was calculated by dividing the conductance-
derived stroke volume by the absolute stroke volume: 
Equation 4.5 
SV
QQ ESED
SV  
Finally, the measurement error, ζ was calculated as a percentage of the absolute ventricular 
volume: 
Equation 4.6 100
)(
)(
tV
tVg
 
The terms ζV(t) and ζSV were used to denote the measurement error associated with αV(t) and αSV, 
respectively. 
4.2.4 Statistical analysis 
Each experiment was conducted three times and, in each, data from 10 consecutive cardiac cycles 
were analysed. The estimated within-experiment standard deviation in the conductance volume 
measurement for the 30 cardiac cycles was 0.45 ml. The standard deviation was not significantly 
correlated with the mean conductance volume (Kendall‟s τ coefficient = -0.72). Subsequent 
analyses were therefore based on the average data from each experiment [435]. 
The coefficients of the linear regression analyses, in both the overall and covariance analyses, are 
expressed as mean ± standard error and a probability, P<0.05, was taken to represent statistical 
significance. The “goodness of fit” of the prediction equation was assessed as the square of the 
correlation between dependent and significant independent variables. 
Data were analysed using SPSS for Windows (v12, SPSS Inc., Chicago, IL, USA). Conductance 
volumes, calibration coefficients and measurement errors were in turn examined as functions of 
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the known volume of the model ventricle. These relationships were evaluated using a stepwise 
least squares linear regression analysis. This analysis was based on fractional polynomials of the 
ventricular volume that included 3 V , V , 3V , 2V , V1 , V, 2V, 3V, 2V and 3V , where V 
represents the ventricular volume. The coefficients of the linear regression analyses are expressed 
as mean ± standard error and a probability, P<0.05, was taken to represent statistical significance. 
The “goodness of fit” of the prediction equation was assessed as the square of the correlation 
between dependent and significant independent variables.  
4.3 RESULTS 
4.3.1 Relationship between conductance and absolute volume 
The simultaneous conductance volume, Q(t), and absolute volume measurements, V(t) for the 
three balloons are illustrated in Figure 4.2. There was a non-linear relationship between these two 
volume measurements. When analysed as a whole, the conductance-absolute volume relationship 
was best approximated by the following relationship (Equation 4.7).  
 
Figure 4.2 Conductance volume measurements, Q(t) versus absolute volume, V(t) at end-diastole (●) and end-
systole (○) for each of the three latex balloons. The curve (dashed line) represents the regression analysis of the 
conductance-absolute volume relationship. The curve (dotted line) representing the line of identity (x=y) is also 
illustrated. 
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Equation 4.7 volumevolumetQ 02.017.039.02.14)( , (r2=0.90, P<0.05) 
Compared with the line of identity (i.e. x = y), conductance volume measurements predicted 
using this model were equal to ventricular volume at approximately 150 ml; slightly overestimated 
ventricular volume when the absolute volume was less than 150 ml; but underestimated 
ventricular volume at volumes over 150 ml.  
The volume measurements formed two distinct subsets. Data from the small and medium 
balloons were clustered on the left-hand side of the plot while data from the large balloon was 
clustered on the right-hand side. When considered individually, the conductance-absolute volume 
relationship was well approximated by linear regression (Equations 4.8 and 4.9). In neither case 
was the quadratic term significant. For the small and medium-sized balloons, the linear regression 
was: 
Equation 4.8 955)(06.063.0)( tVtQ , (r2=0.90, P<0.05) 
while for the large balloon, the corresponding equation was: 
Equation 4.9 5104)(01.027.0)( tVtQ , (r2=0.96, P<0.05) 
The slope of these two mathematical models are significantly different from one another 
(P<0.05), further illustrating that a single, common linear relationship does not hold over the 
entire range of absolute volumes. In addition, the intercepts differ significantly from one another 
and from zero (P<0.05). Therefore, neither of these two lines passes through the origin. This 
introduces a “volume offset”, which in this apparatus cannot be due to parallel conductance.  
4.3.2 Relationship between calibration coefficients and absolute volume 
The calibration coefficients, αV(t) and αSV were calculated using equations 4.4 and 4.5, 
respectively. Neither calibration coefficient was constant or linearly related to the ventricular 
volume. Instead, both calibration coefficients decreased progressively as the ventricular volume 
increased (Figures 4.3A and 4.3B). The calibration coefficient, αV(t) varied as a function of the 
square root of the absolute volume (r2=0.97, P<0.05). By contrast, αSV varied as a function of the 
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inverse absolute volume (r2=0.98, P<0.05; and r2=0.93, P<0.05 for end-diastolic and end-systolic 
measurements respectively).  
 
Figure 4.3 Calibration coefficient, α versus absolute volume, V(t) at end-diastole (●) and end-systole (○) for each 
of the three latex balloons. The calibration coefficient was calculated as the conductance-absolute volume quotient 
(αV(t); A) or the conductance-stroke volume quotient (αSV; B). The calibration coefficient ratio (C) represented αSV 
as a proportion of αV(t). Curves (dashed lines) representing regression analyses of the calibration coefficient-
conductance volume relations are also illustrated. 
The relative ratio of the two calibration coefficients (i.e. αSV / αV(t)) was also examined over the 
volume range (Figure 4.3C). The stroke volume quotient, αSV was lower than αV(t) at each volume 
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measurement. However, the slope calibration coefficient ratio was not constant but became 
progressively smaller as the absolute volume was increased. For example, the αSV / αV(t) ratio 
decreased from 0.98 ± 0.52 to 0.43 ± 0.23 as the end-diastolic volume increased from 100ml to 
500ml.The best approximation for this relationship was that the αSV / αV(t) ratio varied as a 
function of the inverse ventricular volume (r2=0.81, P<0.05; r2=0.75, P<0.05 for end-diastolic 
and end-systolic measurements, respectively).  
4.3.3 Relationship between calibrated conductance and absolute volume and 
measurement error 
Calibrated conductance volume measurements, Vg(t) were calculated using Equation 4.3, in 
which α was either αV(t)-volume or αSV-volume relationship, as previously described (Figure 4.4). 
Conductance volume measurements calibrated with the αV(t)-volume relation increased linearly 
with the absolute volume (r2 =0.99, P<0.05). Conductance volume measurements calibrated with 
the αSV-volume relation also increased linearly with absolute volume (r
2=0.99, P<0.05), but 
overestimated the absolute volume.  
 
Figure 4.4 Calibrated conductance volume measurements, Vg(t) versus absolute volume, V(t) at end-diastole (●) 
and end-systole (○) for each of the three latex balloons. Conductance volume measurements were calibrated using 
either αV(t) (●, ○) or αSV  (▼, ).Curves (dashed lines) representing regression analyses of the calibrated 
conductance volume-absolute volume relations are also illustrated. 
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The volume measurement error, expressed as a percentage of the absolute volume, was calculated 
for each calibration coefficient (Figure 4.5). Conductance volume measurements calibrated with 
the αV(t)-volume relation had a measurement error of 2.0 ± 6.9%, which was relatively constant 
across the span of volume measurements. On the other hand, the measurement error associated 
with the αSV-volume relation was volume-dependent, increasing linearly from 26 ± 20% to 106 ± 
36% as the end-diastolic volume increased from 100ml to 500ml (r2=0.96, P<0.05). 
 
Figure 4.5 Calibrated conductance volume measurement error, δ versus absolute volume, V(t) at end-diastole (●) 
and end-systole (○).Conductance volume measurements calibrated using either αV(t) (●, ○) or αSV (▼, ). 
Volume measurement error was calculated as a percentage of the absolute volume. Curves (dotted and dashed lines) 
representing regression analyses of the measurement error-absolute volume relations are also illustrated. 
4.4 DISCUSSION 
The non-homogeneous electric field generated by the conductance catheter results in a non-linear 
relationship between conductance and true ventricular volume measurements. Conductance 
measurements are, therefore, calibrated using the dimensionless calibration coefficient, α in order 
to obtain absolute volume measurements. This study investigated the accuracy of conductance 
volume measurements, and the effect of calibration, in a series of in vitro experiments that 
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spanned the volume range observed in clinical studies [459]. This model design also avoided the 
potential problems associated with parallel conductance.  
This study has confirmed that there is a non-linear relationship between dual-field conductance 
and absolute volume measurements, such that the conductance-volume relation is concave 
towards the true volume. The conductance volume measurements underestimated ventricular 
volume as the volume was increased above 150ml. This finding is in accord with previous 
experimental studies [404,405]. 
Conductance volume measurements are generally calibrated with the dimensionless calibration 
coefficient in order to improve the accuracy of ventricular volume measurements made using this 
technique [381]. In the isolated post-mortem canine heart, Mur & Baan reported that the 
conductance-volume relation was virtually linear over a finite volume range [382] and the authors 
predicted that a similar, virtually linear conductance-volume relation would be observed for the 
human left ventricle up to a volume of 200ml [382].  
However, this study has shown that the calibration coefficient, α is not constant, but varies as a 
non-linear function of the ventricular volume. Using a fixed or constant α during acute volume 
change will inevitably result in volume measurement errors. These measurement errors may be 
relatively small during the normal cardiac cycle. However, procedures that produce an acute and 
substantial change in volume load, like vena caval occlusion, will potentially result in significant 
measurement errors. 
Kornet et al. suggested that the variation in α observed in vivo might reflect synchronous volume-
dependent changes in parallel conductance during the cardiac cycle [402]. However, this study 
used a physical model of the left ventricle without parallel conductance. Our findings suggest that 
parallel conductance is not a comprehensive explanation for why the calibration coefficient varies 
as a function of the ventricular volume.  
Although conductance volume measurements can be calibrated against another synchronous 
estimate of ventricular volume [381,413,460], they are generally calibrated with an alternate 
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measurement of stroke volume [399,404]. Calibration with either an alternate measurement of 
ventricular volume or stroke volume are generally considered equivalent. However, this study 
identified that the αV(t) and αSV are different. The stroke volume quotient, αSV was lower than αV(t) 
and the calibration coefficient ratio, αSV / αV(t) became progressively smaller as the ventricular 
volume increased. Calibrating conductance volume measurements with αSV resulted in the 
significant overestimation of end-diastolic and end-systolic volume, and the degree of 
overestimation was even more pronounced at higher volumes. This demonstrates that 
conductance volume measurements should ideally be calibrating using an independent measure 
of ventricular volume like, for example, contrast cineangiography, echocardiography or magnetic 
resonance imaging.  
The difference between the αV(t)-volume and αSV-volume relations may be attributed to the non-
homogeneous electrical field distribution established by the conductance catheter [405,406]. 
Conductance volume measurements are disproportionately influenced by the areas around the 
longitudinal axis of the ventricle where the electrical field is strongest. By contrast, changes in 
volume that occur during ejection or when loading conditions are varied primarily affect the 
myocardial boundary where the electrical field density is weakest. Consequently, αSV and αV(t) are 
not equivalent and cannot be used interchangeably.  
4.4.1 Study Limitations 
The physical model of the isolated left ventricle used in this study did not allow changes in the 
volume loading conditions could not be modelled continuously. Instead, a series of steady-state 
experiments were made at incremental end-diastolic volumes in three separate models, which 
carries with it the risk of repeated measurement errors. The changes in ventricular volume 
resulted from changes in the short-axis dimension of the model only. It was not possible to 
examine any effect of changing ventricular length, such as those that may occur during the 
cardiac cycle [223].  
Ideally, the volumes within the model ventricle would have been acquired simultaneously using 
the conductance catheter and another independent method. In the original design, the ejected 
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volume was measured according to the pressure generated within the fluid column [392]. 
However, preliminary experiments demonstrated that the fluid-filled micromanometer was not 
sufficiently accurate to enable instantaneous volume measurements throughout the cardiac cycle 
and, therefore, measurements were made with the calibrated measuring cylinder.  
4.5 CONCLUSION 
The conductance catheter technique incorporates a calibration coefficient, α, in order to obtain 
accurate volume measurements. This study has demonstrated that this calibration coefficient 
varies as a function of absolute volume, independent of parallel conductance. Assuming that the 
calibration coefficient is fixed or constant will introduce measurement errors. The conductance-
stroke volume quotient, αSV is associated with particularly significant and volume-dependent 
measurement errors. This limits the value of volume measurements calibrated using αSV.  
Conductance volume measurements should ideally be calibrated with an alternative measurement 
of ventricular volume, using any one of the techniques that are now available. However, in some 
circumstances this may not be possible. This is particularly true in clinical studies where the 
resources may not be available and the use of another technique may compromise patient safety. 
In the clinical studies described in Chapters 6 and 7, for example, it was decided that there was 
not an alternative, safe and reproducible measurement of ventricular volume that could be 
performed in the operating theatre at Birmingham Children‟s Hospital. Therefore, the 
conductance volume measurements were calibrated using an alternative measurement of stroke 
volume even though this may adversely affect the absolute accuracy of the volume 
measurements.  
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CHAPTER 5. ELECTROCARDIOGRAPHIC INTERFERENCE AND 
CONDUCTANCE VOLUME MEASUREMENTS 
 
5.1 INTRODUCTION 
The assessment of ventricular function is fundamentally important for the evaluation of patients 
with known or suspected heart disease. Analysis of ventricular volume in the time and pressure 
domains allows systolic and diastolic function to be separately quantified. The conductance 
catheter technique was developed to continuously measure ventricular volume in real-time 
[380,382]. These measurements are recorded simultaneously with intraventricular pressure 
measurements to provide instantaneous pressure-volume data [460].  
The conductance catheter technique is associated with two, well-known sources of error. Firstly, 
the current density generated by the conductance catheter is not uniformly distributed 
throughout the ventricular cavity [403-405]. This results in a non-linear conductance-absolute 
volume relationship [382,405,408]. Conductance volume measurements must be corrected with a 
calibration coefficient, α [381]. Secondly, the tissues and fluid surrounding the ventricular cavity 
also contribute to the conductance signal [381,382]. This results in an offset in the conductance-
absolute volume relationship, called parallel conductance. In practice, conductance volume 
measurements are usually calibrated for parallel conductance using the hypertonic saline method 
in order to derive accurate ventricular volume measurements [381].  
In our paediatric clinical experience, we have observed that the pattern of LV volume 
measurements is frequently abnormal (Figure 5.1). The conductance volume measurements are 
characterised by a narrow upward spike followed by a narrow downward spike during late 
diastole without any commensurate change in LV pressure (Figures 5.1A and 5.1B). This alters 
the shape of the pressure-volume loop, with the loss of the normal lower right-hand corner 
(Figure 5.1D). To our knowledge, this abnormal conductance volume pattern has not previously 
been described. However, we understand that similar findings have been observed in other 
patient groups, particularly in patients with a permanent pacemaker [personal communication, 
Professor M.P. Frenneaux, Department of Cardiovascular Sciences, University of Birmingham, 
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UK; Dr P. Steendijk, Department of Cardiology, Leiden University Medical Center, The 
Netherlands]. 
Figure 5.1 Time-varying pressure (A), conductance volume (B) and surface electrogram (C) signals obtained in a 
6 year-old child with tricuspid atresia. The corresponding pressure-conductance volume loop for the same child (D) 
was developed by plotting the instantaneous pressure against the corresponding conductance volume.  
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We observed that the abnormal LV conductance volume measurements occurred synchronously 
with the QRS complex on the surface electrocardiogram (ECG; Figure 5.1C). We hypothesised 
that this abnormal LV conductance measurement may represent the effect of ventricular 
excitation on conductance volume measurements, which is superimposed on the normal 
ventricular volume cycle. This study was undertaken to examine the relationship between the 
ventricular electrogram and conductance volume measurements in a physical model of the left 
ventricle without parallel conductance. In addition, we sought to determine how this relationship 
was influenced by changes in electrical resistance across the model ventricle. 
5.2 MATERIALS AND METHODS 
5.2.1 Model ventricle 
This study used the physical model of the left ventricle previously developed by this laboratory 
[392] and described in Chapter 4. In summary, this consisted of an ellipsoid latex balloon 
enclosed in a pressurised Perspex chamber. The chamber was filled with distilled water and 
hydraulically pressurised with an intra-aortic balloon pump (IABP; Datascope Medical Co. Ltd) 
connected to two 25ml intra-aortic balloon catheters in parallel. A patient simulator (Bioma 
Research Inc) was used to trigger the IABP console at a predetermined rate (60 beats·min-1). 
Inflation of the intra-aortic balloon catheters displaced the stroke volume (SV, 50ml) from the 
model ventricle through a 2/2-way solenoid valve (Bürkert GmbH) into a calibrated measuring 
cylinder at the top of the model ventricle. Deflation of the IABP balloon catheters caused 
ventricular pressure to fall, which allowed the latex balloon to refill. Electronic circuitry was used 
to control the opening and closure times of the solenoid valve in order to simulate different 
contraction patterns. 
The latex balloon was 13 cm in length and had a maximal volume at atmospheric pressure of 
500ml. The balloon was filled with 385 – 500ml of buffered saline solution (V) at room 
temperature. The saline concentration was varied between 0.18 – 1.57%. The resistivity (ρ; 
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conductivity-1) of these solutions was measured before each test using the dedicated measuring 
cuvette (CD Leycom). The resistivity ranged between 37 ± 0.8 to 330 ± 0.5 ·cm.  
Ventricular depolarisation was simulated using a fixed output ECG signal, ECGinput, from the 
patient simulator (maximum 150.4 ± 0.1 mV, minimum -35.8 ± 0.2 mV). This was connected, via 
a resistor (200 ), to a dipole within the latex balloon. This dipole consisted of two copper ring 
electrodes (diameter 30mm, depth 5mm and thickness 1mm) that were positioned perpendicular 
to the long-axis of the balloon, Figure 5.2. The in-series resistor was adjusted so that the signal 
range of the intracavitary electrogram (ECGc) in the model ventricle was equivalent to that 
observed in vivo (~ 1mV). 
In vivo, the intracavitary electrogram primarily reflects the pattern of ventricular depolarisation 
and repolarisation in the endocardium of the ventricle [51]. The position of the endocardium 
relative to the long-axis of the ventricle will vary as the ventricular volume changes during the 
cardiac cycle. This effect was simulated by altering the distance between the two electrodes of the 
dipole. The distance between the two electrodes (D) was varied between 3 cm and 11.5 cm such 
that both electrodes remained equidistant from the centre of the balloon.  
5.2.2 Conductance catheter 
The principle of the conductance catheter technique for measuring LV volume has been 
described in Chapter 3. The details of the conductance catheter used in this study are described in 
Chapter 4. The catheter measured seven time-varying segmental conductance signals, Gi(t). As 
parallel conductance is negligible in our model, the total conductance volume, Q(t), was 
determined using the following formula: 
Equation 5.1 
7
1
2 )()(
i
i tGLtQ , 
where ρ is the blood resistivity and L is the inter-electrode distance.  
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Figure 5.2 Schematic diagram of the model heart used including the modifications for this experiment. The location of the intraventricular dipole electrodes and their 
position relative to the pressure-conductance catheter are illustrated.  
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The dimensionless calibration coefficient, αV(t) was calculated from conductance volume 
measurements without the ECG signal by dividing the conductance-derived volume 
measurement by the absolute volume at end-diastole or end-systole, as detailed in Chapter 4. 
Equation 5.2 
EDV
QED
tV )(  or 
ESV
QES
 
The calibration coefficient, αV(t) varies as a non-linear function of the absolute ventricular volume 
(Chapter 4) and we used this non-linear αV(t)-volume relation to calibrate conductance volume 
measurements:  
Equation 5.3 )(
1
)( tQtV
VV
g , 
where αVV is the αV(t)-volume relation (Chapter 4).  
Instantaneous pressure within the model ventricle was measured using a high-fidelity solid-state 
micromanometer laterally positioned between electrodes 5 and 6 within the conductance catheter. 
This pressure signal was amplified using a combined amplifier-interface unit (PCU-2000; Millar 
Instruments) and statically calibrated using a separate fluid-filled catheter-manometer system.  
The cavitary electrogram, ECGc was measured as part of the conductance catheter technique. 
The conductance signal between electrodes 5 and 6 was measured, amplified and filtered using a 
second-order filter with a high cut-off frequency (-3dB; 125 Hz) in order to derive the ECGc 
[personal communication; CD Leycom].  
5.2.3 ECG interference 
The conductance signal was measured either with, )(tGi , or without the ECG signal, )(tGi . 
ECG interference, GECG(t) was calculated as the difference between these two conductance 
signals: 
Equation 5.4 
7
1
7
1
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i i
iiECG tGtGtG  
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The difference between calibrated volume measurements made with, Vg
+
(t) and without the ECG 
signal, Vg
-
(t) was expressed as a percentage of the Vg
-
(t) signal: 
Equation 5.5 
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tVtV
V
g
gg
ECG  
5.2.4 Experimental data 
Analogue signals representing 7 segmental conductance signals, the pressure within the model 
ventricle, and both ECGinput and ECGc were all digitised at 12-bit accuracy and a sample 
frequency of 250 Hz. End-diastole and end-systole were retrospectively identified. End-diastole 
was defined as the R-wave on the ECG and end-systole was defined as the point immediately 
prior to IABP circuit deflation. 
The effect of intracavitary volume (V), resistivity of the saline solution (ρ) and inter-electrode 
distance (D) on the intracavitary electrogram and conductance volume measurements were 
examined in turn. This involved a series of experiments, in which one variable was altered 
incrementally while the other two variables remained unchanged. This process was repeated until 
the data from the entire range was obtained (see above).   
5.2.5 Statistical analysis 
Each experiment was conducted three times and data from 5 consecutive cardiac cycles were 
analysed. Only 5 cardiac cycles were included, in view of the limited variance associated with 
conductance volume measurements (Chapter 4). The estimated within-experiment standard 
deviation was 0.71 ml and, at its worst, this represented <0.5% of the total conductance volume. 
All subsequent analyses were therefore based on the average data from each experiment. 
Data were analysed using SPSS for Windows (v12, SPSS Inc., Chicago, Il, USA). All values are 
expressed as mean ± SD and comparative analyses have been made using the paired two-tail 
Student t-test.  
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The relationship between the ECGinput, ECGc and the ECG interference pattern was evaluated 
using a stepwise least squares linear regression analysis. This analysis was based on fractional 
polynomials of the data that included 3 x , x , 3x , 2x , x1 , x, 2x, 3x, 2x and 3x , where x 
represented the independent variable in each analysis.  
As the ECG interference pattern will vary according to the resistance of the volume conductor, 
the intracavitary volume, resistivity of the saline solution and the inter-electrode distance were 
included as covariables in the regression analyses.  
Initial examination of the ECG signals demonstrated that changes in the resistance of the volume 
conductor were associated with a change in the scale of ECGc and the ECG interference pattern 
but the basic shape of the signals remained the same. Therefore, separate linear regression 
analyses were performed to examine the relationship between between the intercept values and 
the linear regression coefficient (
0
and 1  in Equation 5.6, respectively) and each covariables. 
Fractional polynomials of each covariable were used, as described previously. Covariables that 
demonstrated a significant association (P<0.05) with β0 or β1 based on univariate analysis were 
combined to create a unified covariable. For example, if A1  and B11 , then A and B 
were combined to create the final covariable, BA .  
Finally, the relationship between the ECGinput, ECGc and the ECG interference pattern was 
evaluated using a further stepwise least squares linear regression analysis that included significant 
covariables. The coefficients of the linear regression analyses, in both the overall and covariance 
analyses, are expressed as mean ± standard error and a probability, P<0.05, was taken to 
represent statistical significance. The “goodness of fit” of the prediction equation was assessed as 
the square of the correlation between dependent and significant independent variables. 
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5.3 RESULTS 
Indices of systolic and diastolic ventricular function showed variability between repeated 
measurements. The coefficient of variation (SD/mean ∙ 100) together with its standard deviation 
was 17 ± 10% for EES, 12 ± 9% for PRSW and 13 ± 9% for dP/dtMAX-EDV′ [461]. The 
coefficient of variation for chamber stiffness was 21 ± 13%.  
5.3.1 Comparison between ECG signal and cavitary electrogram 
The ECG signal, ECGinput, consisted of P, Q, R, S and T deflections that resembled the normal 
lead II electrocardiogram (Figure 5.3A). The P-wave was 84 ms in duration with a peak of 6.2 
mV (40 ms). The P-wave represented approximately half the PR interval (156 ms). The positive 
QRS complex had an overall duration of 84 ms, with a maximum at 192 ms (150.4 mV) and two 
minima at 164 ms (-26.4 mV) and 224 ms (-34.1 mV). The ST segment was isoelectric (-8.2 mV) 
and 36 ms long. The duration of the T-wave was 236 ms, with a peak of 41.4 mV (408 ms). 
Finally, the QT interval and TP segment were both isoelectric and 120 ms and 468 ms long, 
respectively. 
The ECGc signal resembled the ECGinput signal turned upside down, with an inverted P wave, an 
rSR′ wave (i.e. an inverted qRS wave) and an inverted T wave (Figure 5.3B). The overall 
relationship between the two signals was best approximated by a mathematical model in which 
the ECGc signal was inversely proportional to the ECGinput signal (r
2=0.74, P<0.05): 
Equation 5.6 )()( 10 tECGtECGc input , 
where β0 is the intercept value and β1 is the linear regression coefficient. 
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Figure 5.3 The ECG signal (ECGinput; A), cavitary electrogram (ECGc; B) and ECG interference (GECG(t); 
C) signals versus time.  
Although the ECGinput and ECGc signals were similar, they were not identical. There were 
differences in timing and amplitude of the two signals. The ECGc P and S-wave minima and the 
R-wave peak occurred either synchronously or within one data point (i.e. 4 ms) of the 
corresponding points on the ECGinput signal. By contrast, the ECGc R′-wave peak and the T-
wave minimum were 12 ms and 32 ms earlier than the corresponding points on the ECGinput 
signal. The ECGc R′-wave peak was also disproportionately pronounced compared to the 
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corresponding S-wave of the ECGinput signal. The ECGc R′-S wave ratio was -0.51 ± 0.03 
whereas the ECGinput S-R wave ratio was -0.17 ± 0.02 (P<0.05). In addition, the ECGc did not 
accurately reproduce the isoelectric phases of the ECGinput signal. During the PR, R′T and TP 
segments, the ECGc signal was initially elevated and decreased progressively towards the baseline 
signal.  
In the covariance analyses, the intercept value (β0) varied as a linear function of inter-electrode 
distance (P<0.05), but was not affected by variation in the other two factors. By contrast, the 
linear regression coefficient (β1) varied as the inverse function of intracavitary volume and as a 
direct function of inter-electrode distance and resistivity of the solution (all P<0.05).  
When these effects are combined, the relationship between ECGc and ECGinput was influenced 
by the inter-electrode distance (intercept value) and by the total resistance of the volume 
conductor (Equation 5.7; r2=0.65): 
Equation 5.7 )()( 432 tECG
V
D
DtECGc input , 
where β2 = 3.66 ± 0.01; β3 = 7.29∙10
-3 ± 1.53∙10-3 and β4 = -7.00∙10
-3 ± 0.06∙10-3  
(P<0.05 for each coefficient).  
5.3.2 Comparison between ECG interference and ECG input signals 
The ECG interference signal, GECG(t) was characterised by a low amplitude biphasic P-wave; a 
high amplitude equiphasic qRSr′ complex; and a low-amplitude biphasic T-wave (Figure 5.3C). 
Each phase of the GECG(t) signal was synchronous with the P-wave, QRS complex and T-wave 
of the ECG signal, respectively.  
The amplitude of the GECG(t) has been described as a percentage of the maximum GECG(t) signal 
from the isoelectric line. The GECG(t) P wave had a sine wave-like appearance with an initial 
upward deflection immediately followed by a downward deflection of comparable duration and 
amplitude. The maximum and minimum GECG(t) P wave signals were 4.0 ± 2.6% (28 ms) above 
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and 4.4 ± 2.6% (64 ms) below the isoelectric line. The spiked wave GECG(t) qRSr′ complex had 
two maxima at 180 ms (R-wave; 100 ± 3%) and 232 ms (r′-wave; 22 ± 3%) and two minima at 
160 ms (q-wave; -24 ± 3%) and 204 ms (S-wave; -107 ± 3%). The GECG(t) q and R-waves 
occurred 32 ms and 12 ms before the ECGinput R-wave whereas the GECG(t) S and r′-waves 
occurred 12 ms and 40 ms after the ECGinput R-wave. The GECG(t) T wave had a similar overall 
appearance to the GECG(t) P-wave with an initial upward deflection immediately followed by an 
equivalent downward deflection. The maximum and minimum GECG(t) T wave signals were 4.4 ± 
2.6% (352 ms) and 4.8 ± 2.6% (452 ms) below the isoelectric line and occurred 80 ms and 180 
ms after the start of the ECGinput T wave, respectively.  
The relationship between GECG(t) and ECGinput was well approximated (r
2=0.92, P<0.05) by a 
regression equation in which the interference signal varied proportionally to the first-derivative of 
ECGinput with respect to time: 
Equation 5.8 )()( 10 tdECGtG inputECG , 
where β0 is the intercept value and β1 is the linear regression coefficient. 
In the covariance analyses, the intercept (β0) values varied as a linear function of the inter-
electrode distance (P<0.05), but was not affected by variation in the other two factors. By 
contrast, the linear regression coefficient (β1), varied as a function of the intracavitary volume; 
and as the inverse function of both the inter-electrode distance and the resistivity of the solution 
(all P<0.05).  
Overall, the relationship between GECG(t) and the first derivative of ECGinput varied as a function 
of the inter-electrode distance and the conductivity of the volume conductor (Equation 9; 
r2=0.88): 
Equation 5.9 )()( 10 tdECG
D
V
DtG inputECG  
where β0 = 1.49∙10
-3 ± 0.39∙10-3 and β1 = 6.07∙10
-3 ± 0.38∙10-3 (P<0.05 for both coefficients).  
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5.3.3 ECG interference and calibrated conductance volume measurements 
For the purposes of this simulation, the inter-electrode distance was assumed to change in 
accordance with the instantaneous volume within the latex balloon. The inter-electrode distance 
was estimated as the maximal short-axis diameter of the spheroid, which varied from 7.0 cm (VES 
= 335 ml) to 8.6 cm (VED = 500 ml). Calibrated conductance volume measurements with the 
ECG signal, Vg
+
(t) were compared against synchronous calibrated conductance volume 
measurements without the ECG signal, Vg
-
(t).  
A representative example of calibrated conductance volume measurements with and without the 
ECG signal is illustrated in Figure 5.4. The Vg
-
(t) signal had a smooth, sinusoidal pattern that 
varied throughout the model heart cycle. The Vg
+
(t) signal was broadly similar, but had an 
additional spiked-wave pattern that coincided with the simulated ventricular depolarisation. The 
difference between the two ventricular volumes measurements, ΔVECG during this phase of the 
cardiac cycle varied between -12% (i.e. an underestimation) and +9%. By contrast, the difference 
during the remainder of the cardiac cycle varied only slightly from -0.3 to +0.9%.  
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Figure 5.4 Calibrated conductance volume measurements versus time. Conductance volume measurements were 
made with (Vg
+
(t); A) and without ECG interference (Vg
-
(t); B). The ECG signal (ECGinput) has been 
plotted (C) for comparison.  
The pressure-volume loop obtained with the Vg
-
(t) signal had a quadrilateral shape with four 
distinct phases (Figure 5.5). End-diastole and end-systole were each identifiable as the single 
pressure-volume point at the lower right-hand and upper left-hand corners, respectively. The 
ECG interference pattern altered the shape of the pressure-volume loop, primarily affecting the 
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late filling and early isovolumic contraction phases. As a result, end-diastole could not be reliably 
identified (Figure 5.5).  
 
Figure 5.5 Pressure-conductance volume loop from the model ventricle. Conductance volume measurements were 
made with (Vg
+(t); black line) or without ECG interference (Vg
-(t); grey dashed line).  
Comparable results were obtained under all experimental conditions. Increasing the end-diastolic 
volume from 385 ml to 500 ml did not significantly change the discrepancy between the two 
ventricular volume measurements. While increasing the resistivity from 37 Ω·cm to 330 Ω·cm 
increased the median measurement discrepancy slightly, from +0.2% to +1.8%, it did not 
significantly alter the maximal range of the discrepancy.  
5.4 DISCUSSION 
The conductance catheter technique is an established method that enables continuous volume 
measurements based on the electrical conductance of the intraventricular blood pool. This study 
has demonstrated that other electrical signals within the ventricular cavity alter the measured 
conductance. This produces a conductance signal “artefact”, which varies as a function of the 
first-derivative of the additional electrical signal. This artefact represents a novel and additional 
source of error that potentially affects the accuracy of ventricular volume measurements made 
using the conductance catheter technique. 
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Ventricular depolarisation and repolarisation cause a measurable electrical signal within the 
ventricular cavity [462]. In the present study, a simulated ventricular electrogram produced a 
biphasic signal with a high-amplitude spiked wave pattern that coincided with the QRS complex 
and a comparatively low-amplitude sine wave-like pattern during the T wave. This signal was 
associated with a conductance volume measurement error that ranged between a 12% volume 
underestimation to a 9% volume overestimation. The entire range of this measurement 
discrepancy occurred within a 24 ms period during simulated ventricular depolarisation. By 
contrast, simulated repolarisation was associated with a small, clinically unimportant 
measurement error. The precise ECG interference pattern, GECG(t) will vary with the 
morphology of ventricular electrogram [462-464]. Nevertheless, these in vitro findings are 
consistent with our previously unreported clinical findings.  
The haemodynamic events during the cardiac cycle are best displayed by plotting the 
instantaneous left ventricular pressure versus volume [465]. Under steady-state conditions, this 
pressure-volume loop has a quadrilateral shape where each side represents one of four functional 
distinct phases: filling, isovolumic contraction, ejection and isovolumic relaxation. End-diastole 
and end-systole are identifiable as the single pressure-volume points in the lower right-hand and 
upper left-hand corners, respectively. However, ventricular depolarisation overlaps the rapid rise 
in intraventricular pressure that marks the onset of ventricular systole. The conductance signal 
artefact identified in this study meant that end-diastole could no longer be reliably identified on 
the pressure-conductance volume loop alone. 
End-diastole may alternatively be defined using the surface electrocardiogram as the onset of the 
QRS complex [466]; the R-wave peak [434]; or up to 40 ms after the R wave peak [467]. End-
diastole may also be defined as the R-wave peak on the ventricular electrogram. In our 
experience, this time-point occurs synchronously with the onset of ventricular systole [468]. 
However, conductance volume measurements at all of these time-points will be variably affected 
by the conductance signal artefact such that end-diastolic volume cannot be accurately measured 
using the conductance catheter technique. This in turn means that indices of ventricular function 
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that are based on EDV, such as cardiac output, ejection fraction together with the quantitative 
assessment of ventricular compliance, will be adversely affected as a consequence of the 
conductance signal artefact. 
5.4.1 Study Limitations 
The limitations of the physical model have been described in Chapter 4. Electrical activity within 
the ventricle was represented using a fixed dipole within the ventricular cavity. This 
comparatively simple model enabled characterisation and quantification of a new conductance 
measurement error. However, the model did not include any representation of the ventricular 
wall and the effect of parallel conductance was not examined. A moving dipole or multiple 
dipoles within an artificial ventricular wall would also have provided a more physiological model.  
5.5 CONCLUSION 
This study has demonstrated that the accuracy of these conductance volume measurements is 
adversely affected by other electrical signals, such as the ventricular electrogram. The ventricular 
electrogram produced a clinically important volume measurement that meant end-diastole could 
neither be precisely identified nor accurately measured. These original findings have potentially 
important implications for the quantitative assessment of ventricular function and, in particular 
the assessment of chamber compliance made using the conductance catheter.  
Despite this problem, the combined pressure-conductance catheter represents the only technique 
that is approved for clinical research that allows simultaneous, real-time measurements of 
ventricular pressure and volume and so remains one of the most powerful tools for the 
quantitative assessment of ventricular function. For this reason, the pressure-conductance 
catheter were used to evaluate changes in ventricular function and vascular load in the clinical 
studies described in Chapters 6 and 7. 
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CHAPTER 6. ACUTE CHANGES IN VENTRICULAR PERFORMANCE 
FOLLOWING BIDIRECTIONAL CAVO-PULMONARY ANASTOMOSIS  
 
6.1 INTRODUCTION 
The bidirectional cavo-pulmonary anastomosis (BCPA) represents the second stage in the three-
stage management plan for children with functionally single ventricle anatomy [292]. The BCPA 
can be constructed as either a bidirectional Glenn or hemi-Fontan procedure [296,297], as 
described in Chapter 2. Both of these procedures establish a circulation in which the pulmonary 
circulation is connected in-series with the systemic circulation of the upper half of the body, as 
illustrated in Figure 6.1.  
 
Figure 6.1 Schematic diagram of the circulation (A) with a balanced in-parallel circulation and (B) following the 
formation of the BCPA.  
QP, pulmonary blood flow; QS, systemic blood flow; CO, cardiac output.  
The circulation established following the BCPA is associated with a number of theoretical and 
clinical advantages when compared with a balanced in-parallel circulation. The formation of the 
BCPA improves the efficiency of gas exchange, by directing desaturated blood in the superior 
vena cava (SVC) exclusively through the pulmonary circulation. The relative contribution of the 
SVC to systemic venous return [276] means that the “effective” pulmonary blood flow is 
generally increased, with a corresponding rise in the systemic arterial oxygen saturation [271,469-
471].  
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The formation of the BCPA is also accompanied by an immediate and persistent reduction in the 
volume load of the dominant ventricle [342,472-477]. This, in turn, is associated with a change in 
the geometry of the ventricle and a temporary increase in the ventricular mass-volume ratio 
[342,474,475].  
The changes in circulatory haemodynamics and ventricular geometry may both influence the 
function of the dominant ventricle. For example, it has been suggested that the reduction in 
volume load and the development of a more ellipsoid ventricular shape may provide more 
favourable working conditions for the ventricle, and this should be accompanied by an 
improvement in ventricular systolic function [338]. By contrast, an increase in the mass-volume 
ratio may result in the development of diastolic dysfunction, with impaired active ventricular 
relaxation and reduced ventricular compliance [345-347].  
To date, only a limited number of studies have been undertaken to assess how the changes in 
circulatory haemodynamics affect either ventricular function or the performance of the 
cardiovascular system as a whole [351,478,479]. The most important of these studies reported 
longitudinal changes in ventricular function and vascular load in patients with hypoplastic left 
heart syndrome and the effects of surgical palliation [351]. Ventricular function and vascular load 
were analysed using pressure-volume data acquired during routine pre-operative and post-
operative cardiac catheterisation. Tanoue et al. identified that the BCPA was associated with a 
significant improvement in ventricular systolic function those patients that underwent initial 
palliation with a Norwood procedure and systemic-pulmonary arterial shunt (Figure 6.2)[351]. 
The data presented also suggested that there may be an improvement in ventricular efficiency in 
these patients, although this change was not statistically significant.  
The study reported by Tanoue et al. is associated with certain important limitations. Firstly, the 
measurements were made during routine pre-operative cardiac catheterisation before the 
bidirectional Glenn and Fontan procedures, respectively. The mean time period between these 
two procedures was 22.4 months. It is unclear whether the haemodynamic changes reflect the 
effect of the surgical procedure; adaptation to the altered circulatory haemodynamics; age or a 
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combination of all three effects. Secondly, the study used an approximation of end-systolic 
elastance and arterial elastance that has only been validated in an animal model. The more general 
relevance of these techniques, particularly in the assessment of children with severe forms of 
congenital heart disease, has not been proven. Thirdly and finally, Tanoue et al. could not evaluate 
changes in diastolic function, which may be abnormal especially during the early post-operative 
period [478].  
The present study was undertaken to quantitatively determine the effect of the formation of the 
BCPA on changes in volume and pressure loading characteristics and ventricular systolic and 
diastolic function during the immediate post-operative period. In addition, this study aimed to 
investigate whether the relative changes in ventricular function were influenced by the 
morphology of the dominant ventricle.  
6.2 MATERIALS AND METHODS 
Sixteen patients undergoing elective BCPA at the Diana Princess of Wales Children‟s Hospital, 
Birmingham between May 2003 and April 2005 were recruited to this study. All patients had 
functionally single ventricle anatomy with a dominant ventricle of left or right ventricular 
morphology. Children with a single ventricle of indeterminate ventricular morphology were not 
considered for this study. Children with clinically significant (i.e. ≥ moderate) systemic atrio-
ventricular valve regurgitation, as determined by preoperative echocardiography, were also not 
considered for this study. A summary of the children involved in this study is provided in Table 
6.1.  
Written informed consent was obtained from the parents of each child and the study protocol 
was approved by the Local Research Ethics Committee (LREC 2002/0808). 
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Patient Anatomy Ventricular 
morphology 
Gender Initial palliation Age at 
BCPA (m) 
BCPA procedure Concurrent procedures 
1 uAVSD, sub-AS mRV Female Norwood procedure (RMBTS) 5.6 Bilateral BDG CPA patch augmentation 
2 HLHS mRV Male Norwood procedure (RV-PA) 5.1 Bilateral BDG  
3 TA, TGA, restrictive 
VSD, arch hypoplasia 
mLV Male Norwood procedure (RMBTS) 5.7 BDG  
4 PAt- IVS mLV Female RMBTS 18.1 BDG Relief of RVOTO 
5 HLHS mRV Female Norwood procedure (RV-PA) 4.0 BDG  
6 HLHS mRV Female Norwood procedure (RV-PA) 4.0 BDG CPA patch augmentation 
7 HLHS mRV Male Norwood procedure (RV-PA) 4.1 BDG CPA patch augmentation 
8 HLHS mRV Male Norwood procedure (RV-PA) 3.7 BDG CPA patch augmentation 
9 TA, PAt mLV Female RMBTS 7.4 BDG Atrial septectomy 
10 HLHS mRV Female Norwood procedure (RV-PA) 6.5 BDG CPA patch augmentation 
11 HLHS mRV Male Norwood procedure (RV-PA) 4.3 BDG CPA patch augmentation 
12 HLHS mRV Male Norwood procedure (RV-PA) 5.2 BDG CPA patch augmentation 
13 TA, VSD, PS mLV Male N/A 20.2 BDG Atrial septectomy 
14 HLHS mRV Female Norwood procedure (RV-PA) 6.5 BDG CPA patch augmentation 
15 PAt-IVS mLV Male RMBTS 21.0 BDG  
16 DILV, TGA, arch 
hypoplasia 
mLV Male Norwood procedure (RMBTS) 5.2 BDG CPA patch augmentation 
Table 6.1 Summary of patients undergoing BCPA.  
AS, aortic stenosis; BDG, bidirectional Glenn; CPA; central pulmonary arteries; DILV, double inlet left ventricle; HLHS, hypoplastic left heart syndrome; mLV, 
morphologic left ventricle; mRV, morphologic right ventricle; PA, pulmonary atresia; PAt-IVS, pulmonary atresia with intact ventricular septum; PS, pulmonary 
stenosis; RMBTS, right modified Blalock-Taussig shunt; RVOTO, right ventricular outflow tract obstruction; RV-PA, right ventricle to pulmonary artery conduit; 
TA, tricuspid atresia; TGA, transposition of the great arteries; uAVSD, unbalanced atrio-ventricular septal defect; VSD, ventricular septal defect 
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6.2.1 Pre-operative diagnosis 
The study included nine male and seven female children. All of the children had functionally 
single ventricle anatomy with a dominant ventricle of either left (n=6) or right ventricular 
morphology (n=10). The single most common primary cardiac malformation was hypoplastic left 
heart syndrome (HLHS; n=9). Amongst the other children, the primary cardiac malformation 
was tricuspid atresia (n=3); pulmonary atresia with intact ventricular septum (n=2); double-inlet 
left ventricle (n=1); or an unbalanced atrioventricular septal defect (uAVSD) with a dominant 
ventricle of right ventricular morphology (n=1). Two children had bilateral superior vena cavae, 
in which the left-sided SVC opened into the roof of the left atrium. In addition, one child had a 
known chromosomal abnormality with 45, XO / 47, XXX mosaicism.  
6.2.2 Initial surgical palliation 
Fifteen of the sixteen children had previously undergone surgical palliation to establish a balanced 
circulation with the systemic and pulmonary circulations in parallel with one another (Table 6.1). 
Initial surgical palliation consisted of either a Norwood stage I procedure (n=12) or a modified 
Blalock-Taussig (BT) shunt (n=3). Pulmonary blood flow in the Norwood procedure was 
established using either a modified BT shunt (n=3) or a right ventricle-pulmonary artery (RV-PA) 
shunt (n=9), as illustrated in Figure 6.2 [480,481]. Initial surgical palliation was performed at a 
median age of 4 days (range, 2 – 17 days). 
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Figure 6.2 Diagrammatic illustration of the Norwood procedure with a right-sided modified BT shunt (A) or 
RV-PA conduit (B). These procedures represent the usual first-stage palliation for children with HLHS. 
Reproduced from Brawn & Barron [482].  
6.2.3 Assessment prior to bidirectional cavo-pulmonary anastomosis 
Cardiovascular function was routinely assessed using trans-thoracic echocardiography and 
elective cardiac catheterisation prior to the BCPA [480,483]. Ventricular and valvular function 
was qualitatively assessed using echocardiography, as previously described [368]. All the children 
in the present study had good ventricular function. Twelve children had none or trivial atrio-
ventricular valve (AVV) regurgitation while the remaining three children had mild AVV 
regurgitation. None of the children had aortic or neo-aortic valve regurgitation. 
Cardiac catheterisation was electively performed under general anaesthesia at a median age of 4.1 
months (range, 2.8 – 12.1 months). Haemodynamic and angiographic studies were performed in 
all children [480]. The pulmonary-systemic flow ratio (Q
∙
p/Q
∙
s) was retrospectively calculated 
using the modified Fick principle (Equation 6.1). The pulmonary arterial saturation (SpaO2) was 
assumed to be identical to the systemic arterial saturation (SaO2; i.e. complete mixing occurred 
within the ventricle) and the pulmonary venous saturation (SpvO2) was assumed to be 98% [341]. 
Equation 6.1  2222 / SpaOSpvOSsvOSaOsQpQ
 , 
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where SsvO2 is systemic venous saturation, as measured in the superior or inferior vena cava.  
Under general anaesthesia, the median ventricular end-diastolic pressure was 9 mmHg (range, 0 – 
13 mmHg). The median Q
∙
p/Q
∙
s was 1.0 (range, 0.4 – 2.1). Preoperative cardiac catheterisation 
identified nine children (56%) that had clinically important abnormalities of the central 
pulmonary arteries. This included seven patients with discrete central pulmonary arterial stenoses 
and two patients with relatively small branch pulmonary arteries.  
Five patients required cardiological intervention at the time of the cardiac catheterisation. This 
involved an atrial balloon septostomy (n=2), balloon dilatation of neo-aortic arch obstruction 
(n=2) or coil embolisation of a systemic – pulmonary arterial collateral vessel (n=1).  
6.2.4 Formation of bidirectional cavo-pulmonary anastomosis 
The surgical procedures described in this study were all performed by one of two paediatric 
cardiac surgeons (Mr WJ Brawn and Mr DJ Barron).  
6.2.4a Intraoperative anaesthesia 
The anaesthetic technique was tailored according to the pre-procedure evaluation of 
cardiovascular function and the individual preference of the paediatric cardiac anaesthetist. In 
general, patients were pre-medicated with oral midazolam (0.5 mg∙kg-1) approximately 30 minutes 
prior to surgery. Baseline monitoring was instituted following arrival in the anaesthetic room. 
This included peripheral pulse oximetry, non-invasive blood pressure measurement and a 3-lead 
electrocardiogram.   
Anaesthesia was induced using either inhalational or intravenous techniques. In patients with 
stable ventricular function, inhaled sevoflurane (0 - 6%) in an air and oxygen carrier was used. In 
patients with limited haemodynamic reserve, intravenous ketamine  
(1 – 2 mg·kg-1) and fentanyl were given. A bolus of intravenous rocuronium  
(0.75 – 1.0 mg·kg-1) was given to facilitate orotracheal intubation. The tracheal tube was sized to 
minimise gas leak at an inflation pressure of 20 cmH2O. Anaesthesia was maintained with inhaled 
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isoflurane (exhaled concentration 0 – 0.2%), intravenous fentanyl during the pre-
cardiopulmonary bypass phase (up to a total dose of 50 μg·kg-1) and intravenous morphine (20 – 
40 μg·kg-1) during the re-warming and post-bypass phases. Neuromuscular blockade was 
maintained with an infusion of rocuronium  
(0.75 - 1 mg·kg-1·hr-1). 
Following intubation, the patient was mechanically ventilated using a ventilator (Datex Ohmeda 
7900; GE Healthcare Worldwide, Chalfont St Giles, UK) in pressure-control mode to achieve an 
expired tidal volume of 10 ml·kg−1, as measured by the ventilator. This was connected to the 
endotracheal tube via a heat and moisture exchanger. The inspired oxygen concentration (FiO2 = 
0.35 – 0.60) and ventilatory settings were adjusted to maintain acceptable peripheral oxygen 
saturations (SaO2, 75 – 90%) and PaCO2 between 4 - 5.5 kPa (i.e. normocarbia). Positive end 
expiratory pressure was used to a maximum of 5 cmH2O, if required.  
After anaesthesia was established, a 22 – 24G arterial cannula was inserted, ideally in the radial 
artery. A 4.5-French triple-lumen central venous catheter was inserted into the common femoral 
vein. An additional, 20 – 22G single-lumen central venous catheter was also inserted into the 
internal jugular vein. Nasopharyngeal and oesophageal temperature probes were inserted, a skin 
temperature probe was attached and the urinary bladder was catheterised. The ECG, peripheral 
oxygen saturations, arterial and central venous pressures, core and skin temperature, end-tidal 
CO2 and isoflurane concentrations and inspired oxygen tension were monitored continuously. 
Urine output and arterial blood gases were also measured intermittently.  
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6.2.4b Cardiopulmonary bypass management 
Cardiopulmonary bypass (CPB) is a technique that provides partial or complete circulatory and 
respiratory support. During cardiopulmonary bypass, the circulation bypasses the heart and lungs 
allowing the surgeon to operate in a bloodless surgical field. The patient‟s systemic venous return 
is diverted into the venous reservoir of the heart-lung machine via cannulae placed in the superior 
and inferior vena cavae or a single cannula placed in the right atrium. Blood from the venous 
reservoir is then mechanically pumped through a membrane oxygenator into the systemic arterial 
system, usually through a cannula in the ascending aorta (Figure 5.3).  
 
Figure 6.3 Basic cardiopulmonary bypass circuit with membrane oxygenator and centrifugal pump. Reproduced 
from Cohn, pp. 350.[484]. 
The BCPA was performed using deep hypothermic CPB with periods of circulatory arrest. The 
heart-lung machine (Sarns 8000; Terumo Europe NV, Leuven, Belgium) incorporates an 
occlusive roller pump, which was used to generate non-pulsatile blood flow at 2.4 L·min-1·m-2 
[485].  
The CPB circuit was primed with fluid before surgery. A „blood prime‟ was used for all the 
children involved in this study. This consisted of isotonic electrolyte solution to which allogeneic 
red blood cells and fresh frozen plasma were added`[486].  
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Patients were fully heparinised prior to start of CPB. Patients received an initial loading dose of 
300 IU·kg-1 heparin sodium and cardio-pulmonary bypass was started when the activated clotting 
time (ACT) was >300 seconds. The ACT was regularly measured during cardio-pulmonary 
bypass and additional heparin was administered to maintain adequate anticoagulation.   
Cardio-pulmonary bypass was performed by one of two clinical perfusion scientists (Mr RG 
Willetts or Mrs A Horsburgh). Following the start of CPB, the patient was actively cooled to a 
core temperature of 18○C using an alpha-stat (temperature-uncorrected) acid-base management 
strategy. The mean arterial pressure was maintained between 30 – 50 mmHg by adjusting the 
pump flow and the administration of boluses of metaraminol or a phenylephrine infusion as 
required. The PaO2, PaCO2 and acid-base balance were maintained within the normal 
physiological range [Department of Clinical Chemistry, Birmingham Children‟s Hospital]. The 
PaO2 and PaCO2 were controlled by altering the oxygen concentration and flow rate of the 
ventilating gases in the oxygenator, respectively. Metabolic acidosis was corrected with boluses of 
sodium bicarbonate. Boluses of calcium chloride and potassium chloride were also given, as 
clinically indicated. The haematocrit was ideally maintained at greater than 21%. Allogeneic red 
blood cells were added to the perfusion circuit if the haemoglobin concentration fell below 6 g·dl-
1.  
Short periods of reduced flow or circulatory arrest were used in order to facilitate surgical 
exposure. The procedure was generally performed without cross-clamping the aorta. However, 
the aorta was cross-clamped in patients that required concomitant intracardiac procedures. 
During which time myocardial protection was afforded by intermittent cold crystalloid 
cardioplegia (30 ml·kg-1) administered into the aortic root. 
At the end of the procedure, the patient was actively re-warmed to achieve normothermia (37○C, 
measured using the core temperature probes). Modified ultrafiltration is not standard practice at 
Birmingham Children‟s Hospital and was not used in any of the study patients. After successful 
separation from cardio-pulmonary bypass, protamine sulphate was administered in an adequate 
dose to return both the ACT to its baseline value (or less). Remaining blood in the perfusion 
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circuit was processed using a cell saver machine (Dideco Electa; Sorin Group, Milan, Italy) and 
re-transfused during the early post-operative period.  
In this study, the median CPB time was 53 minutes (range, 40 – 73 minutes). All patients except 
one required a period of deep hypothermic circulatory arrest with a median duration of 24 
minutes (range, 3 – 47 minutes). Three patients underwent concomitant intracardiac procedures. 
The aortic cross clamp time for these cases was 6, 23 and 43 minutes, respectively.  
6.2.4c Operative technique 
The BCPA was performed at a median age of 5.3 months (range, 3.7 - 21 months) and a median 
weight of 6.5 kg (range, 4.9 – 13.2 kg). At Birmingham Children‟s Hospital, the BCPA was 
constructed using a bidirectional Glenn procedure. This involved the formation of an end-to-side 
anastomosis between the right-sided SVC and the upper border of the right pulmonary artery 
(Figure 6.4). As a result, systemic venous blood in the SVC can flow freely into both the left and 
the right pulmonary arteries.  
The BCPA was performed via a redo median sternotomy. Following take down of adhesions and 
mobilisation of the great vessels, the child was placed on CPB. The pulmonary blood flow was 
then controlled. In patients with a modified BT or RV-PA shunt, the shunt was ligated between 
two ties and divided. The distal end of the shunt was disconnected from the pulmonary artery. In 
patients with antegrade pulmonary blood flow through the native pulmonary artery, the main 
pulmonary artery was temporarily occluded using a vascular clamp. The azygos vein was then 
ligated.  
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Figure 6.4 Diagram illustrating the bidirectional Glenn procedure. This involves a superior cavo-pulmonary 
anastomosis so that blood in the SVC flows directly into the pulmonary arteries. Deoxygenated blood in the IVC 
continues to flow into the right atrium. Reproduced from Brawn & Barron [482].  
The SVC was divided immediately proximal to SVC-right atrial junction. The distal end of the 
SVC was oversewn. During a period of circulatory arrest, the distal end of the previous shunt was 
excised and the proximal end of the SVC was then anastomosed to a longitudinal incision in the 
superior margin on the right pulmonary artery. In patients with bilateral superior vena cavae 
(n=2), bilateral bidirectional Glenn procedures were constructed. The left-sided SVC was divided 
immediately proximal to SVC-left atrial junction and the distal end of the left SVC was oversewn. 
This proximal end of the left SVC was anastomosed to a longitudinal incision in the upper border 
of the left pulmonary artery. 
Concomitant surgical procedures were performed in 12 patients (Table 5.1). This primarily 
involved pulmonary artery patch augmentation of the central pulmonary arteries (n=9) with a 
pulmonary artery patch. Two patients had a potentially restrictive atrial septal defect and 
underwent atrial septectomy and one other patient required relief of right ventricular outflow 
tract obstruction (Table 6.1).  
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Cardiopulmonary bypass was reinstituted and the heart de-aired once the BCPA was constructed. 
When the patient was warm and haemodynamically stable, CPB was weaned and discontinued.  
In patients with antegrade pulmonary blood flow through the native pulmonary artery, the effect 
of this additional pulmonary blood flow was estimated at the end of the procedure. 
Haemodynamic measurements were made with the main pulmonary artery clamped and 
unclamped. The additional source of pulmonary blood flow might be left in place if it did not 
cause a significant fall in the systemic blood pressure (<10 mmHg fall in systolic arterial blood 
pressure), a high pulmonary artery pressure (CVP ≥15mmHg) or excessive peripheral arterial 
saturations (SaO2 ≥90%). In this study, two patients had antegrade pulmonary blood flow 
through the native pulmonary valve. In both cases, the surgeon chose to allow continued 
antegrade blood flow at the end of the procedure.  
An mediastinal drain was placed beneath the sternum and a GORE-TEX® membrane (W.L. 
Gore & Associates (UK) Ltd., Livingston, Scotland) was attached to the pericardial edges. The 
sternotomy was formally closed in all patients prior to transfer to the intensive care unit. Patients 
were routinely transferred on a dobutamine infusion (5 - 10 g·kg-1·min-1). Additional inotropic 
and vasodilator therapy was administered as clinically indicated.  
6.2.4d Post-operative care 
Following the BCPA, all patients were recommenced on oral diuretic therapy. Patients with 
impaired ventricular function or clinically important systemic AVV regurgitation also received an 
angiotensin converting enzyme inhibitor (Captopril). Patients that underwent either a bilateral 
bidirectional Glenn procedure or pulmonary artery patch augmentation were also discharged 
from hospital on aspirin (5 mg·kg-1·day-1).  
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6.2.5 Experimental protocol 
This study was designed in conjunction with normal clinical practice, as described in the 
preceding section. Following median sternotomy and systemic heparinisation, a nylon tape was 
placed around the IVC. This tape could be used to temporarily reduce ventricular preload as part 
of the study protocol. 
6.2.5a Instrumentation 
Simultaneous intraventricular pressure and volume measurements were made using a custom-
made 3F integrated pressure-conductance catheter (SCD-484; Millar Instruments, Houston, TX, 
USA). The catheter, together with the details of the pressure-conductance measurements have 
been described in Chapter 3. 
A purse-string suture was placed in the right atrium. The conductance catheter was inserted into 
the right atrium through this suture via a 4F sheath (Cordis, Roden, The Netherlands). The 
catheter was then passed across the atrio-ventricular valve into the dominant ventricle. The 
position of the catheter in the ventricle was confirmed by visual inspection of the segmental 
conductance volume signals. Atrial volume signals are easy to distinguish from a ventricular 
signals because they have a low amplitude and are out-of-phase with the ventricular volume 
signals. Measurements were only acquired if 4 or more segmental ventricular volume signals were 
obtained (Figure 6.5). 
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Figure 6.5 Diagram illustrating the position of the pressure-conductance catheter when inserted into the left 
ventricle via the left atrio-ventricular valve. Four intra-ventricular segments are illustrated. Adapted from Steendijk 
et al. [114].  
The pressure signal from the pressure-conductance catheter was amplified using a combined 
amplifier-interface unit (PCU-2000; Millar Instruments) connected to the signal processor unit 
(CFL-512; CD Leycom). Micromanometer pressure measurements were statically zeroed in a 
bath of normal saline at the level of the mid-axillary line.  
Aortic flow was measured continuously with a transit-time ultrasound flow meter (HT 323; 
Transonic Systems Europe B.V.) connected to a perivascular flow probe (A-series flow probes; 
Transonic Systems Europe B.V.) that was positioned around the ascending aorta. Stroke volume 
was calculated from the integrated aortic flow signal.  
The signal outputs from the combined amplifier-interface unit (intraventricular pressure), the 
transit-time ultrasound flow meter (aortic flow) and the lead II surface ECG were each 
connected to the CFL-512 to allow simultaneous recordings.  
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6.2.5b Data acquisition 
The study protocol included three separate sets of measurements. Measurements were made: 
 Prior to the institution of CPB without inotropic support (“Baseline”); 
 Prior to the institution of CPB following the administration of dobutamine  
(10 g·kg-1·min-1) for 10 minutes (“Baseline + dobutamine”); 
 Following completion of the surgical procedure, complete re-warming and weaning from 
cardio-pulmonary bypass support on 10 μg·kg-1·min-1 dobutamine (“BCPA”).  
This protocol allowed the effects of dobutamine on the in-parallel circulation and the formation 
of the BCPA to be separately quantified.  
Intraventricular pressure and volume; aortic pressure and flow; and ECG measurements were 
made under both steady-state conditions and during transient (5 – 10s) inferior vena caval 
occlusion (IVCO). All measurements were made with the chest open at end-expiration.  
Absolute time-varying ventricular volume measurements, V(t) were obtained from the segmental 
conductance signals using Equation 6.2. This equation takes into account the inter-electrode 
distance on the catheter, L and the specific resistivity of blood, ρ [381].  
Equation 6.2 
5
1
21)(
i
Pi GtGLtV , 
where α is the dimensionless calibration coefficient and GP is parallel conductance.  
The specific resistivity of 5ml of blood, ρ was measured immediately before and after CPB using 
a special 4-electrode cuvette connected to the CFL-512 (CD Leycom).  
The changes in the specific resistivity of blood are summarised in Table 5.2. The statistical 
analyses used in such comparisons are described more fully later (Section 6.2.6). Nevertheless, it 
is sufficient to note that the specific resistivity of blood, ρ decreased significantly after CPB. This 
primarily reflects the haemodilution that occurred during CPB, with a fall in the haemoglobin 
concentration and haematocrit (Table 6.2).  
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Variable Baseline BCPA 
Specific blood resistivity, ρ  178 ± 24 128 ± 11 * 
Parallel conductance, GP (ml) 8.8 ± 2.9 7.5 ± 2.5 
Calibration coefficient, α 0.37 ± 0.33 0.47 ± 0.39 
Haemoglobin (g·dl-1) 13.8 ± 1.3 11.6 ± 1.6 * 
Haematocrit (%) 41 ± 4 34± 5 * 
Table 6.2. Conductance catheter calibration factors, haemoglobin and haematocrit at Baseline and following 
BCPA. Data expressed as mean ± SD. 
* P<0.05 versus Baseline as assessed by a paired two-tail Student t-test.   
Conductance volume measurements were retrospectively calibrated for the dimensionless 
calibration coefficient, α and parallel conductance, GP. The dimensionless calibration coefficient, 
α was calculated by dividing the average conductance-derived stroke volume ( SVQ ) by the average 
stroke volume ( AoFSV ) calculated from the integrated aortic flow measurements under steady-
state conditions.  
In patients with antegrade pulmonary blood flow through the native pulmonary valve (n=2) or a 
RV-PA shunt (n=9), the measured aortic blood flow represents blood flow into the systemic 
circulation only. In these cases, the combined ventricular output (i.e. Q
∙
p + Q
∙
s) [487] was 
estimated using Equation 6.3. 
Equation 6.3 QsQsQpQspQsQ  , 
where Q
∙
s is the measured aortic blood flow and Q
∙
p/Q
∙
s is the pulmonary-systemic flow ratio 
measured during the preoperative cardiac catheterisation.  
It was assumed that Q
∙
p/Q
∙
s did not alter substantially in the interval between the cardiac 
catheterisation and surgery and was not changed by the administration of dobutamine. 
Postoperative measurements were all made without any antegrade pulmonary blood flow. In the 
two patients with persistent antegrade pulmonary blood flow, the native pulmonary artery was 
occluded during the period when study measurements were made.   
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Parallel conductance, GP was calculated using the hypertonic saline method originally described 
by Baan et al. [381], which is discussed in detail in Chapter 3. In this study, parallel conductance 
was separately calculated following the injection of 0.25 ml∙kg-1 and 0.5 ml∙kg-1 10% hypertonic 
saline into the SVC. Parallel conductance was measured before CPB and following CPB. These 
measurements were also made during end-expiration. It was assumed that parallel conductance 
was not altered by the administration of dobutamine. 
6.2.5c Technical considerations 
Complete pressure-volume measurements were acquired at all three time-points in 15 patients. 
These patients represent the study group. No data was obtained in the other patient (Patient 
number 5) because the pressure-conductance catheter fractured following insertion into the 
ventricle. The fracture occurred immediately distal to the micromanometer, although the distal 
end was still connected to the remainder of the catheter by one of the wires within the catheter. 
The catheter was removed intact and returned to the manufacturer, who notified the US Food 
and Drug Administration. This malfunction appeared to have occurred because of a 
manufacturing error.  
Application of the caval tourniquet and introduction of the vascular sheath were uncomplicated. 
We had originally intended to introduce the pressure-conductance catheter into the dominant 
ventricle through the aortic valve. However, this could not be accomplished safely. Therefore, 
the conductance catheter was introduced into the dominant ventricle via the right atrium even 
though this may potentially reduce the proportion of the ventricular cavity that was investigated 
[488]. Insertion of the pressure-conductance catheter was safely performed in all patients using 
this approach. Occasionally, placement of the catheter caused ventricular extrasystolic beats, but 
a stable catheter position without arrhythmias could always be obtained.  
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After the second set of measurements (i.e. Baseline + dobutamine), the conductance catheter was 
withdrawn, rinsed with normal saline and left in a bowl of normal saline to be re-used after 
completion of the BCPA. The introducer sheath in the right atrium was removed during surgery 
and the incision temporarily closed with the purse-string suture. Catheter placement and all 
measurements were completed within approximately 30 minutes. 
5.2.5d Data analysis 
Baseline haemodynamic data were calculated from steady-state intraventricular pressure-volume 
measurements. These included: heart rate (HR), end-systolic volume (ESV), end-diastolic volume 
(EDV), end-systolic pressure (PES), end-diastolic pressure (PED), cardiac output (CO), stroke 
volume (SV), stroke work (SW), maximal and minimal rate of ventricular pressure change 
(dP/dtMAX, dP/dtMIN), ejection fraction (EF) and the relaxation time constant (tau). Volume 
measurements have been normalised to the body surface area (BSA) using the method proposed 
by DuBois & DuBois [485]. The volume measurements are expressed as indexed volumes. 
End-systole was defined as the period during ejection where time-varying elastance was maximal 
[45]. This corresponds with the upper left-hand corner of the pressure volume loop (Figure 6.6). 
End-diastole was defined as the peak R-wave of the surface ECG [434]. However, all of the 
ventricular volumes in this study were characterised by an interference pattern that related to the 
intraventricular ECG signal, as discussed in Chapter 5. In the patients included in this study, the 
ECG interference pattern was associated with an end-diastolic volume overestimate of 11 ± 31%.  
For the purposes of this study, end-diastolic volume was approximated as the ventricular volume 
at dP/dtMAX (EDV′). EDV′ always occurred before the onset of ejection (defined as the start of 
antegrade blood in the ascending aorta). In the absence of any AVV regurgitation, EDV′ was 
assumed equivalent to the true EDV.  
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Figure 6.6 Representative example of the intraventricular pressure-volume loop from a Baseline study. Points 
corresponding to end-diastole (red circles), dP/dtMAX (pink circles); the start of ejection (purple circles) and end-
systole (green squares) for each beat are illustrated. 
End-diastolic volume was also calculated as a percentage of the normal left ventricular or right 
ventricular volume (%N-EDV′). Normal values for EDV were derived from the normal right 
ventricular and left ventricular EDV expressed as a function of body surface area in children with 
normal hearts, as reported by Nakazawa et al. [489] (Equations 6.4 and 6.5).  
Equation 6.4 
43.15.72 BSALVEDV , 
where LVEDV = left ventricular end-diastolic volume. 
Equation 6.5 
43.11.75 BSARVEDV , 
where RVEDV = right ventricular end-diastolic volume. 
The ejection fraction was similarly calculated as a percentage of the normal left ventricular 
ejection fraction (%N-EF). Normal values for EF were derived from the normal left ventricular 
EF expressed as a function of body surface area in children with normal hearts, as described by 
Graham et al. [490] (Equation 6.6). 
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Equation 6.6 BSALVEF 08.070.0 , 
where RVEDV = right ventricular end-diastolic volume. 
Indices of ventricular systolic and diastolic function were derived from pressure-indexed volume 
measurements made during temporary occlusion of the IVC. The systolic indices included the 
end-systolic pressure-volume relation (ESPVR, Ees) [45]; the dP/dtMAX-EDV′ relation [108]; and 
preload-recruitable stroke work relation (PRSW) [109]. Each relationship was characterised by the 
slope and volume intercept. Diastolic chamber stiffness was calculated based on the end-diastolic 
pressure-volume relationship (EDPVR).  
Vascular load was estimated using the effective arterial elastance, Ea. The Ea/Ees and SW/PVA 
ratios were calculated as indices of ventricular efficiency [81]. The Ea/Ees ratio reflects the 
ventriculo-vascular coupling efficiency whereas the SW/PVA ratio reflects the mechanical 
efficiency of the ventricle [81]. The SW/PVA ratio was calculated using the method described by 
Nozawa et al. [491], Equation 6.7. 
Equation 6.7 1005.011/ EesEaPVASW . 
6.2.6 Statistical analysis 
Steady-state measurements were repeated two or three times. Extrasystolic and post extrasystolic 
beats were retrospectively identified and excluded from analysis. In each steady-state 
measurement, data from 10 consecutive cardiac cycles were then analysed. The estimated within-
experiment standard deviation for volume measurements (EDV′ and ESV) was 0.9 ml. The 
estimated within-experiment standard deviation for pressure measurements (PED and PES) was 
1.9 mmHg. As these represented <5% of the absolute volume or pressure measurement, all 
subsequent analyses were based on the average data from each measurement. 
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Measurements made during IVCO were also repeated two or three times. Extrasystolic and post 
extrasystolic beats were again retrospectively identified and excluded from analysis. Heart rate did 
not generally change during preload reduction. However, in order to eliminate potential heart rate 
effects, only beats for which heart rate varied by less than 5% of baseline were used for analysis. 
Indices of systolic and diastolic function were calculated using the first 9 heart beats following 
transient IVCO that met the inclusion criteria using least square linear regression [110,112]. For 
each index, the slope of the relationship was identified. In addition, the x-axis (i.e. volume) 
intercept for EES was also calculated [492].  
The haemodynamic parameters, indices of ventricular function and indices of vascular load and 
ventriculo-vascular coupling were obtained at Baseline; Baseline + dobutamine; and following 
BCPA. The effect of dobutamine on the in-parallel circulation was determined by comparing data 
at Baseline with data at Baseline + dobutamine. Similarly, the effect of the formation of BCPA 
was separately established by comparing data at Baseline + dobutamine with data at BCPA. Data 
at Baseline and following BCPA were not compared directly, as this does not address a relevant 
clinical question. 
Data were analysed using SPSS for Windows (v16, SPSS Inc., Chicago, Il, USA). All values were 
expressed as mean ± SD. A probability P<0.05 was considered statistically significant in all 
comparisons.  
The effects of dobutamine and the formation of the BCPA on the steady-state haemodynamic 
data were analysed using the paired two-tail Student t-test. The influence of ventricular 
morphology was then analysed using a two-way analysis of variance (ANOVA) followed by 
Bonferroni correction. The Bonferroni test was used for post hoc analyses.  
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The effects of dobutamine, the formation of the BCPA and ventricular morphology on indices of 
ventricular function calculated during IVCO were separately analysed using a two-way analysis of 
variance (ANOVA) followed by Bonferroni correction. All replicate measurements were included 
in these analyses, which fully accounted for the expected correlation between repeated 
observations. Again, the Bonferroni test was used for post hoc analyses.  
6.3 RESULTS 
Details of the fifteen patients together with the patient who was not subsequently included in the 
study are summarised in Table 5.1 and described in Materials and Methods.  
6.3.1 Clinical outcome 
There were no deaths during the early (30-day) post-operative period. None of the children had 
evidence of impaired ventricular function or clinically significant AVV regurgitation. One child 
sustained right phrenic nerve injury and required a reoperation to plicate the right hemi-
diaphragm. One other child had a prolonged hospital stay (≥21 days) due to the difficulty in re-
establishing enteral feeding. The median length of in-patient hospital stay was 7 days (range, 5 – 
31 days).  
6.3.2 Parallel conductance and dimensionless calibration coefficient 
The changes in parallel conductance, GP and the dimensionless calibration coefficient, α are 
summarised in Table 6.2. Overall, there was no significant change in either parallel conductance, 
GP or the dimensionless calibration coefficient, α. There was similarly no significant change in the 
dimensionless calibration coefficient following the administration of dobutamine (0.37 ± 0.33 
versus 0.34 ± 0.26; P=NS). However, there was a substantial variation between patients. For 
example, pre-CPB parallel conductance measurements varied between 7.2 – 213 ml. This finding 
reaffirms the need to calibrate all conductance volume measurements on an individual basis.  
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6.3.3 Coefficient of variation for indices of ventricular function  
Indices of systolic and diastolic ventricular function showed variability between repeated 
measurements. The coefficient of variation (SD/mean ∙ 100) together with its standard deviation 
was 17 ± 10% for EES, 12 ± 9% for PRSW and 13 ± 9% for dP/dtMAX-EDV′ [461]. The 
coefficient of variation for chamber stiffness was 21 ± 13%.  
6.3.4 Haemodynamic data 
The haemodynamic parameters; indices of ventricular function; and indices of vascular load and 
ventriculo-vascular coupling at the three separate time-points are summarised in Tables 6.3 – 6.5, 
respectively. 
Overall, patients were characterised by only mild dilatation of the single functional ventricle. The 
indexed EDV′ at Baseline was 57 ± 32, which is within the limits found by Graham et al. for 
normal left and right ventricles [490,493]. Nevertheless, in this study there was mild impairment 
of global ventricular function. The normalised ejection fraction (%N-EF) was 71 ± 22%, which is 
outside the range of left ventricular ejection fraction in normal patients found by Graham et al. 
[490].  
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Haemodynamic parameter Baseline Baseline + dobutamine BCPA 
Heart rate (bpm) 129 ± 13 141 ± 22 * 160 ± 12 † 
Cardiac index (L·min-1∙m-2) 3.5 ± 1.7 3.7 ± 2.1 2.1 ± 1.0 † 
Indexed stroke volume (ml∙m-2) 26 ± 12 26 ± 14 13 ± 7 † 
Ejection fraction (%) 52 ± 16 50 ± 14 53 ± 18 
Normalised ejection fraction (%) 77 ± 22 68 ± 19 71 ± 23 
Indexed EDV′ (ml∙m-2) 57 ± 32 54 ± 22 26 ± 10 † 
Normalised EDV′ (%) 120 ± 66 111 ± 39 54 ± 20 † 
PED (mmHg) 4.0 ± 4.4 3.5 ± 4.3 2.2 ± 6.4 
Indexed ESV (ml∙m-2) 34 ± 29 30 ± 19 13 ± 7 † 
PES (mmHg) 53 ± 17 58 ± 14 68 ± 20 
Stroke work (mmHg·ml-1∙m-2) 1555 ± 811 1733 ± 1112 1060 ± 630 † 
dP/dtMAX (mmHg∙s-1) 994 ± 343 1516 ± 740 * 1950 ± 803 
dP/dtMIN (mmHg∙s-1) -938 ± 279 -1066 ± 388 * -1398 ± 522 
Tau (s) 1.44 ∙10-4  ± 0.43 ∙10-4 1.44 ∙10-4  ± 0.60 ∙10-4 1.14 ∙10-4  ± 0.33 ∙10-4 
Table 6.3 Haemodynamic parameters at three intra-operative time-points.  
* P<0.05 versus Baseline; 
 † P<0.05 versus Baseline + dobutamine. 
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 Baseline Baseline + dobutamine BCPA 
Index of ventricular function  Slope Intercept (ml) Slope Intercept (ml) Slope Intercept (ml) 
EES (mmHg∙ml-1∙m-2) 1.8 ± 1.5 -21 ± 97 3.5 ± 1.7 3.7 ± 2.1 6.7 ± 5.6 † -39 ± 84 
dP/dtMAX-EDV′ (mmHg∙s-1∙ml-1∙m-2)  16 ± 11 - 51 ± 43 * - 116 ± 94 † - 
PRSW (mmHg) 14 ± 8 - 21 ± 10 * - 28 ± 14 - 
Chamber stiffness (ml-1∙m-2) 0.06 ± 0.04 - 0.06 ± 0.04 - 0.18 ± 0.12 † - 
Table 6.4 Indices of ventricular function at three intra-operative time-points.  
* P<0.05 versus Baseline 
† P<0.05 versus Baseline + dobutamine. 
 
Parameter Baseline Baseline + dobutamine BCPA 
Ea (mmHg∙ml-1∙m-2) 2.8 ± 1.5 3.2 ± 1.6 7.8 ± 5.0 † 
Ea / EES 2.1 ± 1.3 1.7 ± 1.0 1.6 ± 0.8 
SW / PVA (%) 47 ± 12 54 ± 9 54 ± 10 
Table 6.5 Indices of vascular load and ventriculo-vascular coupling efficiency at three intra-operative time-points.  
* P<0.05 versus Baseline;  
† P<0.05 versus Baseline + dobutamine. 
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6.3.5 Influence of dobutamine infusion 
Figure 6.7 illustrates typical steady-state pressure, dP/dt and volume signals and the 
corresponding pressure-volume loop measured prior to cardiopulmonary bypass with and 
without dobutamine (Baseline and Baseline + dobutamine). 
 
Figure 6.7 Typical steady-state volume (upper panel) and pressure signals (middle panel) together with the 
corresponding pressure-volume loop (lower panel) at Baseline (A) and Baseline + dobutamine (B).   
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Figure 6.8 illustrates the corresponding pressure-volume loop during IVCO together with the 
various systolic and diastolic pressure-volume relations (EES, PRSW, dP/dtMAX-EDV′ and 
EDPVR).  
 
Figure 6.8 Typical example of pressure-volume relations derived during IVC occlusion at Baseline (A) and 
Baseline + dobutamine (B). In this patient, the EES (upper panel) showed an increased in slope (i.e. contractile 
performance) with dobutamine. The dP/dtMAX-EDV′ relation (middle panel) and PRSW relation (lower panel) 
also demonstrated an increased slope with dobutamine. The EDPVR (upper panel) demonstrate no significant 
change in chamber stiffness following dobutamine infusion. 
The selected end-diastolic (red circles) and end-systolic points (green squares) are identified.  
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Dobutamine was associated with an increase in the heart rate (P<0.05) and a corresponding 
increase in the maximal and minimal rate of pressure change (P<0.05, respectively). However, 
there was no change in the end-diastolic or end-systolic pressure.   
Dobutamine was not associated with a change in the indexed end-diastolic or end-systolic 
volumes, indexed stroke volume or ejection fraction. In spite of the change in heart rate, there 
was no change in the cardiac index. There was no difference in the relaxation time constant (tau).  
Dobutamine was associated with a significant increase in ventricular systolic function. The PRSW 
increased from 14 ± 8 mmHg∙m-2 to 21 ± 10 mmHg∙m-2 (P<0.05) and dP/dtMAX-EDV′ increased 
from 16 ± 11 mmHg∙s-1∙ml-1∙m-2 to 51 ± 43 mmHg∙s-1∙ml-1∙m-2 (P<0.05). There was also an overall 
increase in EES (1.8 ± 1.5 mmHg∙ml-1∙m-2 versus 3.5 ± 1.7 mmHg∙ml-1∙m-2), although this change 
was not statistically significant. There was no change in chamber stiffness.  
Dobutamine was not associated with a change in the effective arterial elastance, Ea. Overall, 
there was no change in the ventriculo-vascular coupling ratio (Ea/EES) or mechanical efficiency 
of the ventricle (SW/PVA) with the administration of dobutamine.  
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6.3.6 Effect of formation of bidirectional cavo-pulmonary anastomosis 
Figure 6.9 illustrates typical steady-state pressure, dP/dt and volume signals and the 
corresponding pressure-volume loop measured at Baseline + dobutamine and following the 
formation of the BCPA. 
 
Figure 6.9 Typical steady-state volume (upper panel) and pressure signals (middle panel) together with the 
corresponding pressure-volume loop (lower panel) at Baseline + dobutamine (A) and following BCPA (B).  
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Figure 6.10 illustrates the corresponding pressure-volume loop during IVCO together with the 
various systolic and diastolic pressure-volume relations (EES, EDPVR, PRSW and dP/dtMAX-
EDV′).  
 
Figure 6.10 Typical example of pressure-volume relations derived during IVC occlusion at Baseline + 
dobutamine (A) and following BCPA (B). In this patient, the EES (upper panel) and dP/dtMAX-EDV′ relation 
(middle panel) showed an increased in slope (i.e. contractile performance) following BCPA. There was a reduction 
in the PRSW relation (lower panel). The chamber stiffness, calculated form the EDPVR (upper panel) did not 
change in this patient, in contrast to the overall study group.   
The selected end-diastolic (red circles) and end-systolic points (green squares) are identified.  
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The formation of the BCPA was associated with a further increase in the heart rate (P<0.05). 
There was an overall increase in the maximal and minimal rate of pressure change, although these 
changes were not statistically significant. There was no change in the end-diastolic or end-systolic 
pressure.   
The formation of the BCPA was associated with a reduction in the indexed end-diastolic and 
end-systolic volumes (P<0.05), stroke volume (P<0.05) and stroke work (P<0.05). These 
changes are illustrated on the pressure-volume loop (Figure 6.9). The pressure-volume loop 
following BCPA is narrower and shifted to the left of the plot when compared with the 
corresponding Baseline + dobutamine curve. There formation of the BCPA was also associated 
with a decrease in the cardiac index, which decreased from 3.7 ± 2.1 L∙min-1∙m-2 to 2.1 ± 1.0 
L∙min-1∙m-2 (P<0.05). There was a slight reduction in the relaxation time constant (tau) from 1.44 
∙10-4  ± 0.60 ∙10-4 s to 1.14 ∙10-4  ± 0.33 ∙10-4 s, although this change was not statistically significant.  
The formation of the BCPA was associated with a significant increase in ventricular systolic 
function. The EES increased from 3.5 ± 1.7 mmHg∙ml-1∙m-2 to 6.7 ± 5.6 mmHg∙ml-1∙m-2 (P<0.05) 
and dP/dtMAX-EDV′ increased from 51 ± 43 mmHg∙s-1∙ml-1∙m-2 to 116 ± 94 mmHg∙s-1∙ml-1∙m-2 
(P<0.05). However, there was no significant change in the PRSW (21 ± 10 mmHg∙m-2 versus 28 
± 14 mmHg∙m-2). In addition, there was a three-fold increase in the chamber stiffness, which 
increased from 0.06 ± 0.04 ml-1∙m-2 to 0.18 ± 0.12 ml-1∙m-2 (P<0.05). 
The BCPA was also associated with a significant increase in the effective arterial elastance, Ea, 
which increased from 3.2 ± 1.6 mmHg∙ml-1∙m-2 to 7.8 ± 5.0 mmHg∙ml-1∙m-2 (P<0.05). However, 
there was no change in the ventriculo-vascular coupling ratio (Ea/EES) or mechanical efficiency 
of the ventricle (SW/PVA) following the BCPA.  
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6.3.7 Influence of ventricular morphology 
Figure 6.11 illustrates typical steady-state pressure-volume loops that were obtained in patients 
under equivalent loading conditions. One patient (patient 13) had a dominant ventricle of left 
ventricular morphology (mLV) while the other patient (patient 8) had a dominant ventricle of 
right ventricular morphology. The overall shape of the pressure-volume loops were broadly 
similar. Both groups demonstrated a well-defined end-systolic “shoulder” (i.e. upper left hand 
corner) and both groups had a clearly identifiable isovolumic relaxation phase.  
 
Figure 6.11 Typical ventricular pressure-volume loops in (A) a patient with a morphologic left ventricle and (B) a 
patient with a morphologic right ventricle. Measurements were obtained at Baseline + dobutamine. 
Intraventricular pressure-volume measurements in patients with a mLV and mRV were 
comparable at all three time-points. There was no difference in the steady-state haemodynamic 
parameters; indices of ventricular function; or indices of vascular load and ventriculo-vascular 
coupling between the two groups. In addition, ventricular morphology did not influence the 
relative change in any of the parameters following either dobutamine infusion or the formation 
of the BCPA.  
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6.4 DISCUSSION 
The management of children with functionally single ventricle generally involves three staged 
operations that culminate in the Fontan procedure. This management strategy has evolved to 
ensure adequate interim palliation as well as ensure optimal preparation for the eventual 
formation of the Fontan circulation [292,334]. 
The majority of children with functionally single ventricle anatomy require initial surgical 
palliation as neonates or during early infancy [292]. Initial palliative surgery establishes a balanced 
circulation in which the systemic and pulmonary circulations are in parallel. The systemic and 
pulmonary venous pathways are both connected to the dominant ventricle, which acts as a 
ventricular pump for antegrade blood flow through both the systemic and pulmonary 
circulations. 
The circulation established following initial palliation is primarily characterised by obligate 
volume loading of the dominant ventricle [336,338]. Marc Gewillig estimated that this volume 
load might be almost three-times higher than the volume load in the normal left ventricle [336]. 
Chronic volume loading of the dominant ventricle is associated with progressive dilatation and 
spheroid remodelling of the ventricle [338,339,475,494], such that the indexed end-diastolic 
volume (EDVI) is approximately 150% of normal [339]. The ventricular mass also increases 
incrementally with the increased ventricular volume, thus preserving a normal ventricular mass-
volume ratio [338,339]. However, despite these adaptive changes, ventricular dysfunction and 
failure eventually develop in most children with functionally single ventricle anatomy who have 
been palliated for a long time [340].  
The bidirectional cavo-pulmonary anastomosis (BCPA) represents the second stage in the three-
stage management plan for children with functionally single ventricle anatomy [292]. This 
procedure relieves the chronic volume overload while maintaining adequate systemic arterial 
oxygenation [292,342,472-474,476,477,495]. Early relief of the chronic volume load is expected to 
help preserve the long-term function of the ventricle [271,292,496].  
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The BCPA is a safe procedure with a low in-patient mortality [497]. At Birmingham Children‟s 
Hospital, for example, 380 patients underwent a BCPA between January 2000 and August 2009. 
The in-patient mortality was 1.3% (n=5).  
Previous studies have demonstrated that the BCPA is associated with an immediate and 
persistent reduction in the volume load of the dominant ventricle [342,472-477] together with a 
change in the geometry of the ventricle [342,474,475]. However, only a limited number of studies 
have been undertaken to assess how these changes affect ventricular function or the performance 
of the cardiovascular system as a whole [351,478,479].   
The current study has confirmed that the formation of the BCPA is associated with a substantial 
reduction in the volume load of the dominant ventricle. The indexed end-diastolic and end-
systolic volumes were reduced by 52% and 56%, respectively. This was associated with a 
corresponding reduction in the stroke volume and stroke work. Overall, there was a reduction in 
the cardiac index in spite of a significant increase in the resting heart rate. These finding are 
consistent with the previous studies [342,472,473,475].  
This study has identified a number of novel and clinically important findings. It has demonstrated 
that the formation of the BCPA is associated with an immediate improvement in systolic 
function, with a significant increase in both end-systolic elastance, EES and the dP/dtMAX-EDV 
relation.  
Tanoue et al. have previously demonstrated that the BCPA was associated with an improvement 
in end-systolic elastance [351]. However, that study measured end-systolic elastance during 
cardiac catheterisation prior to either the BCPA or the Fontan procedure. These measurements 
were separated by almost 2 years and it was not clear whether the change reflects the effect of the 
procedure or age. Taken in conjunction with the current study, the study of Tanoue et al. would 
indicate that the immediate improvement in ventricular systolic function is still evident up to the 
time of the Fontan procedure.  
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This study has also demonstrated that the BCPA is associated with a significant decrease in the 
compliance of the ventricle, with a three-fold increase in the ventricular “stiffness”. This is likely 
to be an underestimate of the true clinical effect [498], as all measurements in this study were 
made with the chest and pericardium open. It is unclear what has caused the change in 
ventricular compliance. This may simply reflect the change in ventricular geometry [342,474,475]. 
However, it may also reflect the adverse effects of deep hypothermic cardiopulmonary bypass, 
which is also associated with ventricular diastolic dysfunction [499]. Nevertheless, this finding has 
important implications for the post-operative management of these children. At present, patients 
at Birmingham Children‟s Hospital are not routinely prescribed agents that improve diastolic 
relaxation (lusitropy) unless there is evidence of global ventricular dysfunction or significant AVV 
regurgitation. 
While this study identified abnormal ventricular compliance following the BCPA, abnormal 
ventricular relaxation was not demonstrated. By contrast, the maximum rate of pressure decline 
(dP/dtMIN) and the time constant of pressure decline (tau) both increased following the BCPA, 
although neither of these changes were statistically significant. The findings of the current study 
contrast with the previous study by Selamet Tierney et al., [478] who identified abnormal 
ventricular relaxation, assessed using a number of echocardiographic indices. The reason for this 
difference is not clear but may reflect differences between the techniques used.  
The BCPA is theoretically associated with a significant increase in vascular load as the circulation 
is transformed from an in-parallel circulation to one in which the pulmonary circuit is in-series 
with the systemic circulation of the upper half of the body [470]. In the current study, there was a 
145% increase in the effective arterial elastance following the BCPA. The magnitude of the 
change is greater than one might reasonably expect, and may reflect the additional effects of deep 
hypothermic cardiopulmonary bypass on the vascular system. Nevertheless, the change in 
vascular load was not associated with a change in the performance of the cardiovascular system 
(measured using the Ea/EES ratio and ejection fraction, EF) or the efficiency of the heart (as 
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measured using the SW/PVA ratio). These findings are in agreement with the study by Tanoue et 
al. [351].  
In addition to describing the effects of the BCPA as a whole, this study was designed to 
determine the influence of dominant ventricular morphology on the changes in ventricular 
function. As discussed in Chapter 2, there is a long-standing concern that the mRV may be 
intrinsically less well suited to support either the systemic circulation or the entire circulation. In a 
recent study, Kogon et al. identified that patients with a single ventricle of right ventricular 
morphology (mRV) were associated with an increased risk of morbidity and mortality following 
the BCPA [233]. This may have been associated with the duration of cardiopulmonary bypass, 
which was an independent risk factor for outcome in the same study. Patients with HLHS, for 
example, frequently require extensive pulmonary artery patch reconstruction at the time of the 
BCPA [480,483,500]. However, it is clear from the present study that the BCPA results in 
significant improvements in systolic function.  
This is the first study to evaluate quantitatively the influence of ventricular morphology on 
ventricular function in children with functionally single ventricle anatomy. This study has 
demonstrated that ventricular performance is significantly improved following BCPA, at least 
acutely, and there is no significant difference in the steady-state haemodynamic parameters; 
indices of ventricular function; or indices of vascular load and ventriculo-vascular coupling 
between patients with a mLV or mRV. This represents an important clinical finding that may 
provide some reassurance about the long-term outlook for these children. 
6.4.1 Study Limitations 
The conductance catheter technique is associated with two well-known sources of error that are 
described in detail in Chapter 3. As a result, conductance volume measurements must be 
calibrated in order to obtain absolute volume measurements. The process of calibration is itself 
associated with errors that potentially affect the accuracy of the volume measurements.  
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In this study, parallel conductance was calculated using the hypertonic saline technique devised 
by Baan et al. [381]. One of the limitations of this technique is that the point where the regression 
line intersects with the line of identity (i.e. GP) is distant from the data points used for the 
regression analysis. As a result, small measurement errors can result in big variations in the 
estimated GP and ventricular volume. This issue is particularly important in studies involving 
children, because the absolute ventricular volume is much smaller. However, it is unlikely to have 
changed the conclusions of the present study. Errors in the estimate of parallel conductance, GP 
would not have changed the slope of the relationship for indices of ventricular function. 
Furthermore, this study is based on a within-subject comparison and there was no substantial 
change in parallel conductance, GP between pre-CPB and post-CPB measurements.  
In this study, the dimensionless calibration coefficient, α was estimated by comparing the stroke 
conductance with the stroke volume calculated from the integrated aortic flow measurements. 
Conductance volume measurements are generally calibrated using an alternative measure of 
stroke volume. However, as we have demonstrated in Chapter 4, assuming that the calibration 
coefficient is fixed or constant will introduce measurement errors. Nonetheless, this study is 
based on a within-subject comparison and there was no substantial change in the calibration 
coefficient, α at any of the three time-points.  
6.5 CONCLUSION 
The formation of the BCPA is associated with an immediate reduction in ventricular volume. 
This is associated with an improvement in systolic function but interestingly a decrease in the 
diastolic compliance. The formation is also associated with an increase in vascular load, although 
there is no change in the ventriculo-vascular coupling or mechanical efficiency of the ventricle. 
Importantly, similar changes were observed in patients with either a mLV or a mRV. Long-term 
follow-up studies are necessary to determine whether these changes persist beyond the immediate 
post-operative period.  
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CHAPTER 7. ACUTE CHANGES IN VENTRICULAR PERFORMANCE 
FOLLOWING TOTAL CAVO-PULMONARY CONNECTION 
 
7.1 INTRODUCTION 
The Fontan procedure represents the third and final stage in the management of children with 
functionally single ventricle anatomy [292]. Currently, this generally involves a completion total 
cavo-pulmonary connection (TCPC) procedure, which establishes a direct connection between 
the inferior vena cava (IVC) and the central pulmonary artery. All of the systemic venous return 
passes directly into the pulmonary circulation, completely bypassing the right side of the heart. As 
a result, the Fontan procedure creates a “physiologically normal” circulation in which the 
systemic and pulmonary circulations are separate and in-series, but powered by a single ventricle 
only [501] (Figure 7.1).  
 
Figure 7.1 Schematic diagram of the circulation (A) with BCPA and (B) following the Fontan procedure.  
(CO = Cardiac Output).  
The Fontan procedure is now amongst the most common procedures performed to treat 
complex congenital cardiac defects not amenable to biventricular repair [502]. In appropriately 
selected patients, it is associated with significant functional and clinical improvement and long-
term survival [231,294,348,503-505]. For example, in a recent study from Birmingham Children‟s 
Hospital, Hosein et al. reported that the 15-year survival following the Fontan procedure was 
82%. The majority of these patients were in NYHA functional class I and II (94%) and over half 
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were attending some form of schooling from primary school up to university. More than a 
quarter of the adult patients were working and two women had had successful pregnancies [294]. 
Despite this undoubted success, there are on-going concerns about the long-term outcome for 
children following the Fontan procedure. These concerns primarily relate to the abnormal 
arrangement of the circulation and the ability of the single functional ventricle to support blood 
flow through the systemic and pulmonary circulations in series [293,502]. 
To date, only two clinical studies have been undertaken to assess how the changes in load affect 
ventricular function or the performance of the cardiovascular system in the era of staged surgical 
palliation [343,351]. In 2001, Tanoue et al. reported the changes in ventricular function and 
vascular load in a series of patients following TCPC. Ventricular function and vascular load were 
analyses using pressure-volume data acquired during cardiac catheterisation performed before 
and 6 weeks after surgery. The authors identified that the TCPC was associated with a significant 
improvement in ventricular systolic function and mechanical efficiency [343].  
In a separate study, Tanoue et al. reported longitudinal changes in ventricular function and 
vascular load in patients with hypoplastic left heart syndrome and the effects of surgical palliation 
[351]. That study also demonstrated an early improvement in ventricular systolic function 
following TCPC. In addition, the authors identified that ventricular systolic function and 
mechanical efficiency was even better 1-year following surgery.  
Both of these two studies by Tanoue et al. are associated with important limitations. Firstly, post-
operative cardiac catheterisation was performed approximately 6 weeks after surgery. Their 
results may, therefore, not be representative of the changes that occur during the high-risk, early 
post-operative period. Secondly, their studies used an approximation of end-systolic elastance 
and arterial elastance that has only been validated in an animal model. The validity of these 
assumptions, particularly in the assessment of children with severe forms of congenital heart 
disease, has not been proven. Thirdly and perhaps most importantly, their studies did not 
Chapter 7 
- 175 - 
evaluate changes in diastolic function, which may represent the primary determinant of outcome 
following the Fontan procedure [506].  
The present study was undertaken to determine the effect of the TCPC on changes in volume 
and pressure loading characteristics and ventricular systolic and diastolic function during the 
immediate post-operative. In addition, this study aimed to investigate whether the relative 
changes in ventricular function were influenced by the morphology of the dominant ventricle.  
7.2 MATERIALS AND METHODS 
Twenty-six children undergoing elective TCPC at the Diana Princess of Wales Children‟s 
Hospital, Birmingham between May 2003 and April 2005 were recruited to this study (Table 7.1). 
All patients had functionally single ventricle anatomy with a dominant ventricle of left or right 
ventricular morphology. As in the previous clinical study (Chapter 6), children with either a single 
ventricle of indeterminate ventricular morphology or clinically significant (i.e. ≥ moderate) 
systemic atrio-ventricular valve regurgitation were not considered for this study.  
Written informed consent was obtained from the parents of each child and the study protocol 
was approved by the Local Research Ethics Committee (LREC 2002/0809).
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Patient Anatomy Ventricular 
morphology 
Gender Initial palliation Stage II procedure Age at 
TCPC (y) 
TCPC procedure Fenestration Concurrent 
procedures 
1 HLHS mRV Male Norwood procedure BDG 4.0 Extracardiac conduit 5.0 mm  
2 DILV, TGA mLV Male MPA band, atrial 
septectomy 
BDG, DKS, CPA patch 
augmentation 
4.0 Extracardiac conduit 5.5 mm  
3 PAt- IVS mLV Male RMBTS BDG, atrial septectomy 3.8 Extracardiac conduit 5.0 mm  
4 HLHS mRV Female Norwood procedure BDG 4.9 Extracardiac conduit 5.0 mm  
5 HLHS mRV Male Norwood procedure BDG 6.1 Extracardiac conduit 5.0 mm  
6 TA, VSD mLV Male MPA band BDG, atrial septectomy, 
MPA ligation and CPA patch 
augmentation 
6.5 Extracardiac conduit 5.0 mm  
7 DILV, MA, TGA, 
aortic arch hypoplasia 
mLV Male Norwood procedure BDG 6.1 Extracardiac conduit 5.0 mm  
8 TA, PAt mLV Female RMBTS BDG, atrial septectomy, 
CPA patch augmentation 
4.5 Extracardiac conduit 5.0 mm  
9 DILV, DOLV, PS mLV Female N/A BDG, PA band 9.1 Extracardiac conduit 5.0 mm MPA ligation 
10 HLHS mRV Female Norwood procedure BDG 4.2 Extracardiac conduit 5.0 mm  
11 TA, VSD, sub-PS mLV Male RMBTS Bilateral BDG 6.9 Extracardiac conduit 5.5 mm CPA patch 
augmentation 
12 TS, hypoplastic RV, 
DORV, aortic arch 
hypoplasia 
mLV Female DKS procedure, CoA 
repair, 5mm central 
shunt 
BDG, atrial septectomy 3.9 Extracardiac conduit 5.0 mm  
13 HLHS mRV Male Norwood procedure  BDG 4.2 Extracardiac conduit 5.0 mm  
14 MS, TGA, PAt, 
hypoplastic mLV 
mRV Male Central shunt, atrial 
septectomy 
BDG 4.9 Extracardiac conduit 5.0 mm MPA ligation 
 
Table 7.1 Summary of patients undergoing completion TCPC. 
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Patient 
(cont.) 
Anatomy Ventricular 
morphology 
Gender Initial palliation Stage II procedure Age at 
TCPC (y) 
TCPC procedure Fenestration Concurrent 
procedures 
15 DILV, TGA, VSD mLV Female PA band BDG, DKS 6.3 Extracardiac conduit 5.0 mm  
16 HLHS mRV Male Norwood procedure BDG 6.6 Extracardiac conduit 5.0 mm  
17 uAVSD, TGA mLV Female RMBTS BDG, left SVC ligation 5.0 Extracardiac conduit 5.0 mm  
18 HLHS mRV Male Norwood procedure BDG 4.7 Extracardiac conduit 5.0 mm  
19 HLHS mRV Male Norwood procedure BDG 5.3 Extracardiac conduit 5.0 mm  
20 TA, VSD mLV Female N/A BDG, atrial septectomy 4.2 Extracardiac conduit 5.0 mm Repair of 
diaphragmatic 
hernia 
21 TA, VSD, sub-PS mLV Female RMBTS BDG, atrial septectomy 6.4 Extracardiac conduit 5.0 mm MPA ligation 
22 DILV, TGA, 
restrictive VSD 
mLV Male MPA band BDG, MPA ligation 6.5 Extracardiac conduit 5.0 mm  
23 HLHS mRV Male Norwood procedure BDG 4.6 Extracardiac conduit 5.0 mm  
24 TA, sub-PS mLV Female RMBTS BDG 5.5 Extracardiac conduit N/A  
25 Ebstein‟s anomaly, 
sub-PS, small CPA, 
hypoplastic mRV 
mLV Female Potts shunt, atrial 
septectomy, patch 
closure of tricuspid 
valve 
BDG, atrial septectomy 6.1 Extracardiac conduit 5.0 mm MPA ligation 
26 HLHS mRV Male Norwood procedure BDG 4.9 Extracardiac conduit 5.0 mm  
Table 7.1 Summary of patients undergoing completion TCPC (continued)  
BDG, bidirectional Glenn; CPA; central pulmonary arteries; DILV, double inlet left ventricle; DKS, Damus-Kaye-Stansel procedure; DOLV, double outlet left 
ventricle; HLHS, hypoplastic left heart syndrome; mLV, morphologic left ventricle; MA, mitral atresia; MPA, main pulmonary artery; MS, mitral stenosis; mRV, 
morphologic right ventricle; PAt, pulmonary atresia; PA-IVS, pulmonary atresia with intact ventricular septum; PS, pulmonary stenosis; RMBTS, right modified 
Blalock-Taussig shunt; RVOTO, right ventricular outflow tract obstruction; RV-PA, right ventricle to pulmonary artery conduit; TA, tricuspid atresia; TGA, 
transposition of the great arteries; TS, tricuspid stenosis; uAVSD, unbalanced atrio-ventricular septal defect; VSD, ventricular septal defect
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7.2.1 Pre-operative diagnosis 
All of the children had functionally single ventricle anatomy with a dominant ventricle of either 
left (n=15) or right ventricular morphology (n=11). The single most common primary cardiac 
malformation was hypoplastic left heart syndrome (HLHS; n=10). Amongst the other children, 
the primary cardiac malformation was tricuspid atresia (n=6); double-inlet left ventricle (n=5); 
pulmonary atresia with intact ventricular septum (n=1); an unbalanced atrioventricular septal 
defect (AVSD) with a dominant ventricle of left ventricular morphology (n=1); and Ebstein‟s 
anomaly (n=1).  
Two children had bilateral superior vena cavae, in which the left superior vena cava (SVC) 
opened into the roof of the left atrium. One child was originally diagnosed with abnormal 
pulmonary venous drainage, in which the pulmonary veins drained to the coronary sinus. In 
addition, one child had oculo-auriculo-vertebral spectrum.  
7.2.2 Initial surgical palliation 
The majority of the children (n=24) required initial surgical palliation either as neonates or young 
infants in order to establish a balanced circulation with the systemic and pulmonary circulations 
in parallel with one another (Table 7.1).  
Initial surgical surgery was performed at a median age of 8 days (range, 1 – 90 days). This 
involved a Norwood stage I procedure (n=12); a modified Blalock-Taussig (BT) shunt (n=5); 
formation a central shunt (n=2) between the ascending aorta and either the main pulmonary 
artery or right pulmonary artery; or pulmonary artery banding to limit pulmonary blood flow 
(n=4). Initial surgical palliation in the child with Ebstein‟s anomaly involved patch closure of the 
tricuspid valve, atrial septectomy and a modified BT shunt. This resulted in the creation of 
“functional” tricuspid atresia with pulmonary blood flow supplied via the modified BT shunt.  
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7.2.2 Formation of bidirectional cavo-pulmonary anastomosis 
An interim bidirectional cavo-pulmonary anastomosis (BCPA) similar to that describe din 
Chapter 5 was created in all patients, at a median age of 8.5 months (range, 44 days – 2.7 years). 
Universally, this involved a bidirectional Glenn procedure. One patient with bilateral superior 
vena cavae underwent a bilateral BDG procedure. In the other patient, the left-sided SVC was 
small and there was an innominate vein. In this case, the left-sided SVC was simply ligated.   
7.2.3 Assessment prior to total cavo-pulmonary connection 
The TCPC was indicated in patients with progressive cyanosis or increasing dyspnoea on exertion 
[368]. The median preoperative oxygen saturations in air were 90% (range, 81 – 94%). 
Cardiovascular function was routinely assessed using trans-thoracic echocardiography and 
elective cardiac catheterisation prior to the TCPC [294,368]. Ventricular and valvular function 
was qualitatively assessed using echocardiography [368]. Based on these measurements, the 
majority of children in this study (n=24) had good ventricular function. The remaining two 
children had moderate ventricular function. Fourteen children had no or trivial atrio-ventricular 
valve (AVV) regurgitation while the remaining twelve children had mild AVV regurgitation. 
None of the children had aortic or neo-aortic valve regurgitation. 
Cardiac catheterisation was electively performed under general anaesthesia at a median age of 4.3 
years (range, 2.5 – 8.0 years). Haemodynamic and angiographic studies were performed in all 
children [368]. Cardiac catheterisation demonstrated seven patients who had relatively small 
central pulmonary arteries. One of these children also had an isolated left pulmonary artery 
stenosis. In addition, cardiac catheterisation identified one patient who had evidence of re-
coarctation of the aorta.  
Under general anaesthesia, the median PA pressure was 12 mmHg (range, 7 – 20 mmHg); the 
median atrial pressure was 7 mmHg (range, 1 – 14 mmHg); and the median transpulmonary 
gradient was 4 mmHg (range, 2 – 8 mmHg). Five patients (19%) had elevated PA pressures 
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(≥15mmHg) and 3 patients (12%) had elevated atrial pressures (≥12mmHg). The PVR was not 
routinely calculated.  
Nine patients required cardiological intervention prior to the formation of TCPC. This involved 
coil embolisation of systemic – pulmonary arterial collateral vessels (n=6), left pulmonary artery 
balloon angioplasty and stent insertion (n=4) and balloon dilatation of re-coarctation (n=1).  
7.2.4 The total cavo-pulmonary connection 
The surgical procedures described in this study were all performed by one of two paediatric 
cardiac surgeons (Mr WJ Brawn and Mr DJ Barron).  
7.2.4a Intraoperative anaesthesia 
The anaesthetic technique was tailored according to the pre-procedure evaluation of 
cardiovascular function and the individual preference of the paediatric cardiac anaesthetist. 
However, the intraoperative anaesthesia used during the TCPC was essentially the same as that 
used during the formation of the BCPA (Chapter 6). The differences between the two techniques 
are highlighted in the following section.   
Anaesthesia was induced using either inhalational or intravenous techniques, as previously 
described (Chapter 6). In some older children, anaesthesia was induced using intravenous 
propofol (3 – 5 mg·kg-1). However, total intravenous anaesthesia was not used in any of the 
children [507]. Maintenance anaesthesia invovled the same techniques described in Chapter 6.   
Following intubation, the patient was mechanically ventilated using a ventilator in pressure-
control mode. The ventilator circuit and ventilatory settings were identical to those used during 
the formation of the BCPA (Chapter 6).  
After anaesthesia was established, an arterial cannula was inserted, ideally in the radial artery. A 
4.5-French triple-lumen central venous catheter was inserted into the internal jugular vein. 
Nasopharyngeal and oesophageal temperature probes were inserted, a skin temperature probe 
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was attached and the urinary bladder was catheterised. The ECG, peripheral oxygen saturations, 
arterial and central venous pressures, core and skin temperature, end-tidal CO2 and isoflurane 
concentrations and inspired oxygen tension were monitored continuously. Urine output and 
arterial blood gases were measured intermittently.  
7.2.4b Cardiopulmonary bypass management 
The TCPC was performed using bicaval cardiopulmonary bypass (CPB) with the heart beating 
[294]. The aorta was cross-clamped in those cases in which concomitant intracardiac procedures 
were performed, during which time myocardial protection was afforded by intermittent cold 
crystalloid cardioplegia [294,368]. None of the patients involved in the current study required 
concomitant intracardiac procedures.  
Cardiopulmonary bypass was performed by one of two clinical perfusion scientists (Mr RG 
Willetts or Mrs A Horsburgh). The heart-lung machine and CPB management used during the 
procedure were generally the same as those described in Chapter 6. The only difference related to 
the type of fluid used to fill the CPB circuit before surgery. A „clear prime‟ was used for all the 
children involved in this study. This consists of 500ml isotonic electrolyte solution (Plasmalyte 
148; Baxter Healthcare, Norfolk, United Kingdom) and 100 – 500ml of colloidal plasma volume 
substitute (Gelofusine; Braun Medical Ltd, Sheffield, United Kingdom), supplemented with 3000 
IU heparin sodium, 20 mg·kg-1 methylprednisolone and 0.5 g·kg-1mannitol.  
Patients were fully heparinised prior to start of CPB and adequate anticoagulation was maintained 
throughout the procedure (Chapter 6). After successful separation from CPB at the end of the 
procedure, protamine sulphate was administered to correct the anticoagulation. Remaining blood 
in the perfusion circuit was processed and re-transfused during the early post-operative period as 
described in Chapter 6.  
In this study, the median CPB time was 62 minutes (range, 45 – 101 minutes).  
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7.2.4c Operative technique 
The TCPC was performed at a median age of 4.9 years (range, 3.8 – 9.1 years) and a median 
weight of 18.3 kg (range, 13.3 – 24.6 kg). The procedure was performed via a redo median 
sternotomy. Following take down of adhesions and mobilisation of the great vessels, the child 
was placed on CPB. In patients with antegrade pulmonary blood flow  through the native 
pulmonary artery (n=4), this blood flow was then controlled using a vascular clamp applied to the 
main pulmonary artery. The TCPC involved the interposition of a 20 mm GORE-TEX® tube 
conduit (W. L. Gore & Associates (UK) Ltd.) between the IVC and the right pulmonary artery 
with extension to the central pulmonary artery (Figure 7.2) [294,368]. As a result, systemic venous 
blood in the SVC and IVC can flow freely into both the left and the right pulmonary arteries. A 5 
mm or 5.5 mm fenestration was intentionally created in the Fontan circuit in all except one 
patient (n=25). This involved a side-to-side anastomosis between the extracardiac conduit and 
the lateral wall of the right atrium.  
 
Figure 7.2 Diagram illustrating the completion TCPC. This procedure connects the IVC to the pulmonary 
arteries using a tube conduit. A small fenestration is usually created between the systemic venous pathway and the 
pulmonary venous atrium (illustrated). Reproduced from Brawn & Barron [482].  
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Concomitant surgical procedures were performed in six patients. This involved ligation of the 
main pulmonary artery (n=4), pulmonary artery patch augmentation of the central pulmonary 
arteries (n=1) and repair of an incidental right-sided diaphragmatic hernia (n=1).  
Cardiopulmonary bypass was weaned and discontinued when the patient was warm and 
haemodynamically stable. A right atrial pressure monitoring line was inserted into the right 
atrium. A mediastinal drain and bilateral pleural drains were inserted at the end of the procedure. 
A GORE-TEX® membrane (W.L. Gore & Associates (UK) Ltd.) was attached to the pericardial 
edges. The sternotomy was formally closed in all patients prior to transfer to the intensive care 
unit. Patients were routinely transferred on a dobutamine infusion (5 - 10 g·kg-1·min-1). 
Additional inotropic and vasodilator therapy was administered as clinically indicated.  
7.2.4d Post-operative care 
Following completion TCPC, all patients were recommenced on oral diuretic therapy. Patients 
with impaired ventricular function or clinically important systemic AVV regurgitation usually also 
received an angiotensin converting enzyme inhibitor [294,368]. All of the patients were 
anticoagulated with a lifelong warfarin regimen. The warfarin dose was adjusted to maintain an 
international normalized ratio of 2.0 – 3.0 [368]. 
7.2.5 Experimental protocol 
This study was performed in conjunction with normal clinical practice, as described in the 
preceding section. Following median sternotomy and systemic heparinisation, a nylon tape was 
placed around the IVC. This tape could be used to temporarily reduce ventricular preload as part 
of the study protocol. 
7.2.5a Instrumentation 
Simultaneous intraventricular pressure and volume measurements were made using a 5F 
integrated pressure-conductance catheter (SCD-550; Millar Instruments). The catheter, together 
with the details of the pressure-conductance measurements have been described in Chapter 2. 
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A purse-string suture was placed in the right atrium. The conductance catheter was inserted into 
the right atrium through this suture via a 6F sheath (Cordis). The catheter was then passed across 
the atrio-ventricular valve into the dominant ventricle. The position of the catheter in the 
ventricle was confirmed by visual inspection of the segmental conductance volume signals. 
Measurements were only acquired if 5 or more segmental ventricular volume signals were 
obtained. 
The pressure signal from the pressure-conductance catheter was amplified using a combined 
amplifier-interface unit (PCU-2000; Millar Instruments) connected to the signal processor unit 
(CFL-512, CD Leycom). Micromanometer pressure measurements were statically zeroed in a 
bath of normal saline at the level of the mid-axillary line.  
Aortic flow was measured continuously with a perivascular transit-time ultrasound flow meter 
(HT 323; Transonic Systems Europe B.V.) connected to a flow probe (A-series flow probes; 
Transonic Systems Europe B.V.) that was positioned around the ascending aorta. Stroke volume 
was calculated from the integrated aortic flow signal.  
The signal outputs from the combined amplifier-interface unit (intraventricular pressure), the 
transit-time ultrasound flow meter (aortic flow) and the lead II surface ECG were each 
connected to the CFL-512 to allow simultaneous recordings.  
7.2.5b Data acquisition 
The study protocol included three separate sets of measurements. Measurements were made: 
 Prior to the institution of CPB without inotropic support (“Baseline”); 
 Prior to the institution of CPB following the administration of dobutamine (10  
g·kg-1·min-1) for 10 minutes (“Baseline + dobutamine”); 
 Following completion of the surgical procedure, complete rewarming and weaning from 
cardio-pulmonary bypass support on 10 μg·kg-1·min-1 dobutamine (“TCPC”).  
This protocol allowed the effects of dobutamine in patients with a BCPA and the TCPC to be 
separately quantified.  
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Intraventricular pressure and volume; aortic pressure and flow; and ECG measurements were 
made under both steady-state conditions and during transient (5 – 10s) inferior vena caval 
occlusion (IVCO). All measurements were made with the chest open at end-expiration.  
Absolute time-varying ventricular volume measurements, V(t) were obtained from the segmental 
conductance signals using Equation 7.2. This equation takes into account the inter-electrode 
distance on the catheter, L and the specific resistivity of blood, ρ [381].  
Equation 7.2 
5
1
21)(
i
Pi GtGLtV , 
where α is the dimensionless calibration coefficient and GP is parallel conductance.  
The specific resistivity of 5ml of blood, ρ was measured immediately before and after CPB using 
the 4-electrode cuvette connected to the CFL-512 (CD Leycom).  
The changes in the specific resistivity of blood are summarised in Table 6.2. The statistical 
analyses used in such comparisons are described more fully later (Section 6.2.6). Nevertheless, it 
is sufficient to note that the specific resistivity of blood, ρ decreased significantly after CPB. This 
primarily reflects the haemodilution that occurred during CPB, with a fall in the haemoglobin 
concentration and haematocrit (Table 7.2). 
Variable Baseline TCPC 
Specific blood resistivity, ρ  185 ± 21 119 ± 9* 
Parallel conductance, GP (ml) 127 ± 81 94 ± 87 
Calibration coefficient, α 2.13 ± 1.42 2.10 ± 1.52 
Haemoglobin (g·dl-1) 14.3 ± 1.2 10.3 ± 1.1* 
Haematocrit (%) 42 ± 3 30± 3* 
Table 7.2 Conductance catheter calibration factors, haemoglobin and haematocrit at Baseline and following 
TCPC. Data expressed as mean ± SD. 
* P<0.05 versus Baseline as assessed by a paired two-tail Student t-test. 
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Conductance volume measurements were retrospectively calibrated for the dimensionless 
calibration coefficient, α and parallel conductance, GP. The dimensionless calibration coefficient, 
α was calculated by dividing the average conductance-derived stroke volume ( SVQ ) by the average 
stroke volume ( AoFSV ) calculated from the integrated aortic flow measurements under steady-
state conditions. In patients with antegrade blood flow through the native pulmonary artery, the 
main pulmonary artery was occluded during the period when study measurements were made. 
Parallel conductance, GP was calculated using the hypertonic saline method originally described 
by Baan et al. [381], which is discussed in detail in Chapter 3. In this study, parallel conductance 
was separately calculated following the injection of 0.25 ml∙kg-1 and 0.5 ml∙kg-1 10% hypertonic 
saline into the SVC. Parallel conductance was measured before CPB and following CPB. These 
measurements were also made during end-expiration. It was assumed that parallel conductance 
was not altered by the administration of dobutamine. 
7.2.5c Technical considerations 
Complete pressure-volume measurements were acquired in all patients.  
Adverse events occurred in two patients included in the study. One patient (Patient number 4) 
developed a marked bradycardia associated with profound hypotension following the first 
hypertonic saline injection post-CPB. This lasted for approximately 45 seconds and necessitated 
the administration of a bolus of adrenaline (0.9 μg∙kg-1) with subsequent normalisation of the 
haemodynamics. This event occurred after complete data acquisition and these data have been 
included in the Results.  
One other patient (Patient number 10) developed a significant unexpected ischaemic brain injury 
that resulted in brain death. Treatment was withdrawn and the patient died 2 days following 
surgery. An internal investigation was undertaken to investigate the cause of death, which 
concluded that the study was not implicated in this adverse event. Data from this patient have 
also been included in the Results.  
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As with the previous clinical study (Chapter 6), application of the caval tourniquet and 
introduction of the vascular sheath were uncomplicated. The conductance catheter was 
introduced into the dominant ventricle via the right atrium. Insertion of the pressure-
conductance catheter was safely performed in all patients. Occasionally, placement of the catheter 
caused ventricular extrasystolic beats, but a stable catheter position without arrhythmias could 
always be obtained.  
The management of the conductance catheter during cardiopulmonary bypass was identical to 
that described in Chapter 6. After the second set of measurements (i.e. Baseline + dobutamine), 
the conductance catheter was withdrawn, rinsed with normal saline and left in a bowl of normal 
saline to be re-used after the TCPC. The introducer sheath in the right atrium was removed 
during surgery and the incision temporarily closed with the purse-string suture. Catheter 
placement and all measurements were completed within approximately 30 minutes. 
7.2.5d Data analysis 
Data have been analysed in exactly the same manner as in Chapter 6.  
Baseline haemodynamic data were calculated from steady-state intraventricular pressure-volume 
measurements. These included: heart rate (HR), end-systolic volume (ESV), end-diastolic volume 
(EDV), end-systolic pressure (PES), end-diastolic pressure (PED), cardiac output (CO), stroke 
volume (SV), stroke work (SW), maximal and minimal rate of ventricular pressure change 
(dP/dtMAX, dP/dtMIN), ejection fraction (EF) and the relaxation time constant (tau). Volume 
measurements have been normalised to the body surface area (BSA) using the method proposed 
by DuBois & DuBois [485]. The volume measurements are expressed as indexed volumes. 
End-systole was defined as the period during ejection where time-varying elastance was maximal 
[45]. This corresponds with the upper left-hand corner of the pressure volume loop (Figure 7.3). 
End-diastole was defined as the peak R-wave of the surface ECG [434]. However, all of the 
ventricular volumes in this study were characterised by an interference pattern that related to the 
intraventricular ECG signal (ECGc). This was essentially the same phenomenon observed during 
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the other clinical study (Chapter 6). The ECG interference pattern was associated with an end-
diastolic volume measurement overestimate of 9 ± 23% [see Chapter 5].  
Therefore, for the purposes of this study, end-diastolic volume was approximated as the 
ventricular volume at dP/dtMAX (EDV′). EDV′ always occurred before the onset of ejection 
(defined as the start of antegrade blood in the ascending aorta). In the absence of any AVV 
regurgitation, EDV′ was assumed equivalent to the true EDV.  
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Figure 7.3 Representative example of the intraventricular pressure-volume loop from a Baseline study. Points 
corresponding to end-diastole (red circles), dP/dtMAX (pink circles); the start of ejection (purple circles) and end-
systole (green squares) for each beat are illustrated. 
The end-diastolic volume was also calculated as a percentage of the normal left ventricular or 
right ventricular volume (%N-EDV′) and the ejection fraction was calculated as a percentage of 
the normal left ventricular ejection fraction (%N-EF), as previously described (Chapter 6). 
Indices of ventricular systolic and diastolic function were derived from pressure-indexed volume 
measurements made during temporary occlusion of the IVC. The systolic indices included the 
end-systolic pressure-volume relation (ESPVR, Ees) [45]; the dP/dtMAX-EDV′ relation [108]; and 
preload-recruitable stroke work relation (PRSW) [109]. Each relationship was characterised by the 
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slope and volume intercept. Diastolic chamber stiffness was calculated based on the end-diastolic 
pressure-volume relationship.  
Vascular load was estimated using the effective arterial elastance, Ea. The Ea/Ees and SW/PVA 
ratios were calculated as indices of ventricular efficiency [81]. The Ea/Ees ratio reflects the 
ventriculo-vascular coupling efficiency whereas the SW/PVA ratio reflects the mechanical 
efficiency of the ventricle [81]. The SW/PVA ratio was calculated using the method described by 
Nozawa et al. [491], Equation 7.4. 
Equation 7.4 1005.011/ EesEaPVASW . 
7.2.6 Statistical analysis 
The statistical procedures used in this Chapter as exactly the same as those used in Chapter 5.  
Steady-state measurements were repeated two or three times. Extrasystolic and post extrasystolic 
beats were retrospectively identified and excluded from analysis. In each steady-state 
measurement, data from 10 consecutive cardiac cycles were then analysed. The estimated within-
experiment standard deviation for volume measurements (EDV′ and ESV) was 2.2 ml. The 
estimated within-experiment standard deviation for pressure measurements (PED and PES) was 
1.0 mmHg. As these represented <5% of the absolute volume or pressure measurement, all 
subsequent analyses were based on the average data from each measurement. 
Measurements made during IVCO were also repeated two or three times. Extrasystolic and post 
extrasystolic beats were retrospectively identified and excluded from analysis. Heart rate did not 
generally change during preload reduction. However, in order to eliminate potential heart rate 
effects, only beats for which heart rate varied by less than 5% of baseline were used for analysis. 
Indices of systolic and diastolic function were calculated using the first 9 heart beats following 
transient IVCO that met the inclusion criteria using least square linear regression [110,112]. For 
each index, the slope of the relationship was identified. In addition, the x-axis (i.e. volume) 
intercept for EES was also calculated [492].  
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The haemodynamic parameters, indices of ventricular function and indices of vascular load and 
ventriculo-vascular coupling were obtained at Baseline; Baseline + dobutamine; and following 
TCPC. The effect of dobutamine was determined by comparing data at Baseline with data at 
Baseline + dobutamine. Similarly, the effect of the formation of TCPC was separately established 
by comparing data at Baseline + dobutamine with data at TCPC. Data at Baseline and following 
TCPC were not compared directly, as this does not address a relevant clinical question. 
Data were analysed using SPSS for Windows (v16, SPSS Inc., Chicago, Il, USA). All values were 
expressed as mean ± SD. A probability P<0.05 was considered statistically significant in all 
comparisons.  
The effects of dobutamine and the formation of the superior CP shunt on the steady-state 
haemodynamic data were analysed using the paired two-tail Student‟s t-test. The influence of 
ventricular morphology was then analysed using a two-way analysis of variance (ANOVA) 
followed by Bonferroni correction. The Bonferroni test was used for post hoc analyses.  
The effects of dobutamine, the formation of the superior CP shunt and ventricular morphology 
on indices of ventricular function calculated during IVCO were separately analysed using a two-
way analysis of variance (ANOVA) followed by Bonferroni correction. All replicate 
measurements were included in these analyses, which fully accounted for the expected correlation 
between repeated observations. Again, the Bonferroni test was used for post hoc analyses.  
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7.3 RESULTS 
7.3.1 Clinical outcomes 
In the present study, there was one early death. The patient developed an ischaemic cerebral 
injury that resulted in brain death, This death was unexplained, occurring after an apparently 
uneventful operation and intensive care course [294]. None of the patients required acute 
takedown of the Fontan circulation for Fontan failure. 
One patient required early reoperation for continued early post-operative bleeding from the 
sternotomy. The median duration of pleural drainage was 11 days (range, 5 – 30 days). Six 
patients had prolonged pleural drainage with persistent drainage for 14 days or more. Three of 
these patients had chylothoraces, with chylomicrons in the pleural fluid. The median length of in-
patient hospital stay was 14 days (range, 8 – 32 days). Four patients had a prolonged hospital stay 
(≥21 days). This included the three patients with chylothoraces and one other patient with a 
prolonged non-chylous pleural effusion.  
7.3.2 Parallel conductance and dimensionless calibration coefficient 
The changes in parallel conductance, GP and the dimensionless calibration coefficient, α are 
summarised in Table 6.2. Parallel conductance, GP, decreased from 127 ± 81 ml to 94 ± 87 ml 
after the TCPC. However, this change was not statistically significant (P=0.07). There was no 
significant change in the dimensionless calibration coefficient, α. There was similarly no 
significant change in the dimensionless calibration coefficient following the administration of 
dobutamine (2.13 ± 1.42 versus 2.04 ± 1.28; P=NS). However, there was a substantial variation 
between patients. For example, pre-CPB parallel conductance measurements varied between 5.5 
– 263 ml. This finding reaffirms the need to calibrate all conductance volume measurements on 
an individual basis.  
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7.3.3 Coefficient of variation for indices of ventricular function 
Indices of systolic and diastolic ventricular function showed variability between repeated 
measurements. The coefficient of variation (SD/mean ∙ 100) together with its standard deviation 
was 18 ± 12% for EES, 16 ± 14% for PRSW and 18 ± 11% for dP/dtMAX-EDV′ [461]. The 
coefficient of variation for chamber stiffness was 20 ± 16%.  
7.3.4 Haemodynamic data 
The haemodynamic parameters for the twenty-six patients with complete data and at the three 
time-points are summarised in Table 7.3 – 7.5. 
Overall, patients were characterised by only mild dilatation of the single functional ventricle. The 
indexed EDV′ at Baseline was 57 ± 35, which is within the limits found by Graham et al. for 
normal left and right ventricles [490,493]. Nevertheless, in this study there was mild impairment 
of global ventricular function. The normalised ejection fraction (%N-EF) was 66 ± 24%, which is 
outside the range of left ventricular ejection fraction in normal patients found by Graham et al. 
[490].  
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Haemodynamic parameter Baseline Baseline + dobutamine TCPC 
Heart rate (bpm) 101 ± 14 118 ± 23 * 140 ± 20 † 
Cardiac index (L·min-1∙m-2) 2.5 ± 0.7 3.1 ± 1.0 * 2.5 ± 0.8 † 
Indexed stroke volume (ml∙m-2) 24 ± 8 26 ± 10 18 ± 7 † 
Ejection fraction (%) 50 ± 18 49 ± 19 53 ± 15 
Normalised ejection fraction (%) 66 ± 24 64 ± 26 70 ± 20 
Indexed EDV′ (ml∙m-2) 57 ± 35 61 ± 26 39 ± 25 † 
Normalised EDV′ (%) 87 ± 50 93 ± 38 60 ± 38 † 
PED (mmHg) 5.9 ± 4.3 7.3 ± 5.5 6.7 ± 4.4 
Indexed ESV (ml∙m-2) 33 ± 34 35 ± 25 22 ± 12 † 
PES (mmHg) 66 ± 18 83 ± 25 
*
 77 ± 18 
Stroke work (mmHg·ml-1∙m-2) 1771 ± 731 2350 ± 918 * 1465 ± 557 † 
dP/dtMAX (mmHg∙s-1) 1070 ± 363 2345 ± 1300 
*
 2360 ± 962 
dP/dtMIN (mmHg∙s-1) -1068 ± 317 -1598 ± 621 
*
 -1518 ± 499 
Tau (s) 1.50 ∙10-4  ± 0.38 ∙10-4 1.21 ∙10-4  ± 0.27 ∙10-4 * 1.61 ∙10-4  ± 0.48 ∙10-4 
Table 7.3 Haemodynamic parameters at three intra-operative time-points.  
*
 P<0.05 versus Baseline;  
†
 P<0.05 versus Baseline + dobutamine. 
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 Baseline Baseline + dobutamine TCPC 
Index of ventricular function  Slope Intercept (ml) Slope Intercept (ml) Slope Intercept (ml) 
EES (mmHg∙ml-1∙m-2) 3.1 ± 1.8 -16 ± 75 4.6 ± 2.3 
* 3.7 ± 2.1 6.6 ± 4.2 -0.7 ± 91 
dP/dtMAX-EDV′ (mmHg∙s-1∙ml-1∙m-2)  41 ± 18 - 141 ± 96 
* - 160 ± 96 - 
PRSW (mmHg∙m-2) 56 ± 29 - 80 ± 29 - 85 ± 43 - 
Chamber stiffness (ml-1) 0.06 ± 0.03 - 0.07 ± 0.07 - 0.06 ± 0.05 - 
Table 7.4 Indices of ventricular function at three intra-operative time-points.  
*
 P<0.05 versus Baseline;  
†
 P<0.05 versus Baseline + dobutamine. 
 
Parameter Baseline Baseline + dobutamine TCPC 
Ea (mmHg∙ml-1∙m-2) 3.3 ± 0.7 3.5 ± 1.6 * 5.7 ± 2.6 † 
Ea / EES 1.9 ± 0.7 1.5 ± 0.7 
*
 1.8 ± 0.9 
SW / PVA (%) 56 ± 12 61 ± 14 * 58 ± 16 
Table 7.5 Indices of vascular load and ventriculo-vascular coupling efficiency at three intra-operative time-points.  
*
 P<0.05 versus Baseline;  
†
 P<0.05 versus Baseline + dobutamine. 
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7.3.5 Influence of dobutamine infusion 
Figure 7.4 illustrates typical steady-state pressure, dP/dt and volume signals and the 
corresponding pressure-volume loop measured prior to cardiopulmonary bypass with and 
without dobutamine (Baseline and Baseline + dobutamine). 
 
Figure 7.4 Typical steady-state volume (upper panel) and pressure signals (middle panel) together with the 
corresponding pressure-volume loop (lower panel) at Baseline (A) and Baseline + dobutamine (B).   
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Figure 7.5 illustrates the corresponding pressure-volume loop during IVCO together with various 
systolic and diastolic pressure-volume relations (EES, EDPVR, PRSW and dP/dtMAX-EDV′).  
 
Figure 7.5 Typical example of pressure-volume relations derived during IVC occlusion at Baseline and Baseline 
+ dobutamine. In this patient, there was no significant change in systolic function with dobutamine. The slope of 
the EES (upper panel), dP/dtMAX-EDV (middle panel) and PRSW relations (lower panel) were similar at the 
two time-points. This was in contrast with the group as a whole. There was no change in EDPVR or chamber 
stiffness (upper panel). The selected end-diastolic (red circles) and end-systolic points (green squares) are identified.  
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Dobutamine was associated with an increase in the heart rate (P<0.05). Dobutamine was also 
associated with an increase in the end-systolic pressure and a corresponding increase in the 
maximal and minimal rate of pressure change (P<0.05, respectively). There was no change in the 
end-diastolic pressure.   
There was no change in the indexed end-diastolic or end-systolic volumes, indexed stroke volume 
or ejection fraction following dobutamine infusion. Nevertheless, dobutamine was associated 
with an increase in the indexed stroke work and cardiac index, and also associated with a 
significant shortening of the relaxation time constant (tau).  
Dobutamine was associated with an overall improvement in ventricular systolic function. For 
example, the EES increased from 3.1 ± 1.8 mmHg∙ml-1∙m-2 to 4.6 ± 2.3 mmHg∙ml-1∙m-2 (P<0.05) 
and dP/dtMAX-EDV′ increased from 41 ± 18 mmHg∙s-1∙ml-1∙m-2 to 141 ± 96 mmHg∙s-1∙ml-1∙m-2 
(P<0.05). There was also an overall increase in PRSW (56 ± 29 mmHg∙m-2 versus 80 ± 29 
mmHg∙m-2), although this change was not statistically significant (P<0.06). However, there was no 
change in the diastolic compliance of the ventricle (chamber stiffness).  
There was a significant increase in vascular load (effective arterial elastance) following 
dobutamine infusion. In spite of this increased vascular load, there was a significant reduction in 
the ventriculo-vascular coupling ratio (Ea/EES) and also a significant increase in the SW/PVA 
ratio.   
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7.3.6 Effect of completion total cavo-pulmonary connection 
Figure 7.6 illustrates typical steady-state pressure, dP/dt and volume signals and the 
corresponding pressure-volume loop measured at Baseline + dobutamine and following the 
TCPC. 
 
Figure 7.6 Typical steady-state volume (upper panel) and pressure signals (middle panel) together with the 
corresponding pressure-volume loop (lower panel) at Baseline + dobutamine (A) and following TCPC (B). The 
steady-state pressure-volume loops show a significant reduction in end-diastolic and end-systolic volumes with a 
reduction in the stroke work following TCPC.   
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Figure 7.7 illustrates the corresponding pressure-volume loop during IVCO together with various 
systolic and diastolic pressure-volume relations (EES, EDPVR, PRSW and dP/dtMAX-EDV′).  
 
Figure 7.7 Typical example of pressure-volume relations derived during IVC occlusion at Baseline + dobutamine 
(A) and TCPC (B). In this patient, there was an increase in systolic function following the TCPC, with an 
increase in the slope of the EES (upper panel), dP/dtMAX-EDV′(middle panel) and PRSW relation (lower panel). 
There was no change in the EDPVR following TCPC. The selected end-diastolic (red circles) and end-systolic 
points (green squares) are identified. 
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The TCPC was associated with a further increase in the heart rate (P<0.05). In spite of this 
change, there was no change in maximal and minimal rate of pressure change nor was there a 
change in the end-diastolic or end-systolic pressure.   
The TCPC was associated with a reduction in the indexed end-diastolic and end-systolic volumes 
(P<0.05), stroke volume (P<0.05) and stroke work (P<0.05). These changes are illustrated on the 
pressure-volume loop (Figure 6.6). The pressure-volume loop following TCPC is narrower and 
shifted to the left of the plot when compared with the corresponding Baseline + dobutamine 
curve. There was also a decrease in the cardiac index, which declined from 3.5 ± 1.0 L∙min-1∙m-2 to 
2.5 ± 0.8 L∙min-1∙m-2 (P<0.05).  
The TCPC was not associated with significant changes in ventricular systolic function or chamber 
stiffness.  
The TCPC was also associated with a significant increase in the effective arterial elastance, Ea, 
which increased from 3.5 ± 1.6 mmHg∙ml-1∙m-2 to 5.7 ± 2.6 mmHg∙ml-1∙m-2 (P<0.05). However, 
there was no change in the ventriculo-vascular coupling ratio (Ea/EES) or mechanical efficiency 
of the ventricle (SW/PVA) following completion TCPC.  
7.3.7 Influence of ventricular morphology 
Figure 7.8 illustrates typical steady-state pressure-volume loops that were obtained in two patients 
under equivalent loading conditions. One patient (patient number 21) had a dominant ventricle 
of left ventricular morphology (mLV) while the other patient (patient number 23) had a 
dominant ventricle of right ventricular morphology. The overall shape of the pressure-volume 
loops were broadly similar. Both groups demonstrated a well-defined end-systolic “shoulder” (i.e. 
upper left hand corner) and both groups had a clearly identifiable isovolumic relaxation phase.  
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Figure 7.8 Typical ventricular pressure-volume loops in patients with either (A) a morphologic left ventricle or (B) 
a morphologic right ventricle. Measurements were obtained at Baseline + dobutamine. 
Intraventricular pressure-volume measurements in patients with a mLV and mRV were 
comparable at all three time-points. There was no difference in the steady-state haemodynamic 
parameters; indices of ventricular function; or indices of vascular load and ventriculo-vascular 
coupling between the two groups. In addition, ventricular morphology did not influence the 
relative change in any of the parameters following either dobutamine infusion or the TCPC.  
7.4 DISCUSSION 
The management of children with functionally single ventricle generally involves three staged 
operations that culminate in the Fontan procedure. The Fontan procedure results in the complete 
bypass of the right side of the heart, by connecting the systemic venous return directly to the 
pulmonary arteries. This procedure establishes a circulatory pattern that is as normal as possible 
in patients with functionally single ventricle anatomy [292]. 
The circulation established following the Fontan procedure is not normal. The Fontan circulation 
is characterised by a high afterload [341,343,350,508], which primarily relates to the in-series 
arrangement of the systemic and pulmonary circulations [328]. The lack of pulsatile blood flow 
within the pulmonary circulations also contributes to increase the effective PVR [326,350,509-
512]. The additional resistance imposed by the pulmonary vasculature in-series with the systemic 
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venous return explains the propensity of these patients to develop effusions and protein-losing 
enteropathy [509].  
Completion of the Fontan circulation is also associated with an acute reduction in the volume 
load of the single functional ventricle [343]. The ventricular volume is reduced to approximately 
70% of the normal indexed left ventricular volume [513,514]. Marc Gewillig proposed that this 
chronic reduction in the volume load may result in the development of a “disuse hypofunction”, 
with a progressive decline in ventricular systolic function [336]. In addition, the chronic reduction 
in volume load may also be responsible for the development of diastolic dysfunction, which is 
observed in these patients [346,515]. 
The abnormal pressure and volume loading conditions limit the ability of the Fontan circulation 
to adapt to higher ventricular energy requirements [502]. As a result, the Fontan circulation is 
generally characterised by a decreased cardiac output at rest and during exercise [339,340,516]. 
However, only a limited number of clinical studies have been undertaken to assess how the 
changes in load affect ventricular function or the performance of the cardiovascular system in the 
era of staged surgical palliation [343,351].   
The current study has confirmed that the completion TCPC is associated with an increase in the 
total vascular load, as measured using the effective arterial elastance, Ea [85]. There was a 63% 
increase in the overall effective arterial elastance following the TCPC. The magnitude of this 
change is greater than that observed by Tanoue et al. (20% change) [343]. This may reflect 
differences in the method used to calculate effective arterial elastance or the additional effects of 
cardiopulmonary bypass on the vascular system [517]. 
The TCPC is also associated with a reduction in the volume load of the dominant ventricle. The 
indexed end-diastolic and end-systolic volumes were reduced by 56% and 59%, respectively. This 
was associated with a corresponding reduction in the stroke volume and stroke work. Overall, 
there was a reduction in the cardiac index in spite of a significant increase in the resting heart 
rate. These finding are consistent with the previous studies [339,343,351].  
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In addition, this study has identified a number of clinically important findings. It has 
demonstrated that the TCPC is not associated with any significant change in the systolic or 
diastolic function, in spite of the substantial reduction in volume loading. Indeed, there was a 
small increase in all of the indices of ventricular systolic function, although these changes were 
not statistically significant. Furthermore, this study showed that there is no acute change in the 
performance of the cardiovascular system (measured using the Ea/EES ratio and ejection fraction, 
EF) or the efficiency of the heart (as measured using the SW/PVA ratio). These findings are in 
agreement with the study by Tanoue et al. [351].  
In addition to describing the effects of the completion TCPC as a whole, this study was designed 
to determine the influence of dominant ventricular morphology on the changes in ventricular 
function. As discussed in Chapter 1, there is a long-standing concern that the mRV may be 
intrinsically less well suited to support either the systemic circulation or the entire circulation. In 
two separate studies, Julsrud et al. and Gentles et al. each identified a mRV as an independent risk 
factor for early failure following a modified Fontan procedure [231,232]. However, in a more 
recent study, McGuirk et al. reported that the morphology of the dominant ventricle did not 
influence early mortality, 5-year actuarial survival or functional capacity following the Fontan 
procedure [368].  
The present study has demonstrated that ventricular performance is maintained following the 
TCPC, at least acutely, and there is no significant difference in the steady-state haemodynamic 
parameters; indices of ventricular function; or indices of vascular load and ventriculo-vascular 
coupling between patients with a mLV or mRV. This represents an important clinical finding that 
may provide some reassurance about the long-term outlook for these children. These findings 
support our clinical data that demonstrated that ventricular morphology did not influence the 
early or actuarial survival following the Fontan procedure [368]. 
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7.4.1 Study Limitations 
The conductance catheter technique is associated with two well-known sources of error, which 
are described in detail in Chapter 2 and Chapter 5. Conductance volume measurements must 
therefore be calibrated in order to obtain absolute volume measurements. Calibration is itself 
associated with errors that potentially affect the accuracy of the volume measurements. However, 
as was discussed in Chapter 5, it is felt that the errors associated with calibration do not materially 
alter the conclusions of the present study. 
7.5 CONCLUSION 
The completion TCPC is associated with an immediate reduction in ventricular volume and an 
increase in vascular load. These changes in loading conditions are not associated with any 
significant change in ventricular systolic or diastolic function; ventriculo-vascular coupling or 
mechanical efficiency of the ventricle. This indicates that the procedure does not have any 
adverse effects on cardiac function. The changes in end-systolic elastance indicate that systolic 
function may have improved, although this did not reach statistical significance. Importantly, 
similar changes were observed in patients with either a morphologic left or morphologic right 
ventricle. Long-term follow-up studies are necessary to determine whether these changes persist 
beyond the immediate post-operative period.  
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CHAPTER 8. GENERAL DISCUSSION AND CONCLUSIONS 
 
The studies described in this thesis were designed to investigate ventricular function in children 
with various forms of congenital heart disease that are characterised by functionally single 
ventricle anatomy. The management of these children generally involves three separate 
operations that are performed during the first few years of life [292]. This thesis focussed on the 
acute, intra-operative changes that occurred following the bidirectional cavo-pulmonary 
anastomosis (BCPA; Stage II) and the modified Fontan procedure (Stage III).  
Ventricular function has been assessed, in both the preliminary studies using a model ventricle 
and in the subsequent clinical studies, with invasive pressure and volume measurements made 
using a pressure-conductance catheter. In the clinical studies, this catheter was inserted directly 
into the cavity of the single functional ventricle and measurements were made before and 
immediately after surgical intervention. The pressure-conductance catheter provides 
simultaneous, real-time measurements of pressure and volume. In addition, it allows construction 
of dynamic pressure-volume loops and calculation of the instantaneous pressure-volume relation. 
Analysis of the ventricular pressure-volume relation has evolved as the dominant approach to the 
assessment of global ventricular function [95,384,465]. It provides a number of relatively load-
independent indices of ventricular systolic and diastolic function [95,96,460,518] that enable a 
more sophisticated and precise measurement of global ventricular performance than examination 
of cardiac function based on changes in volume or pressure alone [95]}[96].  
There is a substantial body of evidence to support the value of the conductance catheter in the 
assessment of ventricular function in paediatric patients [66,519,520] and during cardiac surgery 
[521-526]. In particular, it provides the most accurate method of determining myocardial 
contractility in vivo. However, this technique has not previously been used to examine ventricular 
function in children with functionally single ventricle anatomy. This poses a number of problems 
that relate, in particular, to the size, shape and morphology of the ventricle in these patients. 
Parallel conductance may also be different. All of these factors could influence quality and 
accuracy of pressure-volume measurements obtained. Therefore, initial studies were undertaken 
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to assess the accuracy of the conductance volume measurements in a model that more accurately 
reflected the clinical conditions that occur in functional single ventricle anatomy.  
Initial studies described in Chapters 4 and 5 were performed using a physical model of the left 
ventricle that had previously been developed in this laboratory [98]. The experiments described in 
Chapter 4 confirmed that there was a non-linear relationship between conductance and absolute 
volume measurements. As a result, ideally conductance volume measurements should be 
calibrated using an alternative volume measurement. However, this study also demonstrated that 
the dimensionless calibration coefficient, α varied as a function of both the absolute volume and 
the type of calibration coefficient used. Using a fixed or constant calibration coefficient, 
particularly one derived from an alternate stroke volume measurement, would introduce 
measurement errors. These measurement errors were potentially significant during acute changes 
in loading conditions, like those seen during surgical palliation in children with functionally single 
ventricle anatomy.  
In an ideal world, I would have liked to calibrate the conductance volume measurements made in 
this thesis using an independent method of volume measurement. In principle, one might 
envisage simultaneous volume measurements using echocardiography or magnetic resonance 
imaging, for example. However, it would not have been practicable or clinically appropriate to 
perform magnetic resonance imaging during the surgical procedures described in this thesis. 
Two-dimensional echocardiography is often used in the operating theatre, using either a trans-
oesophageal probe or a probe placed on the epicardium [294,368]. However, two-dimensional 
echocardiography is associated with limited accuracy [527,528] and is subject to substantial inter-
observer measurement error [529,530], particularly when used to measure right ventricular 
volume [384]. At Birmingham Children‟s Hospital, two-dimensional echocardiography is not 
used to routinely measure ventricular volume, especially in children with functionally single 
ventricle anatomy.  
For these reasons, conductance volume measurements made in the clinical studies (Chapters 5 
and 6) were calibrated using an alternative measurement of stroke volume. These measurements 
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were calculated from integrated aortic flow measurements made using a transit-time ultrasound 
flowmeter with a perivascular flowprobe around the ascending aorta. The results presented in 
Chapter 4 indicated that the conductance-stroke volume quotient, αSV was associated with 
significant volume measurement error. However, the extent to which this influenced the results 
presented in the clinical studies may have been lessened by within-subject comparison. 
Chapter 5 described a further series of experiments that investigated the effects of additional 
electrical signals on the accuracy of conductance volume measurements. This study identified for 
the first time that the accuracy of conductance volume measurements can be adversely affected 
by the other electrical signals, including a simulated ventricular electrogram. The ventricular 
electrogram produced a clinically important volume measurement error that meant end-diastole 
could neither be precisely identified nor accurately measured, as illustrated in Figure 5.1, 6.6 and 
Figure 7.3. As a result, end-diastolic volume was approximated as the ventricular volume at 
dP/dtMAX, which occurred during the isovolumic contraction phase. Nonetheless, measurement 
error associated with ventricular depolarisation has important implications for the quantitative 
assessment of chamber stiffness made using the conductance catheter technique.  
While this study (Chapter 5) has identified that electrical signals within the ventricular cavity can 
alter the measured conductance, it was first thought that this problem should be easy to resolve. 
In principle, it would appear possible to limit the frequency bandwidth of the recording system to 
filter the intracavitary electrogram. It was suggested that this could be achieved with a 10 Hz 
filter. Unfortunately, this also would have removed potentially important data form the 
conductance volume signal.  
Of course, the physical model provided only a limited simulation of the single functional 
ventricle. The model assumed that parallel conductance was zero. This was important so that a 
true measure of the dimensionless calibration coefficient factor, α was obtained. Further work is 
still required to define how increments in ventricular volume and changes in ventricular shape 
affect parallel conductance; and to define the relationship between parallel conductance and the 
dimensionless calibration coefficient factor, α. Are changes in one the dimensionless calibration 
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coefficient, α always accompanied by changes in the parallel conductance and vice versa, as some 
investigators have suggested [402]? These are questions that remain to be answered but which 
were outside the scope of the present thesis.  
Nevertheless, the initial studies on three different sized model ventricles provided a clear 
indication of the performance characteristics of the pressure-conductance catheter under 
standardised controlled conditions. It was then possible to have greater confidence in the 
interpretation of the data subsequently obtained in the real-life clinical studies and to understand 
better the limitations. 
Thus on the completion of the preliminary studies, two clinical studies were undertaken to 
investigate the separate effects of the BCPA (Chapter 6) and the completion total cavo-
pulmonary connection (TCPC; Chapter 7) on ventricular function. To characterise pump 
function of the single ventricle, pressure-volume loops were constructed. These gave an 
indication of stroke volume, ejection fraction, cardiac output and stroke work. An important 
limitation of these indices is that they are all load-dependent. A series of relatively load-
independent indices of systolic and diastolic function were also derived [112-114], by measuring 
the instantaneous pressure-volume relations over a series of beats during preload reduction (e.g. 
IVCO). 
The first clinical study (Chapter 6) demonstrated that the BCPA was associated with an 
immediate and substantial reduction in ventricular volume. This, in turn, was associated with a 
substantial improvement in systolic function but also a decrease in the diastolic compliance. The 
formation of the BCPA was also accompanied by an increase in vascular load, although this did 
not alter the ventriculo-vascular coupling or mechanical efficiency of the ventricle. The procedure 
resulted in the ventricle become less spheroid and more ellipsoid in shape. Theoretically, this 
should improve pump performance, just as this study observed. These findings provide further 
support to the concept that the BCPA should be performed as early as possible in order to help 
preserve the myocardium and ventricular function [531,532].   
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The second clinical study demonstrated that the completion TCPC (and the formation of the 
Fontan circulation) was associated with an immediate reduction in ventricular volume and an 
increase in vascular load. However, these changes in loading conditions did not adversely affect 
ventricular systolic or diastolic function; ventriculo-vascular coupling or mechanical efficiency of 
the ventricle. Systolic function may even have improved, although this change was not statistically 
significant.  
In both clinical studies, ventricular function was measured immediately following the surgical 
procedure. Ventricular function at this stage is likely to be modified by the effects of anaesthesia 
[533], cardiopulmonary bypass [534,535] as well as the surgical procedure itself. The true benefits 
of the procedure may only become apparent once the heart has fully recovered. The early 
changes in post-operative ventricular function [536] could not be investigated as part of this 
study because it would not be safe or practicable to leave the conductance catheter in situ for that 
time.  
In addition to describing the effects of the two procedures, this thesis also sought to determine 
whether the morphology of the dominant ventricle influenced the change in ventricular function. 
Both studies demonstrated that similar changes were evident in patients with a single functional 
ventricle of left or right ventricular morphology. Further studies will be required to ascertain 
whether this similarity persists, but it is encouraging to note that the midterm survival and 
functional status of these two groups are also comparable [294,368]. 
Finally, it would be extremely valuable to determine how the ventricular function in this group of 
patients‟ changes with time. Unfortunately, the data presented in this thesis does not answer this 
question. There is currently no information to determine how ventricular function (based on the 
pressure-volume relations) changes with time in either normal children or children with 
congenital heart disease. In my opinion, one of the most important areas of future research 
should be the characterisation of normal pressure-volume relations and the changes with age. 
Obviously, it would not be appropriate to use invasive intraventricular pressure-volume 
Chapter 8 
- 210 - 
measurements. However, a less invasive approach, incorporating cardiac MRI and invasive 
arterial pressure measurements may be feasible.  
Pressure-volume analysis using the conductance catheter is a powerful technique for the 
assessment of ventricular performance. The studies in this thesis have confirmed and extended 
our current knowledge. They have shown that the technique has some limitations and hence the 
data have to be interpreted with caution. However, the technique is the best available for the 
assessing changes in the function of the heart. The use of this technique for the first time in 
children with a functionally single ventricle anatomy, as described in this thesis, has enabled direct 
and more precise measurements of the physiological changes that accompany surgical palliation. 
These findings confirm the validity of current clinical practice in the management of children 
with a functionally single ventricle anatomy.  
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APPENDIX A. TRANSFER FUNCTION TO DEFILTER 
MEASUREMENTS MADE USING A TRANSIT-TIME ULTRASOUND 
FLOWMETER 
 
A.1 MATLAB CODE FOR TRANSFER FUNCTION (UNFILTEREDFLOW.M) 
colheaderss=[colheaders {'none'}]; 
[x,v] = listdlg ('PromptString', 'Select AoF signal to defilter:', 'SelectionMode', 'single', 'ListString', 
colheaderss, 'InitialValue', 13); 
if v == 0 
errordlg ('No AoF signal selected' , 'AoF Selection Error'); 
end 
lgnd = colheaderss(x);  
if x ~= length (colheaderss) 
y1 = data; 
y = y1 (: , x); 
for ii=1:length(x) 
dFdt(:,ii) = fiveptder (y (:, ii), 250); 
dF2dt (:,ii) = fiveptder (dFdt (:, ii), 250); 
b = 2*pi*5.2;  
num = [1,sqrt(2)*b,b*b] / b / b; 
AoFnew (:, ii) = dF2dt (:, ii) * num (1) + num (2) *dFdt (:, ii) + num (3) * y (:, ii);  
[B,A] = butter (2,85 / 125); 
AoFnewfilt (:, ii) = filterfilter (B, A, AoFnew (:, ii)); 
 end 
newvarcol = length(colheaders) + 1; 
colheaders{newvarcol}=[lgnd{1} '_defiltered']; 
data(:, newvarcol) = AoFnewfilt; 
t = 1:length(y); 
plot (t/fs, y, '.', t/fs, AoFnewfilt) 
title ('Plot of UnFiltered Data before Butterworth Filter'); 
xlabel('Time (seconds)'); 
ylabel('Units depend on signal'); 
legend('Filtered Data', 'Unfilered Data'); 
end 
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APPENDIX B. STERILISATION PROTOCOL FOR MILLAR  
DUAL PRESSURE-CONDUCTANCE CATHETER  
 
B.1 INTRODUCTION 
Each Millar dual pressure-conductance catheters is licensed for re-use up to 5 times. After each 
application, the catheter was thoroughly cleaned and sterilised using ethylene oxide gas according 
to the manufacturer‟s guidelines. Ethylene oxide sterilisation was performed at the Hospital 
Sterile Supply Unit (HSSU); Sandwell & West Birmingham NHS Trust. The manufacturer‟s 
guidelines are reproduced in the following sub-sections. 
B.1.1 Initial cleaning protocol 
1. Immediately following removal from the patient, immerse the catheter in cold water; 
2. Wipe the catheter with wet swab to remove all blood products; 
3. Soak in detergent solution for 20 minutes, e.g. Alconox® (10 g∙l-1); 
4. Wipe the catheter again and rinse in fresh, pyrogen-free water three times; 
5. Carefully dry the catheter; 
6. Re-pack catheter in tray supplied by manufacturer and send to sterilisation unit. 
A plastic ring was attached to the catheter following each use. Catheters were withdrawn from 
clinical use when they had been re-used five times.  
B.1.2 Ethylene oxide sterilisation cycle parameters used at HSSU 
 Concentration: 1100 mg∙l-1  
 Pressure: 15 – 20 Atm 
 Time: 1 hour 40 minutes 
 Temperature: 55º C 
 Humidity: 50% 
The catheter was stored for two weeks after sterilisation, in order to allow the complete 
evaporation of any residual Ethylene Oxide.
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APPENDIX C. STERILISATION PROTOCOL FOR TRANSONIC  
A-SERIES FLOW PROBES  
 
C.1 INTRODUCTION 
Transonic A-series flow probe can be re-used after appropriate cleaning and ethylene oxide gas 
sterilisation. Ethylene oxide sterilisation was performed at the Hospital Sterile Supply Unit 
(HSSU); Sandwell & West Birmingham NHS Trust. The manufacturer‟s guidelines are 
reproduced in the following sub-sections. 
C.1.1 Initial cleaning protocol 
7. Following removal from the patient, remove all excess soil from the instrument; 
8. Clean the probe for 3-5 minutes with a soft brush and either detergent or alcohol; 
9. Rinse in clean water; 
10. Carefully dry the instrument; 
11. Send for ethylene oxide sterilisation. 
C.1.2 Ethylene oxide sterilisation cycle parameters used at HSSU 
 Concentration: 1100 mg∙l-1  
 Pressure: 15 – 20 Atm 
 Time: 1 hour 40 minutes 
 Temperature: 55º C 
 Humidity: 50% 
The catheter was stored for two weeks after sterilisation, in order to allow the complete 
evaporation of any residual Ethylene Oxide.
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